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The vast majority of all cancers result from some form of genetic 
instability, thus it is important to study the mechanisms involved. The integrity of 
DNA can be influenced by secondary structure, and DNA can adopt alternative 
structures that do not conform to the Watson-Crick B-DNA helix (i.e. non-B DNA). 
To date, >12 different types of non-B DNA structures have been described 
including H-DNA and Z-DNA, and these structure-forming sequences are 
abundant in the human genome, occurring 1/3,000 and 1/50,000 base-pairs for 
Z-DNA and H-DNA, respectively.  
Non-B DNA can alter DNA metabolism and contribute to the development 
of many human diseases. Specific to this project, translocations occurring in the 
c-MYC and BCL-2 genes, which are shown to contain non-B DNA-forming 
sequences at translocation breakpoint “hotspots”, are characteristic of certain 
 ix 
leukemias and lymphomas. However, the mechanism(s) involved in this process 
remains undefined. Previously, we found these structures to be mutagenic in 
bacteria, human cells, and mice, largely by stimulating the formation of DNA 
double strand breaks (DSBs). We speculated that the helical distortions 
produced by non-B DNA may be recognized as “damage” by the cell, eliciting an 
error-prone repair response, resulting in genomic instability.  
Using genetic-based mutation-reporter assays, we have shown for the first 
time that these structures are mutagenic in yeast. Furthermore, we have 
identified DNA repair proteins from both the nucleotide excision repair (NER) and 
mismatch repair (MMR) pathways to be involved in H-DNA and Z-DNA-induced 
mutagenesis via distinct mechanisms in both yeast and human cells. We further 
characterized the functions of these proteins using biochemical and molecular 
biology assays and found that they are enriched at sites of H-DNA and/or Z-DNA, 
and have cleavage activity at or near the structure. 
Taken together, these results suggest that non-B structures are processed 
in an error-prone fashion via various novel structure-specific repair pathways in 
which repair proteins from multiple pathways cooperate. The results obtained 
have enhanced our knowledge of DNA structure-induced genetic instability in 
disease etiology, and will guide future studies in the development of novel 
strategies to treat and/or prevent genetic diseases. 
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Chapter 1: Introduction and Background 
  
 2 
1.1. DNA Structure 
 
The structure of DNA was first described in 1953 by James Watson and 
Francis Crick (1) along with Rosalind Franklin, Raymond Gosling, and Maurice 
Wilkins (2-5). This pioneering work, for which a Nobel Prize was awarded in 
1962, laid the groundwork that inspired decades of research devoted to studying 
DNA, the biological macromolecule that holds all information required for life, and 
is still an active topic of research. Significant advances have been made in our 
understanding the importance of DNA as a result of the last 50 years of research 
dedicated to the structure and function of this essential molecule, and it is clear 
that the structure of DNA is equally important as the genetic information 
embedded in the sequence. 
 
1.1.1. Watson-Crick B-DNA 
 
 The well-known double-helical structure described in 1953 [and again in 
1954 in greater detail (6)], termed “B-DNA” consists of two antiparallel strands of 
DNA (Figure 1.1a). Each strand is made up of four repeating nucleic acids 
(bases) connected by a negatively charged sugar-phosphate backbone. The 
individual units consist of a purine base [adenine (A) and guanine (G)] or 
pyrimidine base [thymine (T) and cytosine (C)], and one strand of DNA is 
hydrogen bonded to the other by specific base pairing (i.e., A pairs with T, and C 
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pairs with G) (Figure 1.1b) (7). This repeating sequence of 3 billion base-pairs in 
each human cell makes up our “genetic code”, and contains all the information 
necessary for a cell to survive, and thus the sequence is extremely important. 
However, the sequence leads to a structure of DNA that allows for the integrity 
and function of the molecule, establishing the importance of the structure to allow 
proper function of DNA.  
The specific structure, including the structure of base-pairs, allows for very 
important functions of the DNA molecule. First, the four bases have structures 
that allow for specific binding to each other: A to T and C to G through hydrogen 
bonding, as well as binding to the sugar-phosphate backbone of the DNA strands 
(Fig. 1.1b) (7). Second, the specific sequences as well as the helical shape allow 
proteins to bind and interact with DNA by recognizing the sequences/structures 
via exocyclic groups in the major and minor grooves in the helix (Fig. 1.1c) (8). 
Third, in order to store the nearly 2 meters of DNA into the nucleus of the each 
cell, the DNA helical structure and negatively charged phosphate backbone 
allows the molecule to wrap around positively charged proteins to form 
nucleosomes, which compacts the DNA into organized chromosomes (Fig. 1.1d) 
(9). Lastly, the double-stranded helix with the negatively charged backbone 
allows for the bases to remain in the center of the helix, and exclude molecules 
such as water, which maintains the bonding between base-pairs and the integrity 
of the DNA molecule (Fig. 1.1e) (8). This also protects the bases from various 
sources of damage that could cause mutations and genomic instability. These 
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structural features allow DNA to carry out functions such as gene expression 
through transcription, efficient replication of the DNA to ensure proper passage of 
genetic information during cell division, and repair of the DNA if the cell senses 





Figure 1.1. Structure of B-DNA. Several aspects of the structure of DNA allow 
for the function of this important biomolecule. (a) The Watson-Crick B-DNA 
double helix consists of two antiparallel strands [adapted from (1). (b) Specific 
base-pairing between nucleic acids within the DNA strands (A to T and C to G) 
occur via hydrogen bonding and allow for the maintenance of the genetic code. 
The base-pairs are anchored by a negatively charged sugar-phosphate 
backbone [adapted from (7)]. (c) The helical turns in the double helix result in the 
formation of distinctive major and minor grooves that serve as recognition sites 
for many proteins [adapted from (8)]. (d) The negatively charged backbone 
allows for wrapping of the DNA around positively charged histone proteins to 
form nucleosomes. This creates supercoiling and allows for the DNA to become 
compacted and stored as chromosomes within the nucleus of each cell [adapted 
from (9)]. (e) The structure of the DNA double helix allows for the important 
sequence of bases to remain in the center of the helix while the backbone acts to 
protect the center and exclude damaging molecules, as seen from an aerial view 
of the helix [adapted from (8)].  
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or kinks, in its helical structure as it winds around the
histones.
The fifth type of histone, H1, is not a part f the core
particle but plays an important role in the nucleosome
structure. The precise location of H1 with respect to the
core particle is still uncertain. The traditional view is that
H1 sits outside the octamer and binds to the DNA where
the DNA joins and leaves the octamer (see Figure 11.5).
However, the results of recent experiments suggest that the
H1 histone sits inside the coils of the nucleosome.
Regardless of its position, H1 helps to lock the DNA into
place, acting as a clamp around the nucleosome octamer.
Together, the core particle and its associated H1 his-
tone are called the chromatosome, the next level of chro-
matin organization. The H1 protein is attached to be-
tween 20 and 22 bp of DNA, and the nucleosome
encompasses an additional 145 to 147 bp of DNA; so
about 167 bp of DNA are held within the chromatosome.
Chromatosomes are located at regular intervals along the
DNA molecule and are separated from one another by
linker DNA, which varies in size among cell types —most
cells have from about 30 bp to 40 bp of linker DNA.
Nonhistone chromosomal proteins may be associated
with this linker DNA, and a few also appear to bind di-
rectly to the core particle.
Higher-order chromatin structure In chromosomes,
adjace t nucleosomes are not separated by space equal to
the length of the linker DNA; rather, nucleosomes fold on
themselves to form a dense, tightly packed structure (see
Figure 11.5). This structure is revealed when nuclei are
gently broken open and their contents are examined with
the use of an electron microscope; much of the chromatin
that spills out appears as a fiber with a diameter of about
30 nm ( FIGURE 11.7a). A model of how this 30-nm fiber
forms is shown in FIGURE 11.7b.
The next-higher level of chromatin structure is a se-
ries of loops of 30-nm fibers, each anchored at its base by
proteins in the nuclear scaffold (see Figure 11.5). On aver-
age, each loop encompasses some 20,000 to 100,000 bp of
◗
◗












1 At the simplest level
is a double-stranded
helical structure of DNA . 
2 DNA is complexed
w ith histones to
form nucleosomes.
3 Each nucleosome consists of
eight histone proteins around




5 The nucleosomes fold up to
produce a 30-nm fiber…
6 …that forms loops averaging
300 nm in length.
7 The 300-nm fibers are
compressed and folded to
produce a 250-nm-w ide fiber. 8 Tight coiling of the 250-nm
fiber produces the chromatid
of a chromosome.
11.5 Chromatin has a highly complex structure with several
levels of organization.
◗
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1.2. Non-B DNA Structures 
 
In cells, the right-handed double helical structure described above, known 
as B-DNA is the most common conformation of genomic DNA. However, DNA 
itself is a dynamic molecule that can adopt many alternative conformations. 
Since the late 1950s, over 12 alternative DNA structures have been discovered 
that do not conform to the canonical B-DNA structure (10-12). Examples include 
hairpins/cruciform (13-15), G-quadruplexes (16,17), Z-DNA (8,18), and H-DNA 
(19-21) (Fig. 1.2). Collectively, these alternative structures are called “non B-
DNA”. During various metabolic processes (i.e., replication, transcription, and 
repair), the DNA duplex is opened, resulting in negative supercoiling stress and 
a high-energy state, which can stimulate the formation of an alternative helical 
structure at structure-specific repetitive sequences. Nearly half of the human 
genome is comprised of repetitive sequences, while simple repeat sequences 
[i.e., those capable of forming several types of non-B DNA structures (22)], 
account for ~3% of the human genome (23). Thus, non-B-DNA-forming 
sequences are very abundant in the human genome and warrant the extensive 
studies that have been performed to determine the physiological role(s) of such 
sequences/structures. A brief background of cruciform, hairpin, and G-
quadruplex structures is included in this chapter; however, the main focus of the 
studies presented in this document concern H-DNA and Z-DNA, which will be 






Figure 1.2. Non-B DNA Structures. Watson-Crick B-DNA (left panel) compared 
to several non-B DNA structures (right panel). Depicted here are cruciform, Z-
DNA, H-DNA, G4 DNA (G-quadruplex), and hairpin structures [adapted from 
(24)].  









Z-DNA is a left-handed, double helix that forms at sequences of 
alternating purine-pyrimidine repeats (e.g., TG or GC) (Fig. 1.2), and the crystal 
structure of the left-handed conformation was determined in 1979 (8). While the 
pyrimidines maintain an anti conformation, the purines within the repeat adopt a 
syn conformation in which the base is positioned over the sugar to maintain 
Watson-Crick base-pairing. The rotation of the purine base that results gives the 
helix a zigzag appearance, for which the structure was named. The crystal 
structure also revealed the extrusion of a base-pair present at the B-Z junction, 
resulting in small, single-stranded regions. Energy from negative supercoiling as 
a result of an open duplex during DNA processing is required for Z-DNA 
formation (8,25). The formation of Z-DNA causes several distortions in the helix 
that differ significantly from the canonical B-DNA conformation. For example, 
there are more base-pairs per helical turn in Z-DNA (12 bp versus 10.5 bp in B-
DNA), a larger distance between bases on the same strand, a smaller diameter 
than B-DNA, and the distinction between the major and minor grooves in Z-DNA 









Figure 1.3. Crystal structure of Z-DNA. The resolution of the crystallized 
structure of Z-DNA revealed significant helical variations from B-DNA. (a) An 
areal view of the two helices demonstrates a smaller diameter in Z-DNA, and the 
bases are no longer in the protected center of the helix. (b) A side-view 
demonstrates the loss of distinct major and minor grooves in Z-DNA [a and b 
adapted from (8)]. (c) An updated crystal structure confirmed the original and 
revealed extruded bases (i.e., adenine and thymine) at the B-Z junctions, 








H-DNA (Fig. 1.2) is an intramolecular triplex that forms at mirror-repeats of 
polypurine-polypyrimidine sequences, occurring when a single-stranded region of 
DNA (resulting from an open duplex during DNA processing) folds back onto a 
nearby B-DNA double helix forming a triplex structure. The triplex structure 
earned the name H-DNA due to the protonation of the cytosine in the third strand 
that must occur to interact with the duplex. The third strand binds in the major 
groove of the double helix and is stabilized via Hoogsteen hydrogen bonds (Fig. 
1.4) (28,29). Hoogsteen hydrogen bonds have a similar energy to Watson-Crick 
hydrogen bonds, and can be just as stable (30). H-DNA can exist in different 
orientations, and can be classified depending on such orientation, including the 
composition of the third strand. For example, if the third strand is pyrimidine-rich, 
it will bind to the duplex in a parallel orientation via Hoogsteen hydrogen bonds 
(Fig. 1.4b); however, a purine-rich third strand will bind in an anti-parallel fashion 
to the duplex via reverse-Hoogsteen hydrogen bonds, the latter of which can 










Figure 1.4. Detailed H-DNA Structure. (a) H-DNA (intramolecular triplexes) can 
form at homopurine:homopyrimidine sequences with mirror symmetry (purine-
rich strand in green; pyrimidine-rich strand in blue). (b) One motif that H-DNA can 
adopt is when the 3’ end of the purine-rich strand binds to the duplex of the other 
half of the mirror repeat and is stabilized via reverse-Hoogsteen hydrogen bonds 
in an anti-parallel orientation [a and b adapted from (32)]. (c) Schematic 
representation of base triplets present in H-DNA motifs (Watson-Crick base-
pairing represented by black dotted lines; Hoogsteen hydrogen bonds 





1.2.3. Cruciform, Hairpins, and G-Quadruplexes 
 
Sequences that contain a palindromic region (inverted repeat that reads 
the same in both directions) are capable of forming hairpin and cruciform 
structures (i.e., 5’-GACTGC….GCAGTC-3’) (Fig. 1.2), resulting from the negative 
supercoiling that is generated when the DNA duplex is opened (33-35). When the 
duplex is opened, half of the single-stranded symmetry base pairs with itself to 
form an intra-strand hairpin stem, leaving the center sequence between the 
inverted repeat as a single-stranded loop. Cruciform structures consist of two 
hairpins forming a four-way junction, similar to a Holliday junction during 
recombination (36), thus the two structures can form at similar sequences. 
Inverted repeat sequences as short as 14 bp (7 bp/repeat) were shown to be 
sufficient to form hairpin structures (37), while longer inverted repeats are 
capable of forming larger, more complex cruciform/hairpin structures (38). 
G-quadruplexes (G4 DNA) form at stretches of guanine-rich sequences in 
which 4 guanines interact via Hoogsteen hydrogen bonds, resulting in a planar 
structure (Fig. 1.2). At physiological temperature and pH, G4-DNA is stabilized by 
monovalent cations, K+ or Na+, and may be formed by the interaction of one, two, 
or four G-rich strands, forming various conformations, depending on the 
sequence, polarity and location of the strands, and microenvironment 
surrounding the sequence (39). 
 
 13 
1.3. Biological Relevance of Non-B DNA Structures 
 
As stated above, nearly 50% of the total human genome is made up of 
repetitive sequences (3% include simple repeats), and those sequences with the 
capacity to form non-B DNA structures were found to occur in the genomes of 
various organisms, though more often in eukaryotic versus prokaryotic genomes 
(40). The conservation of non-B DNA-forming sequences across multiple species 
suggests a biological importance of such sequences, which has been extensively 




While the first description of the left-handed Z-DNA structure was in the 
late 1970’s (8), decades of research has dedicated to defining the physiological 
role of this alternative structure. Z-DNA can form at alternating purine-pyrimidine 
repeats, and although prokaryotic genomes are more CG-rich than human 
genomes, Z-DNA-forming repeats are very abundant in the human genome, 
occurring ~1/3000 bp, as determined by a computer-based search of the human 
genome (41). In fact, GT repeats are the most common simple repeat in the 
human genome, accounting for ~0.25% of the entire genome (23).  
The distribution of Z-DNA-forming regions was not found to be random, 
but rather concentrated near transcription start sites (TSS), particularly in 
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eukaryotes (41,42). Additionally, Z-DNA-specific antibodies were shown to bind 
primarily in actively transcribed regions, suggesting Z-DNA formation can be 
induced by transcription (43-47). In line with the requirement of energy from 
negative supercoiling (that occurs during transcription) for the formation of Z-
DNA, and the placement of Z-DNA-forming structures at TSS, Z-DNA has been 
widely implicated to play a role in gene expression through regulation of 
transcriptional activity (48-50). Interestingly, Z-DNA has been shown to either 
promote or suppress transcriptional activity via various mechanisms including 
stabilizing open chromatin structure, and blocking RNA polymerases (51-60).  
The discovery of proteins that contain a structure-specific Z-DNA binding 
motif (61) across multiple species solidified the theory that Z-DNA is biologically 
relevant. A number of Z-DNA-binding proteins (ZBPs) have been identified in 
virus (62-65), bacteria (66,67), yeast (68), Drosophila (69,70), zebrafish (71), 
mammalian (72-74), and human cells (67,74-76). While the functions of ZBPs are 
still not fully elucidated, studies have suggested a role in gene expression, 
recombination, RNA editing, and viral pathogenicity [reviewed in (77,78)]. Human 




The first polynucleotide triple-helix was described in 1957 (79), and 
significant advances in the field of H-DNA-associated research has enhanced our 
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knowledge of the physiological function of this alternative structure. Computer-
generated analyses across genomes from multiple sequences revealed H-DNA-
forming sequences to be unexpectedly more abundant in eukaryotes than 
prokaryotes, occurring ~1/50,000 bp in human cells (80,81). A search for long 
polypurine-polypyrimidine tracts (>100 bp) in humans found concentrated areas 
in introns, promoter regions, and untranslated regions of genes associated with 
cell membrane, phosphorylation, signal transduction, and development and 
morphogenesis (82). The frequency that which H-DNA-sequences are found in 
promoter regions is higher than that of random distribution, suggesting H-DNA 
may play a role in gene expression (83). We, and others have demonstrated the 
effect of H-DNA on up- or down-regulating gene expression, including evidence 
that H-DNA causes transcription pausing (84-96), while other reports found no 
effect on gene expression from H-DNA (97,98). This discrepancy is likely due to 
multiple mechanisms behind H-DNA-regulation of gene expression, which have 
yet to be fully elucidated. Several H-DNA-binding proteins (HBPs) have also 
been described, mostly specific for the purine- or pyrimidine-rich single-stranded 
region of H-DNA (99-107), further implicating H-DNA in gene regulation and 






1.3.3. Cruciform, Hairpins, and G-Quadruplexes 
 
The biological function of cruciform and hairpin structures has been widely 
studied by many research groups, and has been found to play a role in several 
DNA metabolic processes. Analysis of eukaryotic and prokaryotic genomes 
revealed that inverted repeats capable of forming cruciform/hairpin structures 
have been shown to occur ~1/40,000 bp in the human genome and were more 
abundant in human and yeast genomes than in E. coli (42). Inverted repeats 
have been shown to occur in replication origins of both bacteria and viruses, and 
be required for DNA replication in both eukaryotes and prokaryotes (108,109). 
Additionally, mRNAs that form hairpins can affect the speed of transcription 
(110). Moreover, inverted repeats are largely abundant in the euchromatic region 
of the central male-specific segment on the human Y chromosome (111), and it 
has been suggested that cruciform structures in this region play a role in 
evolutionary conservation of the sex-specific functions of the Y chromosome 
(24). 
Analyses of G4 DNA-forming sequences revealed nearly 37,000 sites in the 
human genome (~1/10,000 bp), the majority in noncoding regions (112,113). G-
quadruplex motifs are frequently found in telomeres (114,115) and promoter 
regions (often at transcription start sites) (116,117), but can also occur in 
mitochondrial DNA and immunoglobulin switch regions (16). Furthermore, longer 
repeats capable of forming G4 DNA were unable to form nucleosome structures 
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(118) and have often co-localized to nucleosome-depleted regions in human cells 
(119). Such studies have implicated G4 DNA in telomere maintenance, 
transcription, and chromatin structure. 
 
1.4. Non-B DNA and Genetic Instability 
 
While several non-B DNA sequences/structures have been shown to play 
physiologically significant roles in various species, a great deal of research 
published by our laboratory (60,120-133) and others (20,37,38,46,134-150) has 
demonstrated that these alternative structure-forming sequences, can also 
contribute to genomic instability associated with a variety of human diseases. 
Several of these findings are outlined below (studies from our laboratory relevant 
to this document are summarized in Table 1.1). 
The vast majority of cancers are due to some form of genetic instability. One 
way that the integrity of the DNA can be influenced is through its structure. Thus, 
it is important to investigate how, why, and when structure-induced genomic 
instability occurs in opposition to known important biological functions as 







Z-DNA-forming sequences have been shown to stimulate recA-
independent plasmid-to-plasmid recombination events in E. coli at a higher 
frequency than background levels (151), and are correlated with recombination 
hotspots in eukaryotes (152-155), possibly due to Z-DNA-stimulated stabilization 
of recombination intermediates, with the potential to stimulate DNA double-strand 
breaks (DSBs) when resolved [reviewed in (11)].  
Computer-based algorithms have been developed (156-158), which allow 
genomic DNA to be screened for sequences that can adopt non-B DNA 
structures. In particular, in the human genome, Z-DNA-forming sequences were 
found to co-localize with mutation “hotspots” such as breakpoints and 
translocations related to diseases such as cancer. For example, the human BCL-
2 gene is mutated in 90% of follicular B cell lymphomas in which a translocation 
event transfers the BCL-2 gene to the immunoglobulin heavy chain gene locus, 
resulting in over-expression of BCL-2, seen in non-Hodgkin’s lymphomas (159). 
Z-DNA-forming sequences were found surrounding a common breakpoint for the 
BCL-2-associated translocation (160,161). Similarly, translocations in the human 
c-MYC gene are associated with ~90% of Burkitt’s lymphomas (162), and 
multiple Z-DNA-forming regions have been found in the c-MYC P1 promoter and 
3’ downstream region near these breakpoints (46,163). Translocations in the 
SCL gene are the most common mutation associated with T-cell acute 
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lymphoblastic leukemia (ALL) occurring in ~30% of patients (164), and Z-DNA-
forming sequences were found at a breakage hotspot in this gene as well 
(147,165). We have also recently shown that Z-DNA and other non-B-forming 
sequences are enriched at known translocation breakpoints in human cancer 
genomes (166). 
 We have shown that sequences with the capacity to adopt Z-DNA have 
been shown to be mutagenic in bacteria and human cells, though apparently by 
distinct mechanisms. In bacteria, a Z-DNA-forming sequence induced small 
deletions, likely due to replication slippage events (167-170), while in mammalian 
cells, DSBs and large-scale deletions were seen at significantly higher levels 
than a non-Z-DNA-forming sequence in replication-independent mechanism 
(170). We demonstrated that the differences across species are likely due to the 
difference in availability of repair mechanisms, such as micro homology-mediated 
end-joining (MMEJ) and non-homologous end-joining (NHEJ), which are not 
available in most prokaryotes, including E. coli. When these mechanisms were 
added to bacteria, the Z-DNA-induced mutation spectra shifted from small to 
large deletions, similar to the effect seen in human cells (171). Importantly, when 
integrated in chromosomes in an in vivo mouse model, this same Z-DNA-forming 
sequence stimulated higher levels of genetic instability, with ~7% of the 
population undergoing large deletions or rearrangement events near the Z-DNA 
region (128). Thus, there are distinct mechanisms for Z-DNA-induced genomic 
instability in different species, and it is possible that the mutations in mammalian 
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cells are a result of error-generating processing by DNA repair components at 
the sites of alternative DNA structures, outlined in the section 1.5 below. 
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Major Finding Ref. 
Z-DNA 
Z-DNA is mutagenic in bacteria and human cells via distinct 
mechanisms, causing large deletions in human cells, and small 
deletions in bacteria. 
(127) 
Z-DNA causes partial blockage of T7 RNA polymerase during 
transcription elongation in a structure-specific manner. 
(60) Demonstrated th t non-homologous end-joining (NHEJ) o  micro 
homology-mediated e d-joining (MMEJ) may play roles in Z-DNA-
induced mutagenesis in human cells. 
(171) 
H-DNA 
Human XPA and RPA cooperate to bind to and recognize a triplex 
structure, perhaps as “damaged” DNA. (120) 
H-DNA is mutagenic in mammalian cells, causing large deletions, 
and coincides with the propensity to form H-DNA. Microhomology 
at breaks suggested NHEJ and/or MMEJ was involved in repairing 
DSBs. 
(125) 
A naturally occurring H-DNA-forming sequence from the human c-
MYC gene can block transcription via inhibiting RNA polymerase.  (32) 
Helicase DHX9 recognizes and binds to H-DNA, and protects 
against H-DNA-induced mutagenesis, suggesting the helicase 
unwinds H-DNA to protect genomic integrity. 
(172) 
The mismatch repair complex, MSH2-MSH3, and nucleotide 




Computer analysis revealed inverted repeats align with 
microinverions that contributed to the evolutionary divergence of 
chimps from humans. 
(173) 
Inverted repeats are enriched at translocation breakpoints in human 
cancer genomes, cause double-strand breaks and deletions in 
yeast and human cells, and stimulate structure-specific cleavage 
via the human XPF protein. 
(133) 
Multiple 
In vivo model demonstrating that stably integrated H-DNA and Z-
DNA into chromosomes are mutagenic in mice. (128) 
Translesion synthesis polymerases (Pol η and Pol κ) prevent 
genomic instability at the human c-MYC sequence capable of 
forming H-DNA, Z-DNA, and G4 DNA. These polymerases are 
normally down regulated in human cancers, implicating non-B DNA 
in cancer etiology. 
(129) 
H-DNA and Z-DNA, as well as WRN helicase deficiency cause 
mutations in human cells via distinct pathways. (132) 
H-DNA, Z-DNA, and G4 DNA-forming sequences were found to be 
enriched at translocation breakpoints in cancer genomes, further 





The notion that triplex structures, such as H-DNA are implicated in 
stimulating genomic instability (i.e., via homologous recombination) is not new 
(174). For example, the unbound, looped, single-stranded region of the H-DNA 
structure may serve as an initiator of recombination by pairing with a homologous 
region, or providing a substrate for homology searching by other loci. 
Recombination intermediates such as four-way Holliday junctions would form 
with the potential to create DSBs when resolved (175-178). Moreover, an H-
DNA-forming sequence was found in the mouse immunoglobulin c alpha switch 
region at sites of recombination and splicing (179). Additionally, an H-DNA-
forming sequence has been shown to pause or arrest DNA replication in 
mammalian cells, potentially causing collapsed replication forks and DSBs if 
processed (180,181), as well as block transcription (32). 
 Analysis of sequences with the capacity to adopt H-DNA, particularly 
those consisting of long polypurine-polypyrimidine mirror repeats revealed that 
these regions were located in genes that had higher frequencies of alternative 
splicing and chromosomal translocations (82). Similar to Z-DNA, H-DNA-forming 
sequences often co-localize with chromosomal mutational “hotspots” for 
breakage and translocations related to human diseases. For example, the human 
c-MYC gene also contains an H-DNA forming region within the promoter, which 
overlaps with a major translocation breakpoint found in lymphomas and 
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leukemias (182-189). Additionally, an H-DNA-forming sequence shown to form 
structure in vitro (141), co-localized with a major breakpoint region (MBr) in the 
BCL-2  gene associated with follicular lymphomas; furthermore, disruption of the 
capacity to form H-DNA reduced the frequency of translocations in this region 
(142). Finally, the PKD1 gene, which contains a highly mutable region associated 
with autosomal dominant polycystic kidney disease (ADPKD) (190), contains 23 
mirror repeats (191) that have been shown to adopt H-DNA in vitro (192), and 
cause DSBs and large deletions in bacteria (122), implicating the triplex structure 
in ADPKD etiology. 
Using a plasmid-based mutation reporter assay, our previous work has 
demonstrated that both a naturally occurring H-DNA-forming sequence from the 
human c-MYC gene, and a model H-DNA-forming sequence were mutagenic in 
mammalian cells, and the majority of mutations were composed of large-scale 
deletions and/or rearrangements (125). Further analyses revealed that DSB-
formation occurred near the H-DNA locus, and that the breaks were likely due to 
processing by an end-joining mechanism (125). When the H-DNA-forming 
sequence from the human c-MYC gene was integrated into mouse 
chromosomes, ~8% of the offspring contained genetic instability, further 
implicating the H-DNA structure in mammalian genomic instability in a 




1.4.3. Cruciform, Hairpins, and G-Quadruplexes 
 
Inverted repeats that can form cruciform/hairpin structures have been 
implicated in generating deletions, gene amplification, and recombination in 
prokaryotes and eukaryotes (149,150,193-197). AT-rich palindromic sequences 
have been co-localized to human translocation breakpoints (198-201). Recently, 
our laboratory has shown that short inverted repeat sequences, able to adopt a 
cruciform structure, map to translocation “hotspots” in cancer genomes and 
stimulate DSB formation and deletions in yeast and mammalian cells (133). 
Sequences composed of triplet repeats can form hairpin structures, which 
have been extensively studied due to replication slippage that can occur, 
resulting in mutations, deletions, and expansions related to more than 30 
neurological diseases [extensively reviewed in (137-139,202)]. Examples include 
Fragile X Syndrome, Huntington’s disease, Friedreich’s Ataxia, Kennedy disease, 
and Myotonic dystrophy (203-215). 
Using the algorithms mentioned above, G4 DNA-forming sequences were 
also found near known breakpoints in the P1 promoter of the human oncogene c-
MYC (216,217), as well as mitotic and meiotic breakpoints associated with 
Fragile X Syndrome in humans (218-220). Furthermore, G4 DNA structures have 
been shown to cause stalling at replication forks, potentially resulting in breakage 
and genetic instability (221-223). 
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1.5. DNA Repair Relative to Non-B DNA 
 
As outlined above, non-B structures cause significant distortions to the B-
DNA double helix, and demonstrate mutagenic potential in various model 
systems, implicating these structures in disease etiology and evolution [also 
reviewed in (11,24)]. Distortions to the DNA helix (i.e., damage caused by UV, 
mismatches, chemical crosslinking, oxidation, etc.) are often recognized by repair 
proteins and signal a subsequent repair mechanism to correct the damage. Thus, 
the helical alterations that occur in non-B DNA structure formation may be 
recognized as “damage” and provide a substrate to stimulate processing by 
repair proteins. Several DNA repair pathways exist to maintain the integrity of the 
genome, including nucleotide excision repair (NER) and mismatch repair (MMR), 
which are relevant to the studies presented here, and are outlined below. 
 
1.5.1. Nucleotide Excision Repair (NER) 
 
The proteins involved in the NER pathway  (Fig. 1.5) recognize and 
remove chemical and physical alterations in the helix caused by bulky DNA 
adducts, such as thymine dimers and 6,4-photoproducts, caused by UV 
exposure (224-226). There are two sub-pathways of NER: (1) transcription-
coupled (TC-NER), which senses damage in actively-transcribed regions of the 
 26 
genome, and (2) global genomic (GG-NER), which can repair damage 





Figure 1.5. Nucleotide excision repair pathway. Pathway responsible for 
repairing lesions caused by bulky DNA adducts. Two sub-pathways exist in NER: 
global genomic (GG-NER) and transcription-coupled (TC-NER), which differ only 
in the initial damage recognition steps. Damage recognition by XPC-hHR23B 
(GG-NER) or CSB, CSA, etc. (TC-NER) is followed by unwinding of DNA at the 
site of damage by TFIIH complex, and damaged validation by XPA, while RPA 
stabilizes single-stranded regions caused by unwinding. Endonucleases ERCC1-
XPF and XPG cleave the DNA flanking the damage to excise the region, while 
replication factors fill and seal the gap [adapted from (226)].  
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The NER sub-pathways differ in recognition components, while incision, 
repair, and ligation steps follow a common mechanism. In TC-NER, damage 
initially signaled by blockage of the transcription process by the damage, which is 
then recognized by CSB, CSA, and other proteins, which stimulate the repair 
process. In GG-NER, the primary lesion detector is XPC-hHR23 (now referred to 
as XPC-RAD23B), which scans the genome for damage to be repaired by the 
NER pathway. Following the recognition step in both sub-pathways, a sixteen-
peptide complex (TFIIH) is recruited to the damage. TFIIH includes XPB and 
XPD helicases, which unwind the DNA at the damage site. XPA then verifies the 
damage, while RPA stabilizes and protects single-stranded regions formed 
during unwinding of DNA. Next a dual incision is made to excise the damage by 
ERCC1-XPF and XPG structure-specific endonucleases at the 5’ and 3’ ends of 
the lesion, respectively, to remove ~30 bp, including the damaged DNA. Finally, 
replication factors fill in the gap, and ligase seals the nick to complete the repair 
process (224-226). 
As described above, NER proteins recognize and process chemical and 
physical alterations in the DNA double helix, and it has been demonstrated that 
the efficiency of the NER pathway to recognize and process DNA damage 
correlates with the level of distortion (e.g., the more significant the distortion, the 
more efficient NER is in repairing the damage) (227-230). H-DNA, Z-DNA, and 
hairpin/cruciform structures significantly deviate from canonical B-DNA helix; 
therefore, these structures may be recognized as “DNA damage” by NER 
 29 
recognition proteins, and evidence suggests that non-B DNA may serve as 
substrates for NER. For example, inter-molecular triplexes between a DNA 
duplex and a triplex-forming oligonucleotide (TFO) have been shown to induce 
NER-dependent mutagenesis in mammalian cells (231). We, and others have 
demonstrated that NER factors are capable of recognizing and processing these 
intra-molecular triplex structures in vitro, and in bacterial and human cells (232-
235). Additionally, several reports in human and bacterial cells have shown that 
NER factors can have opposing effects on hairpin/cruciform structure-induced 
genomic instability, to either increase or prevent deletions of CAG repeats (236-
240) Together, these studies highlight the complexity of non-B DNA recognition 
and processing, and further studies are warranted to clearly define the role of 
NER proteins in this mechanism. 
 
1.5.2. Mismatch Repair (MMR) 
 
The mismatch repair pathway (Fig. 1.6) is responsible for correcting base-
pairing errors (i.e., mismatches and insertion-deletion loops) that are caused by 
base deamination, oxidation, methylation, recombination intermediates, and 
replication errors (241-244). Similar to NER, there are two recognition complexes 
in MMR depending on the size of the mismatch. The MSH2-MSH6 complex can 
recognize single-base mismatches or small insertion-deletion loops as damage 
and signal repair. However, the MSH2-MSH3 complex can also recognize small 
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loops as well as larger insertion-deletion loops (up to ~10 nucleotides). MLH1 
and PMS2 form a heterodimer that is recruited by MSH2-MSH3 (or MSH2-
MSH6) complex to facilitate repair, though the exact role of this complex is 
unknown. In contrast to NER, a single endonuclease, EXO1, is responsible for 





Figure 1.6. Mismatch Repair Pathway. Proteins in the mismatch repair (MMR) 
pathway are responsible for repairing mismatches including single-base 
mismatches, and small and large insertion-deletion loops. Damage is recognized 
by MSH2-MSH3 or MSH2-MSH6 (depicted here) complexes, followed by 
recruitment of MLH1-PMS2 complex to facilitate repair. EXO1 excises the 
damage, while DNA Polymerase δ fills in the gap and ligase completes the 







Small, single-stranded looped regions can be found on several non-B DNA 
structures, including hairpin/cruciform conformations and Z-DNA at B-Z junctions 
(18,246). Therefore, these structures may also serve as substrates for 
recognition by proteins in the MMR pathway, and several studies have eluded to 
this theory. For example, in eukaryotic cells MMR proteins have been shown to 
bind to and/or remove small hairpin/cruciform structures, particularly those 
containing mismatches, rather than those formed at perfect inverted repeats 
(37,247,248). Contrasting results were seen comparing mice and humans, in 
which MMR proteins were found to be responsible for contraction events at CAG 
repeats in humans (238), and responsible for expansion events of long CNG 
repeats in mice (249-251), suggesting additional proteins may be involved in 
CNG repeat processing. Additionally, we have demonstrated that MMR proteins 
are involved in recognition and processing of TFO-directed inter-molecular 
triplexes (130,252,253). For example, MSH2-MSH3 can bind to inter-molecular 
triplex structures in vivo and in vitro, and can interact with XPA-RPA or XPF-
hHR23 to recognize the triplex structure (130).  
Taken together, the evidence presented above implicating non-B DNA 
structures in genomic instability, along with the propensity of non-B DNA 
structures to cause significant helical distortions of the B-DNA double helix, 
prompted our laboratory to develop a working hypothesis that repair proteins 
recognize these distortions as “damage”, and trigger cellular responses for 
repair, potentially leading to mutations (Fig. 1.7) (254). Studies to determine 
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which components are involved the mechanism(s) responsible for non-B DNA-
related mutagenesis and disease etiology are ongoing, several of which are 







Figure 1.7. Proposed model for non-B DNA-induced mutagenesis.  A non-B 
DNA structure, shown here as Z-DNA, forms as a result of DNA processing (i.e., 
transcription, replication, repair, etc.). The Z-DNA structure is mistakenly 
recognized as “damage” by unidentified DNA repair proteins. In an attempt to 
repair the “damage”, subsequent processing of the Z-DNA by additional 
unidentified repair machinery generates breaks at or near the site of “damage”, 
potentially in an error-generating fashion, resulting in genetic instability [adapted 
from (254)].  
“damage” 
Non-B DNA formation 
Error-prone processing 
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1.6. Hypothesis and Specific Aims 
 
DNA can adopt alternative structures that do not conform to the Watson-
Crick B DNA helix (e.g., non-B DNA structures). To date, more than 12 different 
types of non-B DNA structures have been described including H-DNA and Z-
DNA. Sequences that have the capacity to adopt non-B DNA structures are very 
abundant in the human genome. For example, potential Z-DNA-forming 
sequences occur approximately once in every 3,000 base pairs, while H-DNA-
forming sequences occur ~1/50,000 base pairs. Many non-B DNA-forming 
sequences have been mapped to regions of common chromosomal breakpoints, 
known as “hotspots”, which are associated with several human diseases. For 
example, oncogenic translocations occurring in the c-MYC and BCL2 genes, 
which are characteristic of cancers such as leukemia and lymphomas, contain Z-
DNA-forming sequences at the translocation breakpoints. We have discovered 
that sequences with the potential to form Z-DNA and H-DNA can stimulate 
genomic instability in yeast, human cells, and mice, predominantly in the form of 
DNA double-strand breaks (DSBs). Further, non-B DNA can alter DNA 
metabolism (i.e., DNA transcription, replication, and repair), which may also 
contribute to genetic instability. This genomic instability can contribute to the 
development of human diseases; however, the mechanisms involved in these 
processes are not well characterized. We propose the novel hypothesis that 
the helical distortions induced by non-B DNA are recognized as “damage” 
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and processed by DNA repair machinery via an error-generating 
mechanism resulting in genomic instability. The long-term objective of this 
project is to determine the mechanism(s) involved in non-B-DNA-induced genetic 
instability. An immediate objective is to test the hypothesis that multiple repair 
pathways are involved in DNA structure-induced mutagenesis by studying NER 
and MMR proteins for their involvement in H-DNA- and Z-DNA-induced 
mutagenesis in eukaryotic cell lines. 
 
 The specific aims for the proposed project are as follows: 
 
1. Determine the extent to which NER and MMR proteins impact H-DNA 
structure-induced mutagenesis in eukaryotes. We have developed a yeast 
artificial chromosome (YAC)-based genetic instability reporter system containing 
sequence capable of forming H-DNA or a control insert to screen a yeast 
knockout library. Using this system, we have shown that our H-DNA-forming 
sequence is mutagenic, and we will screen several MMR and NER proteins, as 
well as structure-specific nucleases, for involvement in H-DNA-induced 
mutagenesis in yeast. Next, we will characterize the mutation spectra in wild-type 
and mutant yeast strains and compare to the control sequence (i.e. spontaneous 
background mutants). Critical NER (e.g. XPA) and MMR (e.g. MSH2) proteins, 
as well as FEN1, will be investigated in available isogenic proficient and deficient 
human cells, or siRNA techniques will be used to deplete the proteins of interest 
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in human cells. A plasmid-based lacZ mutation-reporter system will be used to 
measure H-DNA-induced mutagenesis in repair-deficient and wild-type human 
cells. We will analyze the types of mutations caused by H-DNA and control 
sequences by direct DNA sequencing of isolated plasmids from mutants.  
2. Determine the extent to which NER and MMR proteins impact Z-DNA 
structure-induced mutagenesis in eukaryotes. Similarly, we will investigate Z-
DNA-induced mutagenesis in yeast and human cells using the YAC and plasmid-
based mutagenesis assays described in Aim 1 with a (CG)14 sequence capable 
of forming Z-DNA. The same gene products will be screened to determine 
components involved in this mechanism, and provide evidence as to whether the 
parallels exists between the mechanisms for genetic instability stimulated by H-
DNA or Z-DNA. 
3. Characterize the function/pathway or the proteins involved in non-B-
DNA-induced mutagenesis. The role of NER and MMR proteins and additional 
proteins identified in Aims 1 and 2 will be further characterized using in vitro 
assays to determine the mechanism(s) involved in DNA structure-induced 
genetic instability. Biochemical and molecular biology-based approaches such as 
Chromatin Immunoprecipitation (ChIP) and Electrophoretic Mobility Shift Assays 
(EMSA) will be used to investigate the mechanistic role of these proteins in 
recognizing and/or maintaining these non-B DNA sequences using cell-free 
extracts and available antibodies and/or purified proteins. To determine the 
extent to which proteins containing nuclease activity (e.g. XPF) are involved in 
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processing H-DNA and Z-DNA leading to DSBs, cleavage assays using cell-free 
extracts and/or available purified proteins and H-DNA-forming oligonucleotides 
will be performed. 	
 With the results obtained from this project we will gain valuable information 
regarding the roles of critical gene products and pathways involved in DNA 
structure-induced genetic instability. This information will enhance our knowledge 
















Chapter 2: The Role of DNA Repair Proteins in Z-DNA 
Induced Mutagenesis In Eukaryotes1 
  
                                                
1 Sections of this chapter are included in the following publications: 
 
Jennifer A. McKinney, Anirban Mukherjee, Guliang Wang, Junhua Zhao, Albino Bacolla, and 
Karen M. Vasquez. Cross-talk between DNA repair pathways results in genomic instability at a 
naturally occurring alternative DNA structure, Molecular Cell (submitted) 2016. For this 
manuscript, I was involved in planning and executing experiments, analysis of data, acquiring 
partial funding for the project, and preparing and editing the manuscript. 
 
Guliang Wang, Jennifer A. McKinney, Albino Bacolla, and Karen M. Vasquez. DNA methylation 
causes genetic instability by altering DNA and chromatin structures [in preparation]. For this 





Alternating purine-pyrimidine sequences that have the capacity to adopt 
alternative Z-DNA structures are abundant in the human genome, with estimates 
of as many as 1/3000 bp. Importantly, non-B DNA-forming sequences, including 
Z-DNA often co-localize with mutation hotspots associated with human disease, 
and we have shown that alternative DNA structures (or non-B DNA) can cause 
genomic instability, implicating these DNA structures in cancer etiology. 
However, the mechanisms involved in these processes are not well 
characterized. Z-DNA causes distortions in the DNA double helix, and therefore, 
we speculated that these non-B DNA structures may be recognized as “DNA 
damage” by repair proteins and initiate a DNA damage response. Multiple repair 
mechanisms may be involved in the processing of non-B structures because they 
are not typical DNA lesions per se, but rather distortions of the B-DNA helix. To 
identify the proteins/pathways that play a role in Z-DNA structure-induced genetic 
instability, we screened a yeast knock-out library. We identified the nucleotide 
excision repair (NER) protein complex, Rad10-Rad1 (XPF-ERCC1), and the 
mismatch repair (MMR) protein complex Msh2-Msh3, to be involved in Z-DNA-
induced mutagenesis in yeast, and confirmed these results in human cells. Using 
chromatin immunoprecipitation (ChIP) assays, we demonstrated that ERCC1-
XPF and MSH2-MSH3 complexes were recruited to Z-DNA-forming sequences 
and that ERCC1-XPF recruitment was dependent on MSH2-MSH3. Furthermore, 
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we showed that ERCC1-XPF cleaved DNA near the Z-DNA-forming site in 
human whole cell extracts. We propose a relationship in which these complexes 
recognize and attempt to repair Z-DNA in eukaryotic genomes, representing a 
novel mechanism of genomic instability. Thus, our results in human cells 




Since the discovery of the B-DNA double helix, by Watson and Crick more 
than five decades ago (1) (Fig. 2.1a), several non-canonical (i.e., non-B) DNA 
conformations have been described. Examples include cruciform, H-DNA and Z-
DNA, which have been studied extensively by our laboratory (60,120-133) and 
others (20,37,38,46,134-150). Z-DNA is a left-handed helix that forms at 
sequences of alternating purine-pyrimidine repeats (e.g., TG or GC) (Fig. 2.1b). 
The purines within the repeat adopt a syn conformation in which the base is 
positioned over the sugar, giving the helix a zigzag appearance, and results in 
single-stranded regions at the B-Z junctions. Energy from negative supercoiling is 
required for the formation of Z-DNA (8,25). Sequences with the ability to adopt Z-






Figure 2.1. Schematic of B-DNA and Z-DNA structures. (a) Watson-Crick 
double-stranded B-DNA. (b) Left-handed Z-DNA structure flanked by two regions 
of B-DNA. B-Z junctions are labeled (red arrows) [adapted from (256)].   
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The biological function of non-B-forming sequences has been of interest 
due to high occurrence and conservation of these sequences across multiple 
species of eukaryotes (24). While the function of such structures remains to be 
fully understood, it has been suggested that some of these structures are 
involved in DNA metabolic processes (11,24). For example, Z-DNA-forming 
sequences are enriched at transcription initiation start sites, thus it has been 
proposed that this structure may play a role in regulation of gene expression 
(257). Z-DNA formation can also alleviate negative supercoiling that occurs 
during transcription and replication by absorbing the energy formed during the 
unwinding of B-DNA, further suggesting a role in transcription and replication 
(18,77).   
Non-B DNA-forming sequences can also contribute to genomic instability. 
Sequences with the potential to adopt Z-DNA map to sites within or near 
chromosomal hotspots that are associated with translocation breakpoints in 
human diseases, such as cancer. For example, Z-DNA-forming sequences are 
located in both the human oncogenes c-MYC and BCL2 near translocation 
breakpoints associated with leukemias and lymphomas (i.e., Burkitt’s 
Lymphoma) (122,123,161,166,258). Some chromosomal translocations that 
occur frequently in leukemias and lymphomas result in the c-MYC or BCL2 
genes being placed next to the heavy chain immunoglobulin gene causing 
overexpression of the translocated oncogene (77). We have discovered that Z-
DNA-forming sequences are mutagenic in bacteria, mammalian cells and in 
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mice, and can stimulate the formation of DNA double-strand breaks (DSBs) that 
may be repaired by non-homologous end-joining (NHEJ) (60,127,128,132,171). 
These results suggest a role for non-B structures in causing gene translocations 
through the formation of DSBs, implicating them in cancer etiology; however, the 
molecular mechanism(s) involved in genomic instability and the generation of the 
DSBs induced by Z-DNA-forming sequences is not fully understood. Because Z-
DNA alters the B-DNA helix there is no longer a canonical major groove within 
the Z-DNA region, the Z-DNA helix is more compact with 12 bp/turn compared to 
the 10.5 bp/turn of B-DNA, and the crystal structure revealed that base extrusion 
is evident at the junctions between B- and Z-DNA (Fig 2.2) (8,18,25). Such 
differences may be recognized as a form of a DNA “damage” by repair proteins 
and initiate a DNA damage response.  
The nucleotide excision repair (NER) pathway recognizes and repairs 
helical distortions caused by bulky adducts (224,225), while the mismatch repair 
(MMR) pathway recognizes and repairs smaller distortions caused by 
mismatches formed during replication, and small slippage loops (242) . The 
helical distortions present in Z-DNA could potentially serve as a substrate for 
recognition and repair by the proteins in the NER mechanism. Furthermore, the 
B-Z junctions consist of at least one unpaired base, resulting in a small single-
stranded region or loop (18,259) that may be a substrate for recognition and 





Figure 2.2. Crystal structure of Z-DNA. The crystal structure of Z-DNA (PDB id: 
2ACJ) revealed extruding bases at the junctions of B-DNA and Z-DNA (red 
arrows) [adapted from (12)].   
 46 
Thus, multiple repair mechanisms may be involved in the recognition and repair 
of non-B structures because they are not typical DNA lesions per se, but rather 
distortions of the B-DNA helix. Results from our laboratory have shown that NER 
and MMR proteins are involved in mutagenesis induced by another non-B DNA 
structure, H-DNA, in yeast and mammalian cells (unpublished data; see Chapter 
3 for a details on these findings). Based on these results it is plausible that repair 
proteins from multiple pathways participate in error-generating repair of Z-DNA 
structures, resulting in genomic instability. Therefore, we hypothesize that NER 
and MMR proteins are involved in Z-DNA-induced mutagenesis in eukaryotes. 
In this study, we investigated the components and mechanisms 
responsible for Z-DNA-induced mutagenesis. We developed >20 wild-type and 
mutant yeast strains containing a yeast artificial chromosome (YAC) with either a 
control B-DNA, or Z-DNA-forming insert flanking a URA3 mutation-reporter gene. 
We demonstrated for the first time that a Z-DNA-forming sequence is mutagenic 
in wild-type yeast, and causes DSBs. By screening mutant strains deficient in 
various repair proteins, we have identified the NER and MMR repair complexes 
Rad10-Rad1(ERCC1-XPF) and Msh2-Msh3, respectively, to be involved in Z-
DNA-induced mutagenesis in yeast.  
We confirmed these results in human cells using a plasmid-based 
mutation-reporter assay and found that while a Z-DNA-forming sequence is 
mutagenic in wild-type human cells, this effect is lost in the absence of XPF or 
MSH2. Furthermore, we demonstrate that both repair complexes are enriched at 
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the site of Z-DNA-formation and that XPF-ERCC1 enrichment is dependent on 
MSH2-MSH3 using chromatin immunoprecipitation (ChIP) assays. Finally, we 
used a plasmid-based in vitro primer extension assay and found that ERCC1-
XPF can cleave DNA near the site of the Z-DNA-forming insert.  
The data presented here suggest a novel relationship between ERCC1-
XPF and MSH2-MSH3 outside of NER and MMR to function in Z-DNA-induced 
mutagenesis. It is clear from these studies that repair proteins from several 
pathways are involved in Z-DNA-induced mutagenesis in eukaryotes and may 







2.3. Materials and Methods 
 
2.3.1. Bioinformatics analyses. We applied an algorithm that we developed 
to search for Z-DNA-forming sequences (133), to the dataset containing ~20,000 
breakpoint locations translocations and deletions mapped to the human cancer 
genome assembly GRCh37/hg19 obtained from COSMIC at 
http://cancer.sanger.ac.uk/.  Z-DNA-forming repeats (ZFRs) located within ±100 
bp from the breakpoints (bins), comprising alternating purine and pyrimidine runs 
of length ≥6 bases each, were identified using custom scripts. For overlapping 
ZFRs only the longest match was used for the output. The bedtools utility was 
used to generate a set of 20,000 non-gap-matching sequences (bins), each 200 
bases long (166). 
 
2.3.2. Yeast strains and yeast artificial chromosomes (YACs). The yeast 
strain 213 cir° (MATa Kar1-1 leu2-3, 112 ura3-52 his7 cyh2R) was used for YAC 
construction and transfer into other yeast strains. The yeast strain BY4742 
(MATα, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0) and derivatives (Yeast deletion library 
GSA-5, ATCC, Manassas, VA) were used in DNA structure-induced YAC fragility 
and spectra assays. A Z-DNA-forming (CGCGCGCGCGCGCGCGCGCGCGCGCGCG) 
or control (CGAGCTATCTGAGTCGAATACAGTTCGAC) sequence was cloned between 
the telomere seed G4T4 and the URA3 gene on a replication-defective plasmid 
derived from pRS306. The plasmids were then linearized and used to construct 
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YACs by homologous recombination with YAC VS5 containing a point mutation 
in the URA3 gene (260-262). YACs containing Z-DNA-forming and control B-
DNA-forming sequences and a functional URA3 gene (Fig. 2.4) were selected on 
plates containing synthetic defined (SD) minimal yeast media (Clontech, 
Mountain View, CA) with complete supplement mixture-uracil (CSM-Ura) (MP 
Biomedicals, Santa Ana, CA), and confirmed by polymerase chain reaction 









Table 2.1. List of oligonucleotides used in this study. 
  
Region Name Sequence 
Z-DNA  
and control on 
YAC 
M13-20 5' TGT AAA ACG ACG GCC AGT 3' 
M13Rev 5' CAG GAA ACA GCT ATG ACC 3' 
URA3 gene on 
YAC 
Ura3S1For 5' AGG CGG CAG AAG AAG TAA CA 3' 
Ura3S1Rev 5' AAT GCG TCT CCC TTG TCA TC 3' 
LEU2 gene on 
YAC 
Leu2S2For 5’ CTG TGG GTG GTC CTA AAT GG 3’ 




pUinsFor1 5' GTT TTC CCA GTC ACG ACG TT 3’ 
pUinsRev1 5' TTT ATG CTT CCG GCT CGT AT 3' 
Z-DNA and 
control on  
plasmid 
548up 5’ GGT GAT GAC GGT GAA AAC CT 3’ 
LM-PCR linker 
LMPCR1 5’ /5phos/CGT ACA TTC ACA ACG ATA GCG ACT GA 3’ 








JMleft 5’ GGA GAA AAT ACC GCA TCA GG 3’ 
JMright 5’ ATT AGG CAC CCC AGG CTT TA 3’ 
MSH2 MSH2 siRNA U.C.U.G.C.A.G.A.G.U.G.U.U.G.U.G.C.U.U.U.U. 
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2.3.3. YAC transfer (kar-cross). Donor cells 213 cir° (canavanine-sensitive) 
containing YACs with the Z-DNA-forming or control B-DNA-forming sequence 
were grown from a single colony in minimum synthetic defined (SD) base with 
CSM-Leucine-Uracil media (MP Biomedicals, Santa Ana, CA) overnight at 30°C. 
A single colony of BY4742 canavanine-resistant recipient cells from the yeast 
deletion library was grown in yeast extract peptone dextrose media (YPD) at the 
permissive temperature overnight. YACs were transferred from donor cells to 
recipient cells via kar-mediated transfer as previously described (260,261,263-
265). Briefly, equal optical density (OD) of donor cells with YACs and recipient 
mutant cells were mixed and inoculated into fresh YPD media, grown in a 
shaking incubator for 6 hours at permissive temperature of 27-30°C, as several 
strains are temperature-sensitive and must be grown at lower temperatures. The 
culture was plated on CSM-Ura-Arg+canavanine (100 mg/L) plates, and 
incubated at permissive temperature. Kar-crossed cells were plated for single 
colonies on CSM-Leu-Ura plates containing canavanine and CSM-lys to confirm 
transfer (i.e., colonies containing the YAC will grow on CSM-Ura-Leu, but not on 
CSM-Lys plates) (Fig. 2.5). Cells were analyzed via direct DNA sequencing using 
the M13-20 primer (flanking the insert) (Table 2.1) to confirm the presence of the 
YAC and the correct Z-DNA-forming or control B-DNA-forming sequence. See 
Table 2.2 for a list of strains developed in this study. 
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Table 2.2. Yeast strains developed in this study. 
(SC) short control; (CG)14 Z-DNA; (JZ) strains developed by Dr. Junhua Zhao. All other 











Wild-type BY4742 ✔ (JZ) ✔ (JZ) 
NER 
rad4Δ(XPC) ✔ ✔ 
rad26Δ(CSB) ✔ ✔ 
rad14Δ(XPA) ✔ ✔ 
rad1Δ(XPF) ✔ ✔ 
rad2Δ(XPG) ✔ ✔ 
rad10Δ(ERCC1) ✔ ✔ 
Structure-specific 
endonucleases 
rad27Δ(FEN1) ✔ ✔ 
mre11Δ ✔ ✔ 
sae2Δ ✔ ✔ 
rad50Δ ✔ (JZ) ✔ 
MMR 
msh2Δ ✔ ✔ 
msh3Δ ✔ ✔ 
msh6Δ ✔ ✔ 
mlh1Δ ✔ ✔ 
exo1Δ ✔ ✔ 
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2.3.4. YAC fragility assay. As previously described (261,262) single colonies 
containing YACs with either the Z-DNA-forming or control B-DNA-forming 
sequence were used to inoculate 2 mL cultures in SD base with CSM-Leu media, 
and were grown for 20 hours at permissive temperature of 27-30°C, as several 
strains are temperature-sensitive and must be grown at lower temperatures. For 
each culture, 50 µL were plated on SD base with CSM-Leu plates containing 5-
fluoroorotic acid (5-FOA) (Zymo Research, Irvine, CA) to select for mutagenic 
events resulting in the loss of functional URA3 on the YAC. For each culture, 10 
µL was diluted 1:10,000 and plated on SD base with CSM-Leu plates to serve as 
a total cell number count. The mutation frequencies were calculated as the 
number of FOA-resistant (FOAR) colonies divided by the number of total colonies 
(Fig. 2.6). This assay was performed in triplicate on five separate clones for the 
Z-DNA-containing and control YACs for all wild-type and mutant yeast strains 
analyzed in this study. Student’s t-test was used to determine significant 
differences between strains.  
 
2.3.5. YAC mutation spectra analysis. For each strain containing the Z-DNA-
containing or control B-DNA-containing YAC studied in the fragility assay, 30 
FOAR colonies were streaked onto SD base with CSM-leu+FOA plates to confirm 
FOAR (Fig. 2.12). Single colonies were inoculated in water and cells were lysed 
by boiling at 95°C for 5 min, and used as template for PCR with the sets of 
primers listed in Table 2.1. The M13 primer set was specific to the Z-DNA-
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forming or control B-DNA-forming region, the URA set serving as a measure of 
FOAR, and the LEU set served as a loading control. Amplified DNA was 
separated on a 1% agarose gel, stained with ethidium bromide, and visualized on 
a ChemiDoc Imaging System (Bio-Rad, Hercules, CA).  
 
2.3.6. Determination of mutation index (MI). We define the mutation 
frequency index (MFI) computed as the ratio between the mutation frequencies 
determined for the cells containing the Z-DNA-forming YAC, and that of cells 
containing the control B-DNA-forming YAC for each mutant yeast strain (Fig. 
2.9d). MFI values from different experiments were pooled to obtain means and 
standard deviations. MSI, or mutation spectra index, was computed as follows. 
For each yeast strain we assessed the mutation spectra observed in 29-30 FOAR 
colonies by calculating the percent of FOAR colonies for each of the 4 types of 
mutations observed (described in Fig. 2.13b; Table 2.3). The percent values 
obtained with the strains harboring the control B-DNA-forming YAC were then 
subtracted from the values obtained with the corresponding strain harboring the 
Z-DNA-forming YAC. MSI corresponds to the sum of the absolute differences for 
each mutation category for each strain. The mutation index (MI) represents the 
product of MFI multiplied by MSI; specifically MI = MFI * (MSI + 1) / 10. Thus, 
when comparing among different yeast strains, the larger the MI values, the more 
pronounced are the differences in mutation frequencies and mutation spectra for 
the Z-DNA-containing clones relative to the control B-DNA-containing clones. 
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2.3.7. Chromatin immunoprecipitation (ChIP) assay in yeast. ChIP assays 
were performed using a Simple ChIP Enzymatic Chromatin IP Kit (Cell Signaling, 
Inc., Santa Cruz, CA) with some modifications to the manufacturer’s protocol. 
Cultures of SD base CSM-Leu media were inoculated with a single colony of 
yeast cells containing YACs with the Z-DNA-forming or control sequence, and 
were grown overnight at permissive temperatures. Cultures were fixed with 1% 
formaldehyde for 10 min at room temperature to crosslink DNA and proteins. 
Crosslinking was quenched by adding 10X Glycine and incubating for 5 min at 
room temperature. Cells were washed three times with cold PBS (Corning Inc., 
Corning, NY) containing 1 mM cold phenylmethylsulfonyl fluoride (PMSF) 
(Sigma-Aldrich, St. Louis, MO) (100 mM in 100% ethanol). The yeast cells were 
lysed in buffer [0.1 M Tris-Cl pH 8.0, 50 mM ethylenediaminetetraacetic acid 
(EDTA), 1% sodium dodecyl sulfate (SDS)] and Zymolyase (Zymo Research) 
with rotation at 37°C for 1 hour. To ensure cell lysis, sterile, acid washed glass 
beads (RPI Corp., Mount Prospect, IL) were added to the cells and the samples 
were vortexed for a total of 5 min, alternating 30 sec on vortex, 30 sec on ice. 
The supernatant was transferred to a new tube, and sonicated to obtain an 
average DNA fragment size of <800 bp. Fragment size was confirmed following 
the ChIP kit protocol, and fragments were separated on a 1% agarose gel, 
stained with ethidium bromide, and visualized on a ChemiDoc Imaging System. 
The fragmented chromatin was aliquoted for incubation with primary antibody, 
and 2% of the chromatin was stored as input DNA. Aliquots were incubated with 
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5 µg of antibody (α-IgG antibody (ChIP kit) and α-H3 antibody, (Abcam 8895)) at 
4°C with rotation overnight. The remainder of the assay was performed following 
the ChIP kit protocol. Purification of the DNA was performed using a PCR 
Purification Kit (Qiagen). Fractions of purified ChIP and input DNA were used for 
PCR analysis. Primer sets for PCR amplification included M13-20 and M13Rev 
for specificity surrounding the Z-DNA-forming or control B-DNA sequence and 
Leu2S2For and Leu2S2Rev as a non-specific control within the LEU2 gene 
(Table 2.1). Amplified products were separated on a 1% agarose gel, stained 
with ethidium bromide, and visualized on a ChemiDoc Imaging System. ImageJ 
software was used to quantify band intensity. 
 
2.3.8. Z-DNA-induced mutagenesis assay in human cells. Isogenic human 
XPF-proficient (GM08437B-XPF) or XPF-deficient cells (GM08437B-pLPC) 
(266,267) were maintained in Dulbecco’s Modified Eagle Medium (DMEM, Life 
Technologies, Carlsbad, CA) with 10% fetal bovine serum (FBS) and antibiotics. 
The Z-DNA-containing (pU(CG)14) (CGCGCGCGCGCGCGCGCGCGCGCGCGCG) or 
control B-DNA-containing plasmid (pUCon) 
(CGAGCTATCTGAGTCGAATACAGTTCGAC) was transfected into human cells using 
GenePORTER (Genlantis Inc., San Diego, CA) according to the manufacturer’s 
recommendations using 3 µg of plasmid DNA. Cells were harvested at 48 hours 
following transfection, and plasmid DNA was extracted using Hirt’s method (268) 
with slight modifications as previously described (262). Purified plasmid DNA was 
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treated with DpnI digestion as previously described to remove plasmids that were 
not replicated in the mammalian cells (262), and again purified using phenol-
chloroform extraction and ethanol precipitation prior to transformation via 
electroporation into E. coli DH10β electrocompetent bacterial cells (New England 
Biolabs, Inc., Ipswich, MA), which were used in the lacZ-based blue/white 
screening assay to determine mutation frequencies as previously described 
(262). Experiments were performed in triplicate and Student’s t-test was used to 
calculate statistical values. DNA from individual mutant colonies was sequenced 
to characterize the mutations/deletions near the Z-DNA or control B-DNA 
regions. 
 
2.3.9. siRNA knockdown of MSH2 in human cells. Human MSH2 siRNA or 
non-targeting siRNA (Dharmacon, GE Healthcare) (Table 2.1) was transfected 
into cultured human XPF-proficient cells (GM08437B-XPF) with GenePORTER 
(Genlantis Inc., San Diego, CA) using the manufacturer’s recommended protocol 
at a final siRNA concentration of 0.1 µM. A second siRNA transfection together 
with the pU(CG)14 and pUCon mutation reporter plasmids was carried out 48 
hours (T48) after the first transfection using GenePORTER according to 
manufacturer’s recommended protocol at a final siRNA concentration of 0.1 µM, 
and 3 µg of plasmid DNA. Cells were harvested at T48 as well as 16 or 48 hours 
after the second transfection (T64 and T96) as indicated for Western blotting to 
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confirm the knockdown of MSH2, and plasmids were extracted for analysis by 
mutagenesis and ChIP assays.  
 
2.3.10. Determination of siRNA knockdown by Western blotting. XPF-
proficient cells (GM08437B-XPF) were harvested 48 hours after plasmid 
transfection. Cells were lysed in 1x radioimmunoprecipitation assay (RIPA) buffer 
(with proteinase inhibitor cocktail) on ice for 1 hour, followed by sonication. A 
portion of the supernatant (equivalent to 10-30 µg of protein) was mixed with 2x 
SDS loading buffer and boiled for 5 min at 95°C. Samples were separated by 
SDS-PAGE on a 4-15% Criterion™ TGX™ (Tris-Glycine-eXtended) midi gel, and 
transferred to a polvinylidene difluoride (PVDF) membrane using a Trans-Blot® 
Turbo™ Transfer System (Bio-Rad, Hercules, CA). The membrane was blocked 
for 1 hour at room temperature with 1x TBST (tris buffered saline (0.02 M tris 
base, 0.15 M NaCl) plus 0.05% Tween 20) with 5% blotting grade dry milk (Bio-
Rad), and probed with antibodies against MSH2 (1:100, Calbiochem, Billerica, 
MA), XPF (1:1000, Cell Signaling), and PCNA (1:10,000, Santa Cruz), and 
visualized on a ChemiDoc Imaging System. ImageJ software was used to 
quantify band intensity. 
 
2.3.11. Chromatin immunoprecipitation (ChIP) assay in human cells. 
Detection of protein enrichment at a Z-DNA-forming site was performed as 
previously described with some modifications (130,269). Briefly, human cells 
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were plated in antibiotic-free Dulbecco’s Modified Eagle Medium (DMEM, Life 
Technologies, Carlsbad, CA) with 10% fetal bovine serum (FBS) at a 
concentration of 240,000 cells/plate in 60 mm plates. The next day, 3 µg of 
pU(CG)14 or pUCon mutation reporter plasmids were transfected into the cells 
using GenePORTER (Genlantis Inc., San Diego, CA) according to 
manufacturer’s suggested protocol. At 16 hours post-transfection, the cells were 
fixed with formaldehyde at a final concentration of 1% for 10 min at room 
temperature. The remainder of the ChIP assay was performed using Simple 
ChIP Enzymatic Chromatin IP Kit (Cell Signaling, Inc., Santa Cruz, CA), following 
manufacturer’s protocol with some modifications. Aliquots of the chromatin were 
incubated with 1 µg of primary antibody (α-IgG and α-H3 antibodies (ChIP kit), α-
MSH3 antibody (Thermo Fisher), α-MSH2 antibody (Calbiochem), α-MSH3 
antibody (Thermo Scientific), α-MSH6 antibody (Abcam), α-XPA antibody 
(Abcam), and α-XPF antibody (generous gift from Dr. Richard Wood, University 
of Texas M.D. Anderson Cancer Center) at 4°C with rotation overnight. The 
remainder of the assay was performed following the ChIP kit protocol. DNA 
fragments were purified using Wizard® SV Gel and PCR Clean-Up System 
(Promega, Madison, WI). Fractions of purified ChIP and input DNA were used for 
PCR analysis. Primers used for PCR amplification included pUinsFor1 and 
pUinsRev1 (Table 2.1). Amplified products were separated on a 1% agarose gel, 
stained with ethidium bromide, and visualized on a ChemiDoc Imaging System. 
ImageJ software was used to quantify band intensity. Experiments were 
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performed in triplicate and Student’s t-test was used to calculate statistical 
values. 
 
2.3.12. Confirmation of Z-DNA structure formation in plasmids by S1 
nuclease sensitivity assays. As previously described (270) with slight 
variations, Z-DNA-containing or B-DNA-containing control plasmids (2 µg) 
(pUCG14 and pUCon, respectively) were incubated at room temperature for 5 
min with 50 mM NaCl and 4 mM MgCl2, then digested with 2 µL S1 nuclease 
(Promega Corporation, Madison, WI) in 25 µL reactions in provided S1 reaction 
buffer for 20 min at 37°C. Reactions were stopped by heat inactivation at 65°C 
for 20 min and diluted to 100 µL. Plasmid DNA was extracted using phenol 
chloroform, and precipitated using ethanol. For some experiments, purified 
plasmid DNA was further digested with a combination of 1 µL each of XmnI, 
and/or AflII endonucleases (at position 93, and 1716 respectively; Fig. 2.20) in 20 
µL reactions for 3 hours at 37°C. Reactions were stopped by heat inactivation at 
65°C for 20 min. Cleaved products were separated on 1.4% agarose gels, 
stained with SYBR® Gold (Life Technologies), and visualized on a ChemiDoc 
Imaging System. ImageJ software was used to quantify band intensity. 
Experiments were performed in triplicate. 
 
2.3.13. In vitro DNA cleavage assay via primer extension. Isogenic human 
XPF-proficient (GM08437B-XPF) or XPF-deficient (GM08437B-pLPC) whole cell 
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extracts (WCE) were prepared from human XPF+/- cells (described in section 
2.3.8) using Nucbuster™ Protein Extraction Kit (EMD Millipore, Temecula, CA) 
starting with Reagent 2. Reaction mixtures contained 600 ng of Z-DNA-forming 
or control B-DNA-forming plasmid DNA (pU(CG)14 and pUCon, respectively), and 
were incubated at room temperature for 5 min with 50 mM NaCl and 4 mM 
MgCl2. Samples were then incubated in reaction buffer (5 mM MgCl2, 40 mM 
Hepes-KOH pH 7.8, 0.5 mM DTT, 2 mM ATP, 22 mM phosphocreatine, 0.36 
mg/mL BSA, 50 ng/µL CPK, 30 mM KCl), and water or 100 ng of WCE for 30 min 
at 30°C. After incubation, samples were treated with 0.02 M 
ethylenediaminetetraacetic acid (EDTA) and 80 µg/mL RNAse A and further 
incubated at 37°C for 10 min. Samples were then treated with 0.5 % SDS and 1 
mg/mL proteinase K and incubated at 65°C for 30 min. Plasmid DNA was purified 
using phenol-chloroform and ethanol precipitation, resuspended in nuclease-free 
water and used as template for PCR with JMLeft or JMRight primer (Table 2.1 
and Fig. 2.21) to detect nicks on the plasmid DNA. Amplified DNA was separated 
on a 1.5% agarose gel, stained with SYBR® Gold (Thermo Fisher Scientific, 
Waltham, MA) and visualized on a ChemiDoc Imaging System (Bio-Rad, 
Hercules, CA). Experiments were performed in triplicate. 
 
2.3.14. Analysis of Z-DNA-induced DSBs by linker-mediated PCR (LM-
PCR). LM-PCR analysis was performed as previously described by our 
laboratory (125,127,262). Briefly, 8 µg of pUCon (control B-DNA) or pU(CG)14 (Z-
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DNA) plasmid DNA was transfected into isogenic human XPF-proficient 
(GM08437B-XPF) or XPF-deficient (GM08437B-pLPC) cells using 
GenePORTER (Genlantis Inc., San Diego, CA) according to manufacturer’s 
suggested protocol. At 24 hours post-transfection, plasmids were recovered and 
purified using Hirt’s method (268) with slight modifications as previously 
described (262). Purified plasmid DNA was treated with Pol I Klenow fragment 
(New England Biolabs, Inc., Ipswich, MA) according to manufacture’s 
recommendations to create blunt-ended DNA, and plasmid DNA was purified by 
phenol-chloroform extraction and ethanol precipitation. Purified Klenow-treated 
DNA was ligated to linker DNA containing one blunt end and one 3’ overhang 
(product of annealed 5’ phosphorylated LMPCR1 and LMPCR2 primers, Table 
2.1) at 16°C overnight, followed by 20 min at 70°C, and allowed to cool to room 
temperature. Ligation products were used as templates in the PCR reactions to 
amplify the region between the linkers and the upstream primer 190 bp upstream 
of the (CG)14 insert (LacZleft741 and LMPCR2, respectively, Table 2.1). PCR 
products were separated on a 1.2% agarose gel, stained with ethidium bromide 





2.4.1. Z-DNA-forming sequences map to breakpoints in human cancer 
genomes. 
 
To determine the impact of Z-DNA-forming sequences in human cancer 
etiology, our laboratory recently searched for Z-DNA-forming repeats (ZFRs) 
within ±100 bp (thereafter referred as to bins) of 19,956 human cancer genome 
translocation breakpoints (database from COSMIC at 
http://cancer.sanger.ac.uk/). We determined the distributions of each ZFR 
midpoint relative to the breakpoint positions (taken to be 0). ZFRs were 
significantly enriched in regions within ±100 bp of the 19,967 cancer translocation 
breakpoints, compared to the 20,000 randomly picked loci that served as the 
control, with an obvious peak centering at the breakpoint in the cancer genomes 
(166) (Fig. 2.3). Thus, Z-DNA-forming sequences are significantly enriched 
surrounding human cancer translocation breakpoints, implicating Z-DNA in 









Figure 2.3. Enrichment of Z-DNA forming repeats (ZFRs) at human cancer 
translocation breakpoints. Normalized numbers of ZFRs found at cancer 
translocation breakpoints (black) and random loci (green) are shown. These data 
were obtained by our laboratory [variation of data from Bacolla, et. al. Nucleic 
Acids Res 2016 (166)]. 
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2.4.2. Z-DNA-induced chromosomal instability in yeast. 
  
We, and others, have shown that Z-DNA-forming sequences can cause 
genomic instability in bacteria, human cells, and mice, and can alter DNA 
metabolism (i.e., DNA transcription, replication, and repair) (11,127,128,257). To 
determine if a Z-DNA-forming sequence was mutagenic in yeast, we transformed 
a yeast artificial chromosome (YAC) containing a Z-DNA-forming (CG)14 
sequence or a control B-DNA-forming sequence (control) (Fig. 2.4) into wild-type 
BY4742 cells via kar-mediated transfer (Fig. 2.5, Table 2.2), and screened for 5-
Fluoroorotic acid-resistant (FOAR) colonies as a measure of mutation frequency 
(Fig. 2.6). We demonstrated for the first time that the (CG)14 Z-DNA-forming 
sequence stimulated significantly higher mutation frequencies in wild-type yeast 























Figure 2.4. Schematic diagram of the Yeast Artificial Chromosome (YAC) 
used in this study. Representation of the YAC used in these studies (not to 
scale). The full-length YAC is ~62 kb in length, containing a yeast origin of 
replication (CEN/ARS), a telomere seed (C4A4), and two selective genes (LEU2 
and URA3). Thus, cells grown in CSM-leu-ura selective media will only grow if 
they contain the YAC. The red star represents the location of either the control B-
DNA-forming or Z-DNA-forming sequence (shown above the YAC). There is ~41 









Figure 2.5. Kar-mediated transfer of YAC from donor to recipient cells. The 
213 donor cell line (purple) containing the YAC is CanS, while the recipient 
BY4742 WT or mutant cells (peach) are CanR, which is verified prior to the kar 
cross by plating on YPD plates with canavanine. Liquid cultures containing either 
donor or recipient cells are mixed and inoculated into YPD media and incubated 
for 6 hours at permissive temperature (I), resulting in various progeny (II). Cells 
are plated onto CSM-ura+canavanine to select for only those cells with the 
BY4742 background that contain the YAC (III). To ensure cells are haploids that 
only contain the BY4742 background and are not a result of mating between 
recipient and donor, CanR colonies are replica-plated onto both CSM-leu-ura and 
CSM-lys plates (IV). Colonies that grow on the CSM-leu-ura plates, but do not 
grow on CSM-lys plates (blue stars), are selected as BY4742 background 
containing the YAC (LYS-, CanR, LEU2+, URA3+). The black line represents the 






Figure 2.6. YAC fragility assay. A single colony containing the full-length, 
URA3+ YAC is harvested from a CSM-leu-ura plate, inoculated into 2 mL CSM-
leu-ura liquid culture, and grown for 24 hours at permissive temperature (I). Cells 
from the CSM-leu-ura culture are inoculated into 2 mL CSM-leu cultures, and 
grown for 20 hours at permissive temperature (II). By allowing the cells to grow 
in CSM-leu only selective media, mutations can occur in the URA3 gene, 
resulting in a mutated YAC that will become FOAR. CSM-leu media selects for 
cells containing either the full-length wild-type YAC, or a mutated YAC. Cells are 
then plated onto CSM-leu+FOA plates to select for cells containing a mutated 
YAC, as well as diluted 10,000-fold and plated onto CSM-leu plates as a 
measure of total cell number (III). Mutation frequencies are calculated as a ratio 
of the number of colonies on the FOA plates (mutants) to the number of colonies 






Figure 2.7. Z-DNA is mutagenic in wild-type yeast. YAC fragility assay 
performed on BY4742 wild-type (WT) cells containing either a control B-DNA-
containing YAC (SC) or a YAC Z-DNA-containing YAC (Z-DNA). Mutation 
frequencies were measured as number of FOAR colonies divided by total cell 
number. [P value from two-sided Student’s t-test <1x10-5 (***)]. These 
experiments were performed by Jennifer McKinney.   
*** 
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To identify gene products involved in Z-DNA-induced mutagenesis in 
yeast, we obtained an S. cerevisiae genome library deficient in non-essential 
genes from American Type Culture Collection. The deletion library allowed us to 
screen multiple knockout strains for a variation of the effect on the induction of 
mutagenesis we see in wild-type cells caused by Z-DNA using the YAC fragility 
assay. By using this assay on mutant strains and comparing mutation 
frequencies of mutant cells with the Z-DNA-containing YAC versus the same 
mutant cells with the control B-DNA-containing YAC, we were able to identify 
proteins that are involved in Z-DNA-induced mutagenesis (Fig. 2.8). For 
example, if the Z-DNA-induced mutagenesis in a mutant strain is increased 
compared to the induction seen in WT cells, the protein that is deficient in the 
mutant strain may be involved in preventing Z-DNA formation or in error-free 
repair of the Z-DNA structure (Fig. 2.8a and b). Alternatively, if the induction 
caused by Z-DNA is decreased compared to WT cells, the protein may be 
involved in promoting Z-DNA formation, stabilizing the Z-DNA structure following 
its formation and subsequently blocking error-free repair, or recognizing or 
processing the Z-DNA structure resulting in mutations via error-prone repair (Fig. 
2.8c-e). Finally, it is possible that the same induction seen in WT cells would be 
seen in a mutant strain, suggesting the protein that is deficient in the mutant 
strain may not play a role in Z-DNA-induced mutagenesis, and further studies 






Figure 2.8. Potential outcomes of YAC fragility assay. This assay was used 
to measure Z-DNA-induced mutagenesis in wild-type cells and mutant cells. 
There are several possible outcomes of the fragility assay shown here. (a-b) If 
there is an increased mutation frequency in the Z-DNA-containing YAC 
(compared to wild-type cells) in the deficient cells, then this may indicate that the 
protein either prevents the non-B structure from forming, or it repairs the 
structure in an error-free manner. (c-e) However, a decreased mutation 
frequency may indicate that the protein promotes the formation of non-B-DNA, or 
stabilizes the structure once formed and prevents repair by other proteins, or 
attempts to repair the structure in an error-prone manner leading to subsequent 
mutations.   
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The helical distortions induced by Z-DNA formation and single-stranded 
regions at the B-Z junctions mimic substrates for the NER and MMR pathways. 
Therefore, we predicted that Z-DNA might also be recognized and/or processed 
by components of such pathways; thus we screened NER and MMR proteins as 
well as other structure-specific endonucleases for an effect on Z-DNA-induced 
mutagenesis. Each mutant strain was transformed with the control B-DNA-
containing (control) or Z-DNA-containing YAC via kar-mediated transfer (Fig. 
2.5). We performed the YAC fragility assay (Fig. 2.6) on all mutants listed in 
Table 2.2.  
When comparing absolute values, there were significantly more mutations 
in cells containing the YAC with the Z-DNA-forming sequence compared to the 
control B-DNA-forming YAC in most strains tested, similar to the effect seen in 
WT strains (Fig. 2.9). Interestingly, the most striking differences from wild-type 
cells occurred in the NER mutants rad1Δ(XPF) and rad10Δ(ERCC1) (Fig. 2.9a), 
MMR mutants msh2Δ and msh3Δ (Fig. 2.9b), and structure-specific nuclease 
mutants mre11Δ and sae2Δ (Fig. 2.9c; P value <0.001) (e.g., a decrease of 
mutation frequency to background levels), suggesting that in the absence of 
these proteins, Z-DNA is no longer mutagenic in this assay.  
Due to the inherent increased level of spontaneous background mutations 
in several of the repair mutant strains, we also considered the fold induction of 
the Z-DNA-containing YAC compared to the control B-DNA-containing YAC 
within each strain. Compared to the 18.6-fold induction seen in WT, there was an 
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overall significant decrease in the fold induction seen within each mutant set 
comparing the Z-DNA YAC to control B-DNA YAC (Fig. 2.9d and Table 2.3). 
Again, the most dramatic loss of effect caused by Z-DNA in the WT strains 
occurred in the rad1Δ(XPF), rad10Δ(ERCC1), msh2Δ, msh3Δ, mre11Δ, and 
sae2Δ mutant strains. In contrast to the overall decrease seen in the fold 
induction within the mutant strains compared to the induction seen in WT (Fig 
2.9d), subtracting the background from the Z-DNA-induced mutation frequency 
demonstrated a significant increase in Z-DNA-induced mutagenesis in the 
rad14Δ(XPA), rad2Δ(XPG), rad27Δ(FEN1), and mlh1Δ strains (Fig. 2.10 and 
Table 2.3). In accordance with the absolute and fold data, rad1Δ(XPF), 
rad10Δ(ERCC1), msh2Δ, msh3Δ mutants display a highly significant decrease in 
Z-DNA-induced mutagenesis compared to that of WT, that was not detected in 
other mutant strains within the respective pathways. Regardless, whether we 
considered absolute values, fold induction, or values with background subtracted, 
it was clear that the dramatic effect seen in these mutants was not observed in 
other mutants within the same pathways; thus, these data suggest that proteins 












Figure 2.9. Z-DNA-induced mutagenesis in wild-type and repair-deficient 
yeast cells. The Z-DNA-forming (CG)14 insert resulted in increased mutation 
frequencies compared to the control B-DNA-forming insert in BY4742 wild-type 
yeast cells deficient in NER (a), MMR (b), and other repair proteins including 
structure-specific nucleases (c). However, the fold increase of the (CG)14 insert 
compared to control insert within each mutant set was decreased compared to 
the fold increase in BY4742 wild-type cells (d). [Student’s t-test was used to 
calculate P value <0.001 (*), <1x10-10 (***)]. These experiments were performed 








Table 2.3. Mutation frequencies listed as a ratio (Z/C) and with background 
subtracted (Z-C).  
P value <1x10-4 compared to WT (**) 








 Yeast Strain Z/C 
Z-C 
(x10-6) 
WT BY4742 18.6 153.2 
NER 
rad4Δ(XPC) 5.6 243.1 
rad26Δ(CSB) 4.9 263.8 
rad14Δ(XPA) 10.1 461.2 
rad1Δ(XPF) 2.6 29.6** 
rad2Δ(XPG) 6.3 255.7 
rad10Δ(ERCC1) 1.7 15.1** 
MMR 
msh2Δ 2.0 42.5** 
msh3Δ 3.0 19.3** 
msh6Δ 5.9 120.7 
mlh1Δ 8.2 305.9 
exo1Δ 5.2 147.2 
Structure-specific 
endonucleases 
rad27Δ(FEN1) 5.0 1404.6 
mre11Δ 3.1 65.1 
sae2Δ 4.3 71.0 






Figure 2.10. Z-DNA-induced mutagenesis with background subtracted. Raw 
data from Fig. 2.9a-c with background mutations (i.e. spontaneous mutations) 
subtracted results in the observation of several strains with a significant 
difference from that of WT [P value <0.01 (*), <1x10-4 (***)].  
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2.4.3. Mutation spectra of spontaneous and Z-DNA-induced mutations in 
yeast. 
 
 The URA3 gene encodes orotidine-5’phosphate decarboxylase (ODCase), 
an enzyme required for the biosynthesis of pyrimidine ribonucleotides. In strains 
expressing the functional URA3 gene, ODCase converts 5-FOA to the toxic form 
of 5-flurouracil (271-273) (Fig. 2.11). Thus, the YAC fragility assay evaluates 
FOAR as a measure of the frequency of mutations that occur due to the loss of 
the URA3 gene on the YAC. We are most interested in frank DSBs that occur 
near Z-DNA structure formation, resulting in the loss of the right arm of the YAC, 
as these events may relate to translocations. However, there are other events 
that can result in loss of a functional URA3 gene and cause the cells to become 
FOAR. Any mutation, including point mutations and small or large deletions within 
the URA3 gene result in FOAR.  
To determine if FOAR is due to complete loss of the right arm of the YAC, 
caused by a DSB, or due to inactivation of the URA3 gene by a point mutation, 
we analyzed FOAR colonies by PCR using primers that amplify the Z-DNA or 
control B-DNA sequence, a region of the URA3 gene, and a region of the LEU2 
gene (Fig. 2.12a and b; Table 2.1). All three primer sets were verified to be 
specific to the YAC, and did not amplify any region in the yeast wild-type or 











Figure 2.11. 5-FOA is toxic to cells expressing URA3 gene. (a) The URA3 
gene encodes for the orotine-5-monophosphate decarboxylase (ODCase) 
enzyme that is required for conversion of orotidine 5’phosphate to uridine 
5’phosphate in the biosynthesis of pyrimidine ribonucleotides. (b) Functional 
ODCase will also result in the conversion of 5-fluorotic acid (5-FOA) to the toxic 
5-flurouracil, resulting in cell death. Thus, cells that have lost a functional URA3 
gene become resistant to 5-FOA, as 5-FOA itself is nontoxic to the cells [adapted 










Figure 2.12. Primers used in this study are specific to the YAC. (a) To 
determine the type of mutation that occurred in the URA3 gene to result in FOAR, 
we designed several primers that are specific to the URA3 gene (red arrows), Z-
DNA or control B-DNA insert (blue arrows), or the distal region in the LEU2 gene, 
which also served as a loading control (green arrows). The black arrow 
represents the direction of the URA3 promoter. (b) For the mutation spectra, 
single colonies from the FOA-containing or CSM-leu-ura plates were harvested, 
lysed at 99°C for 5 min, and used as template for PCR reaction. (c) We tested 
this assay using BY4742 and a mutant strain that did not contain the YAC to 
verify that the primers did not amplify any region in the yeast genome, and were 
specific to the YAC, as well as the BY4742 wild-type strains containing the 
control or (CG)14 Z-DNA-forming YAC. The lighter bands on the gel are primer 
dimers. These experiments were performed by Jennifer McKinney [McKinney, et 
al. (submitted Molecular Cell 2016)].  
 80 
We analyzed 30 FOAR colonies for each mutant and wild-type strain using 
all three primer sets as described above. Results obtained from PCR and gel 
electrophoresis were categorized according to potential causes of FOAR as 
follows: 1) samples with amplification from all three sets of primers were 
categorized as having a point mutation or small deletion within the URA3 gene; 
2) samples with amplification from the M13 and LEU primer sets were 
categorized as having a deletion within the URA3 gene; 3) samples with 
amplification from the URA and LEU primer sets were categorized as having a 
point mutation or small deletion in the URA3 gene; and 4) samples with 
amplification from only the LEU primer set were categorized as having a double-
strand break (DSB) and loss of the right arm of the YAC.  
 In the wild-type strain, there was a clear distinction between the control B-
DNA-containing YAC, in which the majority of the mutants were point 
mutations/small deletions, and the Z-DNA-forming YAC, in which the majority of 
the mutants resulted from frank DSBs and loss of the right arm of the YAC (Fig. 
2.13a). There were several mutant strains that demonstrated a mutation spectra 
similar to WT, in which there was a substantial increase in the number of DSBs 
and arm loss in the Z-DNA-forming YAC compared to the control B-DNA YAC, 
including Δmsh6 and Δrad26(CSB) strains (Fig. 2.13c and d, respectively). In 
contrast, the mutation spectra for several mutants strains deviated from that of 
WT. For example, in Δrad10(ERCC1), Δmsh2, and Δmsh3 strains, the mutation 
spectra of the Z-DNA-forming YAC compared to the control B-DNA-forming YAC 
 81 
were quite similar, suggesting that the mutations that occurred in cells lacking 
these proteins, were not influenced by Z-DNA-formation (Fig. 2.13c and d).  
Interestingly, the mutation spectra of the Δrad1(XPF) strain demonstrated 
a difference between the control B-DNA and Z-DNA YACs. While the control 
YAC resulted in a majority of point mutations/small deletions similar to WT with 
the control B-DNA YAC, the Z-DNA YAC in the Δrad1(XPF) strain differed from 
the WT, resulting in an increase in small deletions within the URA3 gene, rather 
than in increase in DSBs and arm loss as seen in the WT strain (Fig. 2.13c). It is 
clear that in these NER- and MMR-deficient strains [(Δrad10(ERCC1), 
Δrad1(XPF), Δmsh2, and Δmsh3], frank DSBs and arm loss is markedly 
decreased in both control and Z-DNA-forming YACs compared to the WT, 
suggesting that these repair proteins are involved in DSB formation in yeast, 
while other proteins in similar pathways are not. Comprehensive results of 









Figure 2.13. Z-DNA-induced mutation spectra in wild-type and repair-
deficient yeast. FOAR mutants were analyzed by PCR and gel electrophoresis 
as shown in Fig. 2.12. (a) In wild-type cells, the (CG)14 insert (WT Z) resulted in 
greater arm loss events caused by a frank DSB (purple), while the control insert 
(WT C) resulted in a greater number of point mutations and small deletions within 
the URA3 gene (blue). (b) Possible mutagenic events detected by this assay 
corresponding to the graphs in this figure. Mutation spectra of representative 
MMR-deficient (c) and NER-deficient (d) strains that varied or were similar to 
wild-type spectra. These experiments were performed by Jennifer McKinney. 
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C 60 0 0 40 
Z 13 0 0 87 
rad4Δ (XPC) 
C 48 21 7 24 
Z 0 100 0 0 
rad26Δ (CSB) 
C 17 17 17 47 
Z 0 0 0 100 
rad14Δ (XPA) 
C 13 87 0 0 
Z 0 90 0 10 
rad1Δ (XPF) 
C 93 7 0 0 
Z 53 47 0 0 
rad2Δ (XPG) 
C 69 24 0 7 
Z 20 67 3 10 
rad10Δ (ERCC1) 
C 63 30 0 7 
Z 63 30 0 7 
msh2Δ 
C 63 23 3 10 
Z 43 37 0 20 
msh3Δ 
C 60 40 0 0 
Z 50 47 0 3 
msh6Δ 
C 30 10 23 37 
Z 17 3 7 73 
mlh1Δ 
C 73 0 7 20 
Z 47 3 7 40 
exo1Δ 
C 58 10 6 27 
Z 0 0 0 100 
rad27Δ (FEN1) 
C 0 17 0 83 
Z 0 0 0 100 
mre11Δ 
C 47 13 10 30 
Z 0 0 17 83 
sae2Δ 
C 43 0 10 47 
Z 0 0 7 100 
rad50Δ 
C 90 0 7 3 
Z 13 0 30 57 
*Mutation spectra of WT in bold; mutants with spectra notable different than wild-type 
are denoted in red. n≥30. 
[McKinney, et al. (submitted Molecular Cell 2016)] 
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2.4.4. Correlation of mutation frequency and spectra data as determined by 
mutation index (MI). 
 
  Although several mutant strains tested displayed an effect in both 
mutation frequency and spectra assays that differed from the wild-type, 
suggesting a role in Z-DNA-induced mutagenesis in yeast, a few of the strains 
demonstrated a more prominent effect in one of the assays and not the other. To 
determine which gene products we tested had the most meaningful effect on Z-
DNA-induced mutagenesis, and thus the most-likely component(s) involved in 
the mutagenic mechanism, we needed to consider data collected from both 
assays in a way that did not emphasize the importance of one assay over the 
other. 
  As elaborated in Materials and Methods (Section 2.3.6.), we combined the 
data from mutation frequencies and the data from mutation spectra to compute 
MI, a single mutation index whose magnitude is directly proportional to the 
mutagenic potential of a Z-DNA-forming sequence in a given yeast strain. Thus, 
a drop in MI may be used as a proxy for determining whether a repair protein 
was relevant or not in eliciting Z-DNA-dependent mutations. Importantly, ranking 
based on decreasing MI values provides a snapshot of the relevance each repair 
protein played in Z-DNA-induced mutagenesis, combining data from mutation 
frequency and spectra assays (Fig. 2.14).  




Figure 2.14. Compilation of mutation frequency and spectra data as 
mutation index (MI). Bubble plot of MSI versus MFI, in which the area of each 
circle was computed from the value of MI = MFI * (MSI + 1) / 10, as the radius. 
Ranking is listed as the number on each bubble with the lowest ranking 
representing that of the mutant strain with the greatest divergence from wild-type 
(i.e., rad10Δ(ERCC1), ranked 1 versus wild-type, ranked 16). These data 
prepared by Jennifer McKinney with assistance from Dr. Albino Bacolla. 





 As expected, the MI was highest for the wild-type strain. Interestingly, the 
individual components of both the Rad1-Rad10 (XPF-ERCC1) and Msh2-Msh3 
complexes all rank within the top 5, while several of the other components of the 
NER and MMR pathways rank much higher, closer to WT. This suggests that the 
Rad1-Rad10 (XPF-ERCC1) and Msh2-Msh3 complexes play a role in Z-DNA-
induced genetic instability outside of the traditional roles the complexes provide 
in the respective DNA repair pathways, and possibly in conjunction. Thus, we 
chose Rad1-Rad10 (XPF-ERCC1) and Msh2-Msh3 to continue our studies and 
further determine if there is a dependent relationship between the two complexes 
and/or nuclease activity that is required for Z-DNA-induced mutagenesis. 
 
2.4.5. Rad1(XPF) and Msh3 are associated with Z-DNA-forming sequences 
in yeast. 
 
 To determine if the Rad10-Rad1(ERCC1-XPF) and Msh2-Msh3 repair 
complexes were enriched at the Z-DNA-forming sequence, and further confirm 
our hypothesis of these proteins in Z-DNA-induced mutagenesis, we performed 
ChIP assays in wild-type yeast. Using antibodies against XPF (Rad1) and Msh3, 
our results demonstrated a significant enrichment (3.0- and 3.3-fold, respectively) 
at the Z-DNA-forming insert compared to the control B-DNA-forming insert (Fig 
2.15). Due to lack of availability and quality of antibodies to yeast-specific repair 
proteins, we were unable to test the full spectrum of repair proteins in yeast. 
 87 
Furthermore, experimental difficulties including growth rate of repair-deficient 
strains proved difficult to perform ChIP assays on these strains. However, we 
were able to achieve testing of a more comprehensive panel of NER and MMR 
repair proteins during follow-up experiments in human wild-type and repair-




Figure 2.15. NER and MMR repair proteins are enriched at Z-DNA-forming 
regions on YACs in yeast. ChIP assays performed on YACs containing control 
B-DNA-forming (C) or Z-DNA-forming (Z) sequences in yeast wild-type BY4742 
strain. (a) Antibodies to Rad1(XPF), Msh3, H3 (positive control) and IgG 
(antibody specificity control) were used for pull-down. Resulting purified 
chromatin and 2% input were used for PCR template and analyzed on a 1% 
agarose gel stained with ethidium bromide. Primer sets included M13-20 and 
M13Rev (Table 2.1). (b) Quantification of the gel revealed a 3.3-fold increase in 
Rad1(XPF) and ~3-fold increase in Msh3 enrichment at the Z-DNA-forming 
sequence when compared to the control B-DNA-forming sequence (P values 
calculated by Students t-test). Rad1(XPF) and Msh3 values were normalized to 
corresponding input, then IgG values. Experiments were performed in triplicate. 
These experiments were performed by Jennifer McKinney. 
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2.4.6. Nucleosome positioning is effected by Z-DNA in yeast. 
 
 The formation of Z-DNA has been shown to effect nucleosome positioning 
(59,274,275). Due to the distorted and left-handed nature of the structure, DNA 
that is in the Z conformation cannot wrap around histone proteins to form 
nucleosomes. By using a yeast-specific histone H3 antibody and performing a 
ChIP assay, we demonstrated that the formation of Z-DNA, which is not 
dependent on transcription in our system, excludes histones, thereby effecting 
nucleosome positioning. We saw a 13-fold decrease in H3 enrichment at the Z-
DNA site when compared to the control sequence (Fig. 2.16). Our methods and 
results are in agreement with those published previously (59,274,275), thus we 
conclude that these results indirectly verify that our Z-DNA-forming sequence is 






Figure 2.16. Z-DNA effects nucleosome positioning in yeast. ChIP assay 
performed on YAC containing control B-DNA-forming (C) or Z-DNA-forming (Z) 
sequences in yeast wild-type BY4742 strain. (a) Antibodies to H3 as well as IgG 
(negative control) were used for pull-down. Resulting purified chromatin and 2% 
input were used for PCR and analyzed on a 1% agarose gel stained with 
ethidium bromide. Primer sets included M13-20 and M13Rev (proximal), as well 
as Leu2s2For and Leu2s2Rev (distal) (Table 2.1). (b) Quantification of the gel 
revealed a 13-fold decrease in H3 enrichment at the Z-DNA-forming sequence 
when compared to the control B-DNA-forming sequence (P value <0.05 (*). H3 
values with the M13 primers were normalized to H3 values with the Leu2s2 
primers. Experiments were performed in triplicate. These experiments were 




2.4.7. Z-DNA-induced genetic instability in wild-type and repair-deficient 
human cells. 
 
To further confirm our results obtained in yeast and to determine if the 
ERCC1-XPF and MSH2-MSH3 repair complexes were required for Z-DNA-
induced mutagenesis in human cells, we performed mutagenesis assays via 
blue/white screening using control B-DNA-containing and Z-DNA-containing 
mutation-reporter plasmids as previously described (Fig. 2.17a) (127,262). 
Isogenic human XPF-proficient (GM08437B-XPF) (wild-type) or XPF-deficient 
(GM08437B-pLPC) cells (Fig. 2.17b, top panel) were transfected with mutation-
reporter plasmids containing either a control B-DNA-forming or Z-DNA-forming 
sequence (Fig. 2.17a). Using blue/white screening mutagenesis assays, we 
found that the Z-DNA-forming plasmid resulted in a significant 6.7-fold increase 
in mutations in wild-type human cells when compared to the control plasmid (Fig. 
2.18, purple bars, P value 1x10-5). In contrast, we found that in the XPF-deficient 
human cells, the Z-DNA-forming plasmid resulted in only a 1.1-fold increase 
when compared to the control (Fig. 2.18, green bars, P value 0.11), suggesting 
that the ERCC1-XPF repair complex is required for the significant increase in Z-
DNA-induced mutagenesis seen in wild-type cells. These results are in 






Figure 2.17. Cell lines used for mutagenesis assays in human cells. 
Blue/white screening using mutation-reporter plasmids was performed to 
determine levels of Z-DNA-induced mutagenesis in human cells. (a) Schematic 
of mutation-reporter plasmid (variation of pUCNIM, 7075 bp) containing control 
B-DNA-forming or Z-DNA-forming sequence [(CG)14] inserted between the LacZ 
gene and promoter [top panel, adapted from (127)]. Reporter plasmids (LacZ+) 
were transfected into human cells, extracted and purified after 48 hours, 
transformed into bacterial cells, and plated onto media containing X-Gal to 
screen for mutants (white colonies, LacZ-) as a frequency compared to wild-type 
(blue colonies, LacZ+) [bottom panel, adapted from (276)]. (b) Human XPF-
proficient and -deficient cell lines confirmed by Western blotting using antibodies 
against XPF (top panel) and MSH2 (bottom panel). PCNA was used as a loading 
control. (c) MSH2 depletion by siRNA knockdown in human XPF-proficient cells 
confirmed by Western blotting using an antibody against MSH2, and PCNA as a 
loading control. Plasmid only and a non-targeting siRNA (siCon) were used as 
negative controls. Various time points were tested, indicating hours following first 
transfection. These experiments were performed by Jennifer McKinney. 
[McKinney, et al. (submitted Molecular Cell 2016)].  
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Similarly, we wanted to determine if the MSH2-MSH3 complex was 
required for Z-DNA-induced mutagenesis. Using targeted siRNA knockdown, we 
depleted MSH2 from the XPF-proficient cells (wild-type, and thus are also MSH2-
proficient, Fig. 2.17b, bottom panel) resulting in 80-95% knockdown (Fig. 2.17c). 
Following treatment with a non-targeting siRNA, the Z-DNA-forming plasmid 
stimulated an ~5-fold increase in mutations compared to the control B-DNA-
forming plasmid (Fig. 2.18, blue bars, P value 0.002), similar to the induction 
seen in wild-type cells. Depletion of MSH2 by siRNA knockdown in the wild-type 
cells resulted in a decrease of Z-DNA-induced mutagenesis to 1.1-fold over 
control (Fig. 2.18, red bars, P value 0.78), suggesting that MSH2 was required 
for the Z-DNA-induced mutagenesis seen in wild-type cells. Direct DNA 
sequencing was performed on mutant plasmids from human wild-type, XPF-
deficient, and MSH2-depleted cell lines to determine mutation spectra; however 
no difference was seen in the types of mutations in either plasmid across cell 
lines. The majority of mutations in all cases were large deletions, with no obvious 
bias in location relative to the control B-DNA-forming or Z-DNA-forming inserts. 
This may be explained by the tendency of this particular pUCNIM plasmid to 
detect large-scale deletions. Nonetheless, while the types of mutation did not 
differ significantly, the frequency of these mutations was significantly higher with 
the Z-DNA-forming plasmid when compared to control.  
The results obtained in human cells were consistent with our yeast data 
suggesting that repair complexes from both NER and MMR pathways are 
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involved in Z-DNA-induced mutations, possibly acting in a novel pathway outside 
of their canonical roles within the respective DNA repair pathways. Previous 
results from our laboratory have shown that there is no significant effect on Z-
DNA-induced mutagenesis in human XPA-deficient cells when compared to wild-
type cells (unpublished data), suggesting that functional NER was not required 
for the Z-DNA-induced mutagenesis. Thus, we continued our focus on the 
ERCC1-XPF and MSH2-MSH3 repair complexes to further characterize the 





Figure 2.18. Z-DNA-induced mutagenesis is decreased in human XPF-
deficient and MSH2-deficient cells. Plasmids containing control B-DNA-forming 
or Z-DNA-forming sequences were transfected into human wild-type and repair-
deficient human cell lines. Plasmids were isolated 48 hours following transfection 
and subjected to bacterial blue/white screening to determine mutation 
frequencies (Fig. 2.16a). Mutation frequencies were calculated as an average 
from three separate experiments in wild-type (purple bars), XPF-deficient (green 
bars), wild-type treated with sicontrol (blue bars), and siRNA-depleted MSH2 (red 
bars) cell lines. Statistical differences between Z-DNA and control B-DNA 
plasmids within cell lines (diagonal lines vs. solid bars, respectively) were 
calculated using Student’s t-test. The Z-DNA-forming plasmid resulted in 6.7-fold 
increase in mutations, which was significantly decreased following depletion of 
either XPF or MSH2. These experiments were performed by Jennifer McKinney. 
[McKinney, et al. (submitted Molecular Cell 2016)]. 
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2.4.8. Association of NER and MMR proteins with Z-DNA-forming 
sequences in human cells. 
 
 To further investigate the involvement of ERCC1-XPF and MSH2-MSH3 
repair complexes in Z-DNA-induced mutagenesis, we tested whether these 
complexes were enriched at a Z-DNA-forming sequence in human cells. We 
performed ChIP assays in the wild-type and repair-deficient human cell lines that 
were used for the mutagenesis studies. Using antibodies against NER (XPA and 
XPF) and MMR proteins (MSH2, MSH3, MSH6), our results in wild-type and 
XPF-deficient cells demonstrated an enrichment at the Z-DNA-forming insert 
compared to the control B-DNA-forming insert of XPF (4-fold in wild-type cells 
only, as XPF-deficient cells cannot be considered, because, in theory, there is no 
functional XPF in these cell lines) (Fig. 2.19a and d), MSH2 and MSH3 (5-6-fold, 
and 4-9-fold, respectively) (Fig. 2.19b and d). This result suggests that these 
proteins have a higher affinity for Z-DNA than B-DNA, perhaps playing roles to 
recognize and process the structure, and that XPF is not required for recruitment 
of MSH2-MSH3 to the Z-DNA-forming insert, as it is enriched at Z-DNA in both 
XPF-proficient and XPF-deficient cell lines. Moreover, in both cell lines, XPA 
demonstrated only a slight enrichment (1.8-2-fold) at the Z-DNA-forming insert 
over control, and MSH6 exhibited no fold change. When comparing enrichment 
between cell lines, the values did not change between XPF-proficient and XPF-
deficient cell lines, other than the expected enrichment of XPF, suggesting that 
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the lack of XPF does not influence the enrichment of MSH2-MSH3 (Fig. 2.19a 
and b, values represented below each gel).  
To determine if ERCC1-XPF recruitment to the Z-DNA-forming insert was 
dependent on MSH2-MSH3, we performed ChIP assays on MSH2 siRNA 
knockdown human cell lines. Interestingly, the knockdown of MSH2 resulted in 
the loss of the enrichment of XPF at the site of the Z-DNA-forming insert that was 
present in wild-type (XPF-proficient) cells (4-fold enrichment of Z/C in wild-type 
decreased to 1.1-fold in MSH2 KD cells) (Fig. 2.19c and d). There was no effect 
on XPA or MSH6 recruitment by MSH2 depletion. Taken together, these results 
further implicate a role for ERCC1-XPF and MSH2-MSH3 complexes in Z-DNA-
induced mutagenesis as a separate component from NER and MMR pathways, 
rather than one or both pathways acting as a whole, and that ERCC1-XPF 
recruitment to a Z-DNA-forming site was dependent on MSH2-MSH3 via a novel 












Figure 2.19. MSH2-MSH3 is required for ERCC1-XPF enrichment at Z-DNA-
forming regions in human cells. 
 99 
Figure 2.19. MSH2-MSH3 is required for ERCC1-XPF enrichment at Z-DNA-
forming regions in human cells. ChIP analysis performed on plasmids in 
human cells verified enrichment of ERCC1-XPF (a) MSH2/MSH3 (b) repair 
complexes at a Z-DNA-forming sequence (pU(CG)14) when compared to control 
(pUCON) in wild-type (WT) and XPF-deficient human cell lines (XPF-/-). No 
significant enrichment of XPA or MSH6 was detected. (c) In MSH2 depleted cells 
by siRNA-knockdown (MSH2 KD), the enrichment of XPF at Z-DNA was not 
detected. Antibodies to IgG and H3 were used as negative and positive controls, 
respectively. (d) Quantification of enrichment comparing the Z-DNA-forming 
region to the control B-DNA-forming region (Z/C). All values were an average of 
three repeats, normalized to input. Fractions of purified ChIP and input DNA were 
used for PCR analysis. Primers used for PCR amplification included pUinsFor1 
and pUinsRev1 (Table 2.1). Amplified products were analyzed on 1% agarose 
gels stained with ethidium bromide. These experiments were performed by 
Jennifer McKinney and Dr. Anirban Mukherjee. [McKinney, et al. (submitted 
Molecular Cell 2016)]. 
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2.4.9. In vitro cleavage of Z-DNA by the NER nuclease complex, ERCC1-
XPF. 
 
 To determine if ERCC1-XPF can process Z-DNA, we first confirmed Z-
DNA structure formation on plasmids in vitro. When Z-DNA formation occurs, 
single-stranded regions are formed at the B-Z junctions (18,22), and S1 nuclease 
assays have been widely used to assess the presence of Z-DNA and other non-
B DNA structures (125,127,134,277). We treated the control B-DNA (pUCon) and 
Z-DNA-forming plasmid [pU(CG14)] with S1 nuclease, followed by restriction 
digestion to form fragments of known lengths and to detect fragments caused by 
S1 nuclease to confirm Z-DNA formation (Fig. 2.20a). Following S1 treatment, 
the plasmid with the Z-DNA-forming sequence clearly resulted in a cleaved 
fragment mapping to the Z-DNA-forming insert that was not present with the 
control plasmid (Fig. 2.20b). These results confirm the presence of Z-DNA on the 
pU(CG)14 plasmid, providing a viable substrate to determine if ERCC1-XPF could 
process Z-DNA.  
Previously, we have shown that Z-DNA-forming sequences can stimulate 
the formation of DSBs, resulting in large-scale deletions (127) and in this study 
we have shown that ERCC1-XPF is likely to be involved in this mechanism. 
Initially, we performed linker-mediated PCR (LM-PCR) using control B-DNA and 






Figure 2.20. Formation of Z-DNA on plasmid substrates as detected by S1 
nuclease sensitivity. (a) S1 nuclease assay schematic. Plasmid DNA 
containing control B-DNA-forming sequence (pUCon) or Z-DNA-forming 
sequence [pU(CG)14] (red box) was treated with S1 nuclease, then digested with 
restriction endonucleases XmnI (A) and AflII (B) to release the fragment 
containing the insert (red box). Fragments were separated on 1.4% agarose gels 
stained with SYBR® Gold and visualized on a ChemiDoc Imaging System. S1 
nuclease cleaves at single-stranded regions of DNA. If Z-DNA formation occurs, 
then several fragments are expected as shown above. The control plasmid 
should yield fewer fragments, as it does not form Z-DNA. (b) Top panel: SYBR 
Gold-stained agarose gel demonstrating Z-DNA structure formation as 
determined by an extra fragment at ~700 bp (red arrows) in the pU(CG)14 
plasmid that is absent in the pUCon plasmid. Bottom panel: enlarged and higher 
exposure of 700-bp fragment. Blue arrow represents A-B fragment; green arrow: 
represents plasmid backbone. Black arrow represents a fragment resulting from 
a secondary structure that forms a substrate for S1 nuclease between the XmnI 
restriction site and the insert on both Z-DNA and control plasmids. Experiments 
were performed in triplicate to confirm results. These experiments were 
performed by Jennifer McKinney. 
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Our results clearly demonstrate that DSBs are indeed formed at the Z-DNA-
forming region as indicated by the presence of a major band at 210 bp, revealing 
a hotspot for breakage in the (CG)14 sequence, which is absent at this location in 
the control B-DNA plasmid (Fig. 2.21). However, similar to our mutation spectra 
results, DSBs were detected both in the presence and absence of XPF and we 
were unable to quantify a difference between the proficient and deficient cell 
lines. These studies are on-going to optimize conditions to determine if a 
quantifiable difference exits between cell lines.  
ERCC1-XPF nicks DNA on the 5’ side of a lesion; however, it is unknown 
whether ERCC1-XPF alone can lead to DSBs via multiple nicks, or if ERCC1-
XPF nicks once and another component is responsible for subsequent 
processing leading to DSBs. Thus, we developed an assay to detect single-
stranded nicks on either side of the Z-DNA-forming sequence. We performed in 
vitro cleavage assays using whole cell extract (WCE) from the human XPF-
proficient (WT) and XPF-deficient cell lines used in the mutagenesis and ChIP 
assays with the control B-DNA-forming or Z-DNA-forming plasmid. The addition 
of aphidicolin was used to block the repair synthesis of nicks or breaks that 
occurred, allowing easier detection of the nicks (Fig. 2.22a). By using PCR to 
extend a primer up or downstream of the insert, we detected shorter products in 
the samples containing the Z-DNA-forming sequence that were incubated with 
XPF-proficient WCE that were not present in either the control samples or the 





Figure 2.21. Analysis of Z-DNA-induced DSBs by LM-PCR. Control B-DNA 
and pU(CG)14 Z-DNA plasmids were transfected into isogenic human XPF-
proficient (XPF+) and XPF-deficient (XPF-) cells. Plasmids were purified and used 
as substrates to perform LM-PCR. Final LM-PCR products were separated on a 
1.2% agarose gel, stained by ethidium bromide and visualized. Bands indicate 
breakpoints, and a major breakpoint at the location of the Z-DNA-forming region 
on the pU(CG)14 Z-DNA plasmid (Z) resulted in a prominent band at 210 bp (red 
arrow) that is not detected at the same location in the control B-DNA control (C) 
plasmid. A negative control for the PCR reaction was used in which no template 
was added (-). This experiment was performed by Jennifer McKinney and Dr. 
Guliang Wang.  
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Interestingly, shorter products were detected with both the left and right primers 
suggesting that ERCC1-XPF may cleave both upstream and downstream on the 
3’ side of the Z-DNA-forming sequence.  
A frank DSB at the site of insert would result in a product ~160-180 bp in 
length, similar to the EcoRI positive control used in this assay (Fig. 2.22b, black 
arrow). Although the extension of the primers terminated ~500-600 bp away from 
the insert, this distance may not reflect the exact site of cleavage. Aphidicolin 
prevents DNA synthesis by blocking DNA polymerase α (278,279), therefore it is 
likely that the 500-600 bp products are a result of subsequent nuclease activity, 
resulting in chewing back of the DNA from the ERCC1-XPF-generated nick on 
either side of the insert during repair of the “damage”. The data from this result 
suggests that ERCC1-XPF can cleave at a Z-DNA-forming site further implicating 
this complex in Z-DNA-induced mutagenesis in eukaryotes. 
The results from this study suggest a novel mechanism for Z-DNA-
induced mutagenesis in eukaryotes involving components of DNA repair working 
outside of traditional repair pathways. We propose a model (Fig. 2.23) in which 
Z-DNA formation occurs during various DNA metabolic processes (i.e., 
transcription, replication, etc.), which is recognized by MSH2-MSH3 (and other 
possible factors) as “damage” and triggers a DNA damage response. MSH2-
MSH3 recruits ERCC1-XPF (and other possible factors) to the site of “damage” 
(Z-DNA structure), which processes the DNA in an attempt to remove the 
“damage”. This processing, if error free, can remain undetected with no adverse 
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outcomes. However, if error-prone, DSBs can occur, potentially resulting in large 
deletions or translocations at or near the site of “damage”, possibly explaining 









Figure 2.22. ERCC1-XPF cleaves near Z-DNA-forming sequences in plasmid 
DNA. (a) Schematic of assay. Plasmid DNA containing a B-DNA-forming control 
(C) or a Z-DNA-forming sequence (Z) was incubated in human XPF-proficient or 
XPF-deficient whole cell extract (WCE) containing aphidicolin to block repair of 
nicks, or digested with EcoRI. DNA was purified and used as a template for a 
PCR reaction using either the left or right primer (green arrows). PCR products 
were separated on 1.5% agarose gels stained with SYBR® Gold and visualized 
on a ChemiDoc Imaging System. (b) Representative gel from PCR primer 
extension assay demonstrates that cleavage of the area surrounding the Z-DNA-
forming insert on plasmid DNA occurs in XPF-proficient WCE that does not occur 
in the control plasmid or in XPF-deficient WCE as seen by extra cleavage 
products (red arrows). Included in each experiment were a negative control of 
plasmid DNA only, as well as a positive control in which plasmids were restricted 
with EcoRI at the site of the insert to demonstrate that the assay would detect a 
break resulting in a ~160 or ~180 bp product with the right or left primers, 
respectively (black arrow). These experiments were performed by Jennifer 





Figure 2.23. Model for Z-DNA-induced mutagenesis. During DNA metabolic 
processes such as replication, transcription, repair, etc., negative supercoiling is 
generated, stimulating Z-DNA formation. The structure of Z-DNA is recognized 
as “damage” by the repair complex, MSH2-MSH3 (and other possible factors), 
signaling repair. The ERCC1-XPF complex (and other possible factors) is 
recruited to the site for cleavage near the Z-DNA-forming region, resulting in 
DSBs in an attempt to repair the “damage”. The breaks may be repaired by 
factors yet to be identified, resulting in error-free repair, or the breaks may be 
processed by an end-joining mechanism resulting in genomic instability in the 
form of large deletions, translocations, which may contribute to disease etiology. 
This model was prepared by Jennifer McKinney with the assistance of Dr. Karen 




We have shown that Z-DNA-forming sequences can lead to increased 
genetic instability and DSBs in various model systems including bacteria, 
mammalian cells, and mice (60,127,128,132,171). Importantly, we, and others, 
have shown that sequences that can form Z-DNA have been shown to map to 
translocation breakpoint hotspots associated with leukemias and lymphomas 
(122,123,161,166,258). Here, we identified two major components involved in a 
mechanism responsible for Z-DNA-induced mutagenesis in eukaryotes. 
To our knowledge, this is the first demonstration that Z-DNA is mutagenic 
in yeast. We have shown that a (CG)14 Z-DNA-forming sequence is significantly 
more mutagenic in wild-type yeast strains, and leads to frank DSBs near the Z-
DNA-forming sequence, when compared to a control B-DNA-forming sequence. 
By using a yeast artificial chromosome (YAC) containing a control B-DNA or Z-
DNA-forming sequence to screen a deletion library of repair-deficient yeast 
strains, we identified several gene products that are likely to be involved in a 
mechanism of Z-DNA-induced mutagenesis. Interestingly, the most striking of 
these gene products (i.e., the gene deficiency resulting in the greatest loss of 
effect seen in wild-type caused by Z-DNA) included the NER and MMR repair 
complexes Rad10-Rad1(ERCC1-XPF) and Msh2-Msh3, respectively. In yeast 
cells deficient in Msh2, Msh3, Rad10(ERCC1), or Rad1(XPF), the frequencies 
and types of mutations seen in the Z-DNA-containing YAC were significantly 
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reduced to background levels when compared to wild-type cells. Thus, in the 
absence of these repair complexes, a Z-DNA-forming sequence was no longer 
mutagenic, suggesting that the Msh2-Msh3 and Rad10-Rad1 complexes play an 
important role in Z-DNA-induced genetic instability in yeast.  
We confirmed our results from yeast in wild-type and repair-deficient 
human cells using a plasmid-based mutagenesis assay (127,262). A plasmid 
containing a Z-DNA-forming sequence resulted in significantly higher mutations 
in wild-type human cells when compared to a control plasmid that did not contain 
Z-DNA-forming sequences. However, deficiency in XPF or MSH2 resulted in a 
decrease of mutations to near background levels when compared to control, wild-
type cells, similar to our results in yeast. Furthermore, we demonstrated that both 
ERCC1-XPF and MSH2-MSH3 complexes, but not other repair proteins in the 
NER or MMR mechanisms (i.e., XPA and MSH6, respectively), were enriched at 
a Z-DNA-forming sequence, and that ERCC1-XPF enrichment to the Z-DNA-
forming region was dependent on MSH2-MSH3, suggesting a relationship 
between the two complexes outside of canonical NER and MMR, respectively. 
We speculate that MSH2-MSH3 may recognize and bind to Z-DNA-forming 
sequences and recruit ERCC1-XPF for processing of the “damage” (Fig. 2.22).  
Although we were able to demonstrate the formation of DSBs at the Z-
DNA-forming sequence on plasmids in human cells by LM-PCR, we were unable 
to detect a quantifiable difference between WT and XPF-deficient cells lines. The 
LM-PCR results support the mutation spectra data we obtained in human cells 
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using the plasmid-based mutagenesis assay in which we saw mostly large 
deletions in WT and XPF-deficient cell lines; however, the LM-PCR assay may 
not have been sensitive enough to detect differences between cell lines. By using 
an in vitro assay with whole cell extract from wild-type and XPF-deficient human 
cells we found that wild-type WCE resulted in cleavage products near the Z-
DNA-forming site that were not present in the non-Z-DNA-forming site or in XPF-
deficient WCE, suggesting that ERCC1-XPF can cleave on either side of the Z-
DNA-forming sequence, identifying a new substrate for this structure-specific 
nuclease. 
Collectively, the data obtained from our yeast screen, as well as from our 
studies in human cells, suggest that other NER and MMR proteins are not likely 
to be involved in Z-DNA-induced mutagenesis in yeast, implicating a novel 
function for Msh2-Msh3 and ERCC1-XPF(Rad10-Rad1) complexes acting 
outside of the canonical DNA repair pathways which these protein complexes are 
known to participate. Msh2-Msh3 and Rad10-Rad1 have been shown to 
cooperate in yeast for functions other than MMR and NER pathways, including 
processing intermediates leading to efficient recombination in targeted gene 
replacement (TGR) and single-strand annealing (SSA) pathways, suggesting the 
role of Msh2-Msh3 is to either recruit or aid in the cleavage activity of Rad10-
Rad1 (280-291). Msh2-Msh3 and Rad10-Rad1 are also known to cooperate in 
the resolution of mismatches that can form between heteroalleles during meiotic 
recombination (292-295). However, neither Msh6, nor other MMR factors, were 
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found to be required for SSA or loop repair in meiotic recombination 
(282,283,287,291,293).  
In mammalian cells, ERCC-XPF and MSH2-MSH3 have also been shown 
to interact outside of the NER and MMR pathways. For example, ERCC1-XPF 
and MSH2-MSH3 have been shown to cooperate in the mechanism responsible 
for cellular resistance to chemotherapeutic interstrand crosslinking (ICL) agents 
such as cis-diamminedichloroplatinum(II) (CDDP) by facilitating ICL repair (296). 
Additionally, MSH2 and ERCC1-XPF (in addition to other repair factors) have 
been shown to interact in the repair of site-directed psoralen-induced ICLs 
(297,298). A physical interaction between MSH2 and Rad1(XPF) and 
Rad10(ERCC1) has been shown in yeast by two-hybrid analysis (291) as well as 
in mammalian cells (296). Previously, our lab has shown that MMR components 
MSH2-MSH3 and MLH1 are required for the repair of triplex-forming 
oligonucleotide (TFO)-directed psoralen ICLs (252,253), and that MMR and NER 
proteins can interact in recognizing TFO-directed ICLs (130), further implicating 
roles for such proteins outside of the canonical MMR and NER pathways during 
DNA damage recognition and processing.  
We have identified MSH2-MSH3 and ERCC1-XPF complexes to be 
involved in the mechanism responsible for Z-DNA-induced mutagenesis in 
eukaryotes. It is likely that other components are involved in this mechanism and 
subsequent studies are warranted to identify candidates, which will provide 
insight into the contribution of Z-DNA-induced genomic instability to the 
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development of human disease. Understanding the mechanisms involved in DNA 
structure-induced mutagenesis in disease etiology will allow for the advancement 
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Repetitive DNA sequences capable of adopting alternative structures (i.e. 
H-DNA) co-localize with chromosomal breakage/mutation hotspots and induce 
genetic instability. Previously, we found that an H-DNA-forming sequence from 
the c-MYC promoter that maps to a translocation hotspot in cancer, stimulates 
genetic instability in mammalian cells and mice, implicating H-DNA-forming 
sequences in disease etiology. However, the mechanism(s) of H-DNA-induced 
genetic instability is unknown. We report that H-DNA-forming sequences are 
enriched at translocation breakpoints in human cancer, implicating H-DNA in 
cancer etiology. We demonstrate for the first time that a 23-bp H-DNA-forming 
sequence is mutagenic in wild-type Saccharomyces cerevisiae cells when 
compared to a control sequence. We screened repair-deficient cells and found 
that H-DNA-induced mutagenesis was suppressed in yeast and human cells 
deficient in the nucleotide excision repair nucleases, ERCC1-XPF and XPG; and 
in contrast, was stimulated in cells deficient in FEN1, a replication-related 
endonuclease. We identified novel mechanisms with H-DNA as a substrate for 
cleavage by ERCC1-XPF, XPG, and FEN1 in distinct replication-independent 
and replication-dependent pathways of genetic instability. These results provide 
critical information for understanding the etiology of cancer and other DNA 




Repetitive DNA sequences capable of adopting alternative DNA 
secondary structures (i.e. non-B DNA) are abundant in the human genome, and 
often co-localize with endogenous disease-related mutation and breakpoint 
hotspots (11,299,300). For example, H-DNA-forming sequences are found at 
translocation hotspots in the c-MYC gene in Burkitt’s lymphoma, L3 type acute 
lymphoblastic leukemias, and plasmacytoma (141,187,301). H-DNA is an intra-
molecular triplex structure formed at alternating purine-pyrimidine mirror repeats 
(Fig. 3.1) (21). We found that a 23-bp H-DNA-forming sequence from a Burkitt’s 
lymphoma translocation hotspot in c-MYC (21) stimulated DNA double-strand 
break (DSB) formation and induced mutations, deletions, and translocations in 
mammalian cells and mice (125,128). However, the mechanisms involved in H-
DNA-induced genetic instability are largely unknown.  
The formation of the H-DNA structure causes significant helical distortion, 
which may mimic a bulky DNA adduct, similar to substrates of several DNA 
repair pathways, such as nucleotide excision repair (NER) and mismatch repair 
(MMR). Thus, we hypothesize that proteins involved in NER, MMR and structure-










Figure 3.1. DNA structures. (a) Watson-Crick double-stranded B-DNA. (b) H-
DNA intra-molecular triplex structure [adapted from (256)].    
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To evaluate the involvement of repair proteins in H-DNA-induced genetic 
instability, we developed a yeast artificial chromosome (YAC)-based genetic 
screen and found that Rad1(XPF) was required for H-DNA-induced mutagenesis. 
Additionally, we confirmed these results in human cells using a plasmid-based 
assay, and performing in vitro assays, and found that XPF was involved in the 
formation of DSBs, and had the capacity to cleave H-DNA structures along with 
both XPG and FEN1. Interestingly, FEN1 was found to be critical for maintaining 
genome stability during replication.  
Rad1(XPF) is a structure-specific nuclease required for NER, an important 
pathway for repairing a wide variety of structurally diverse DNA lesions. Once 
DNA damage is recognized and verified by the NER complexes XPC-RAD23B 
and XPA-RPA, the ERCC1-XPF complex incises the double-stranded DNA 
(dsDNA) 5’ to the lesion, while XPG incises the dsDNA 3’ to the damage. Both 
ERCC1-XPF and XPG are structure-specific endonucleases with substrate 
preferences such as NER pre-incision bubbles containing dsDNA/ssDNA 
junctions, stem loops, and 3’ and 5’ flaps respectively (302-304). 
Naturally occurring H-DNA (i.e. intra-molecular triplex) structures cause 
distortions to the DNA backbone, raising the possibility that H-DNA may be 
recognized as “damaged DNA” by the NER machinery. In support of this notion, 
NER damage/distortion recognition complexes XPA-RPA and XPC-RAD23B bind 
inter-molecular DNA triplexes, which are structurally similar to intra-molecular H-
DNA triplexes (31), with high affinity (120,126). Here, we identified H-DNA as a 
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novel substrate for the NER endonucleases ERCC1-XPF and XPG independent 
of DNA replication, and that these nucleases are involved in H-DNA-induced 
genetic instability, in the presence or absence of DNA replication. In contrast, we 
identified a novel function for another XPG-family endonuclease, FEN1, in 
preventing H-DNA-induced genetic instability in a replication-dependent manner. 
During replication, FEN1 is responsible for removing the 5’ flaps of Okazaki 
fragments and thereby prevents chromosome breaks and deletions 
(261,305,306). In support of this genome maintenance function, mutations in 
FEN1 can lead to genetic instability (307) and homozygous knockout of FEN1 is 
embryonic lethal in mice (308), underscoring the importance of FEN1 in 
proliferating cells. Our results of replication-independent genomic instability 
induced by H-DNA in FEN1 knockdown cells, taken together with the role of 
ERCC1-XPF and XPG in the presence or absence of replication provides, for the 
first time, distinct nuclease-associated, replication-dependent and replication-




3.3. Materials and Methods 
 
3.3.1. Bioinformatics analyses. The dataset containing the breakpoint 
locations of cancer genomes translocations and deletions mapped to the human 
genome assembly GRCh37/hg19 was obtained from COSMIC at 
http://cancer.sanger.ac.uk/. The total number of unique breakpoints for 
translocations and deletions was 19957 and 46372, respectively. Triplex-forming 
repeats (TFRs) located within ±100 bp from the breakpoints (bins), comprising 
two adjacent purines or pyrimidine runs of length ≥6 bases each, displaying 
mirror symmetry, and separated by a loop size of 0-7 bases, were identified 
using custom scripts. For overlapping TFRs only the longest match was output. 
The bedtools utility was used to generate a set of 20,000 non-gap-matching 
sequences (bins), each 200 bases long (166). 
 
3.3.2. Yeast strains and YACs. Yeast strain 213 (MATa Kar1-1, his7, leu2-3, 
112, ura3-52) was used for YAC construction and transfer into other yeast 
strains. The yeast strain BY4742 (MATα, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0) and 
derivatives (Yeast deletion library GSA-5, ATCC) were used in mutation 
screening. H-DNA or control sequences were cloned between the telomere seed 
G4T4 and the URA3 gene on a replication-defective plasmid derived from 
pRS306. Plasmids were linearized and used to construct YACs by homologous 
recombination with YAC VS5 containing a point mutation in the URA3 gene 
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(261,263). H-DNA or control sequences and a functional URA3 gene were 
selected on yeast minimal media SD base (Clontech, Mountain View, CA) with 
CSM-Ura (MP Biomedicals, Santa Ana, CA) plates and confirmed by polymerase 
chain reaction (PCR) with primers T7 and T3 (Table 3.1), followed by direct DNA 
sequencing. 
 
3.3.3. YAC transfer (kar-cross). Donor cells K213 containing YACs with 
human H-DNA or control sequences were grown from a single colony in SD base 
with CSM-Ura-Leu medium (MP Biomedicals) overnight at 30°C. Canavanine 
resistant recipient cells from the yeast deletion library (BY4742 background) were 
grown in yeast complete media YPD at the permissive temperature overnight. 
YACs were transferred from donor cells to recipient cells via kar-mediated 
transfer as described in Chapter 2 (Fig. 2.5) and previously (260,261). Kar 
crossed colonies were replica-plated onto CSM-Ura-Leu and CSM-lys plates to 
confirm YAC transfer (i.e.: colonies positive for YAC would grow on CSM-Ura-
Leu, but not on CSM-Lys plates). Insertion sequences on YACs were further 
confirmed by PCR amplification with primers T7 and T3 (Table 3.1) followed by 
sequencing. 
 
3.3.4. YAC fragility assay. Single yeast cells harboring YACs containing 
human H-DNA or control sequences were used to inoculate cultures and were 
grown for 20 hours at the permissive temperature in SD base with CSM-Leu 
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medium. 50 µL of each culture was plated on the SD base with CSM-Leu plates 
with 5-fluoroorotic acid (5-FOA, Zymo Research, Irvine, CA) to select for 
breakage events. 10 µL of each sample was diluted and plated on the SD base 
with CSM-Leu plates for a total cell number count. The mutation frequencies 
were calculated as the number of FOA resistant (FOAR) colonies divided by the 
number of total colonies (Fig. 2.6).  
 
3.3.5. PCR and Southern blot analysis of FOAR YAC structure. FOAR 
colonies were harvested in 30 µL water, boiled at 95°C for 5 min to lyse the cells, 
and 6 µL were used as templates for PCR reactions with URA3For and 
URA3Rev, and T3 and T7 primer sets (Table 3.1). Amplification products were 
separated on a 1% agarose gel to detect the mutations/deletions in the URA3 
gene in the YAC. Samples positive for the PCR product (i.e. the URA3 region) 
were gel purified using a Qiagen gel purification kit, and analyzed by direct DNA 
sequencing to confirm URA3 mutation resulting in FOAR. Southern blotting was 
performed on FOAR colonies as previously described (261,263). Briefly, FOAR 
colonies were grown 16 to 24 hours in CSM-Leu media, and genomic DNA was 
isolated using glass beads and Zymolyase (Zymo Research, Irvine, CA). 
Genomic DNA was digested with BstEII (New England Biolabs), separated on a 
0.8% agarose gel at 45 volts overnight, probed with a digoxigenin-labeled 
(Roche) probe of lambda DNA digested with HindIII (NEB), and detected by a 
chemiluminescent system (Roche). To detect the H-DNA sequences in the right 
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arm of YAC, genomic DNA samples were digested by PvuII (NEB) and separated 
on a 1.0% agarose gel at 45 volts overnight. A digoxigenin-labeled specific H-
DNA probe was used, and the blot was detected using a chemiluminescent 
system as described (Callahan MCB 2003) (Roche). 
 
3.3.6. H-DNA-induced mutagenesis assay in human cells. HeLa cells, 
human XPF-proficient (GM08437B-XPF) or XPF-deficient cells (GM08437B-
pLPC) (266,267), and human XPG-proficient or XPG-deficient cells (309) were 
maintained in Dulbecco’s Modified Eagle Medium (DMEM, Life Technologies, 
Carlsbad, CA) with 10% fetal bovine serum (FBS) and antibiotics. Human XPA-
proficient (XP12RO) and XPA-deficient (XP12RO Clone12) cells (310) were 
maintained in RPMI medium with 10% FBS and antibiotics. Human MSH2-
deficient (HEC59) and isogenic control MSH2-proficient (HEC59 + Chr2) cells 
[provided by Dr. Randy J. Legerski, The University of Texas, M.D. Anderson 
Cancer Center (311,312)] were maintained in DMEM with 10% FBS and 
antibiotics; MSH2-proficient selection was maintained in DMEM with 10% FBS 
and 600 µg/mL G418Sulfate (Enzo Life Sciences, Farmingdale, NY). Human 
MLH1-deficient (A2780-MNUCL1) and isogenic control MLH1-proficient (MLH1-
1) cells [provided by Dr. Margherita Bignami, Instituto Superiore di Sanita, Rome, 
Italy (313-315)] were maintained in DMEM with 10% FBS and 500 µg/mL 
G418Sulfate. The H-DNA-containing (pMexY) or control plasmids (pCex) were 
transfected into human cells using GenePORTER (Genlantis Inc., San Diego, 
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CA) according to the manufacturer’s recommendations. E. coli MBM7070 cells 
(F-lacZ (am)CA7020, lacY1, hsdR−, hsdM+, araD139 Δ(araABC-leu)7679, galU, 
galK, rpsL, thi) (316) were used in the supF-based mutation frequency assays. 
Shuttle vectors carrying human H-DNA or control B-DNA sequences were 
extracted from human cells and transformed into MBM7070 cells mutation 
frequencies were assayed by blue/white screening as previously described (262). 
DNA from individual mutant colonies was sequenced to characterize the 
mutations/deletions near the H-DNA or control B-DNA regions.  
 
3.3.7. siRNA knockdown in cultured human cells. Human FEN1 or non-
targeting siRNA (Dharmacon, GE Healthcare) were transfected into cultured 
XPF-proficient or XPF-deficient human cells with RNAimax (Invitrogen, Life 
Technologies) using the manufacturer’s recommended protocol. A second siRNA 
transfection together with the mutation-reporter plasmids was carried out 48 
hours after the first transfection using GenePORTER (Genlantis). Cells were 
harvested 48 hours later for Western blotting to examine the FEN1 protein levels, 
and plasmids were extracted for mutation analysis.  
 
3.3.8. Replication effect on H-DNA-induced mutation frequency. The SV40 
origin of replication in the plasmids carrying the human H-DNA-forming or control 
B-DNA sequences was deleted by restriction digestion (using Nco1) and ligation. 
Plasmids with or without the SV40 replication origin (pMexY and pCex; pMexY-
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SV40 and pCex-SV40, respectively) were transfected into human cells using a 
Nucleofector (Lonza, Walkersville, MD). Cells were collected 24 or 48 hours after 
transfection for blue/white screening in E. coli MBM7070 cells as described 
above.  
 
3.3.9. Ligation mediated-PCR (LM-PCR) analysis of H-DNA-induced DSBs. 
Plasmids were recovered from human cells using a modified Hirt extraction 
method that we have described previously (125,262). Briefly, extracted plasmids 
were treated with Pol I Klenow fragment to blunt the DNA ends, and ligated to the 
PCR Linkers (annealed from oligonucleotides LMPCR1 and LMPCR2). The 
ligation products were used as templates in the PCR reaction with a specific 
primer (LMsupF183) to the supF-reporter gene and a linker primer (LMPCR2) 
(Table 3.1). Amplified products were separated on a 2% agarose gel, and 
fragments of interest were purified from the gel and sequenced to map the DSB 
sites.  
  
3.3.10. Chromatin immunoprecipitation (ChIP) assay. ChIP assays were 
performed using a Simple Chip Enzymatic Chromatin IP Kit (Cell Signaling, Inc., 
Santa Cruz, CA) according to the manufacturer’s recommended protocol and as 
described previously (130). Some modifications in protocols were specific to 
yeast cells. Yeast cells containing YACs with human H-DNA-forming or control B-
DNA sequences were grown overnight at a permissive temperature and 5 mL of 
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culture was fixed with 1% formaldehyde for 8 min at room temperature to 
crosslink DNA and proteins. After quenching and washing, the YACs from the 
yeast cells were extracted using lysis buffer (0.1 M Tris-Cl pH 8.0, 50 mM EDTA, 
1% SDS) and Zymolyase (Zymo Research), followed by sonication to obtain an 
average DNA fragment length <500 bp. Approximately 1% of the total chromatin 
was stored as “input DNA” and the remaining chromatin was incubated with 5 µg 
of specific antibody (α-FEN1, α-XPG, α-XPF, Abcam, Cambridge, MA) or control 
α-IgG antibody and samples were incubated overnight at 4°C on a rotator. The 
rest of steps were performed according to the ChIP Kit protocols. Fractions of 
purified ChIP DNA and input DNA were used for PCR analysis. The primers for 
PCR amplification were T3 and T7 surrounding the H-DNA-forming or control 
sequences (Table 3.1). Amplified products were separated on 1.5% agarose gels 
containing ethidium bromide and visualized on a ChemiDoc (Bio-Rad 






Table 3.1. List of oligonucleotides used in this study. 
[modified from Zhao, et al. (submitted Nature Communications 2016)]  
  
Name Sequence 
MCR2-5’ 5’-cag gaa atc acc cct ccc ttt ttg gga ggg gcg ctt atg ggg agg g 
71 5’-ggt acc gaa ttt cgg ccg agg ggg agg ggg tgg tgg ggg ggg aag gat tcg aac ctt 
72 5’-aag gtt cga atc ctt ccc ccc cca cca ccc cct ccc cct cgg ccg aaa ttc ggt acc 
FENS1 5’-gtc atg ata gat ctg atc gct cga att cct gca gcc cgg 
FENS2 5’-ccg ggc tgc agg aat tcg ata tca agc tta tcg ata ccg tcg acc tcg a 
FENS3 5’-tcg agg tcg acg gta tcg ata agc ttg ata 
T7 5’-taa tac gac tca cta tag gg 
T3 5’-att aac cct cac taa agg ga 
URA3For 5'-tgc tgc tac tca tcc tag 
URA3Rev 5'-tcc cag cct gct ttt ctg ta 
LMPCR1 5’-cgt  aca  ttc  aca  acg  ata  gcg  act  ga 
LMPCR2 5’-gct  atc  gtt  gtg  aat  gta  cg 
LMsupF183 5’-aga tcc  agt  tcg  atg  taa  cc 
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3.3.11. Substrate preparation. The H-DNA substrate was formed by a single 
stranded oligonucleotide MCR2-5' (Table 3.1); the duplex DNA substrate was 
formed by annealing oligonucleotides 71 and 72 (130); the FEN1 cleavage 
control substrates were formed by annealing oligonucleotides FENS1, FENS2, 
and FENS3 (317); the stem-loop substrate was formed by a single-stranded 
oligonucleotide SL46 (302). The H-DNA fold-back oligonucleotide MCR2-5' was 
incubated in triplex-forming buffer (20 mM NaCacodylate, 0.1 mM EDTA, 10 mM 
MgCl2, 100 mM NaCl), and the other substrates were formed by annealing 
oligonucleotides in buffer (10 mM Tris, pH 8.0, 50 mM NaCl, 1 mM EDTA), boiled 
for 10 min, and slowly cooled to room temperature. Formation of the various 
structures was confirmed by native acrylamide gel electrophoresis and/or circular 
dichroism. 
 
3.3.12. Circular dichroism (CD). Blank and sample-containing quartz cuvettes 
were matched prior to use. The CD spectrum of 10 µM MCR2-5’ was measured 
at pH 7.0 in 20 mM HEPES, 100 mM NaCl, 0.1 mM EDTA and 10 mM MgCl2 at 
25°C. Samples were evaluated on a Jasco J-815 CD Spectrometer (JASCO, 
Inc., Easton, MD) equipped with a Peltier temperature controller and scanned 
from 200 – 350 nm. Data were processed using the JASCO software and 
exported to Sigma Plot 10. The negative peak at 210-220 nm represents the 
formation of a triplex structure.  
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3.3.13. Cleavage assays. Radiolabeled H-DNA-forming fold-back 
oligonucleotides, duplex DNA, and flap substrates (at 6x10-8 M) were incubated 
with 20 ng of purified human recombinant FEN1 protein (Provided by Dr. Binghui 
Shen, City of Hope) in reaction buffer (40 mM Tris-HCL pH 7.5, 10 mM MgCl2, 5 
mM DTT, 200 mg/mL BSA) (317) at 30°C for 15 min. Cleaved products were 
separated on a 20% denaturing polyacrylamide gel, and visualized using a 
Typhoon PhosphorImager (GE Healthcare Life Sciences). Forty-eight ng of 
purified human recombinant XPG protein (provided by Dr. Richard D. Wood, The 
University of Texas M.D. Anderson Cancer Center) (318), or BSA was incubated 
with 4x108 M DNA substrates at 30°C overnight in a buffer containing 25 mM 
HEPES (pH=6.8), 4 mM MnCl2, 1 mM DTT, 250 µg/mL BSA, and 10% glycerol. 
Formamide/dye was added to stop the reactions and the cleavage products were 
resolved on a 12% denaturing polyacrylamide gel. Cell extracts were prepared 
from XPF-proficient or XPF-deficient cells (266,267) using a NucBuster kit (EMD 
Millipore, Temecula, CA). The triplex structure formed by oligonucleotide MCR2-
5' (Table 3.1) was incubated with cell extract in reaction buffer (40 mM Tris-HCL 
pH 7.5, 10 mM MgCl2, 5 mM DTT, 200 mg/mL BSA) at 30°C for 1 hour. 
Formamide/dye was added to stop the reactions and the cleavage products were 







3.4.1. H-DNA-forming sequences map to breakpoints in human cancer 
genomes. 
 
To determine the impact of H-DNA-forming sequences in human cancer 
etiology, we mapped H-DNA (triplex)-forming sequences (TFRs) within ±100 bp 
(thereafter referred as to bins) of 19,956 translocation breakpoints from 
sequenced cancer genomes (COSMIC at http://cancer.sanger.ac.uk/). We 
determined the distributions of each TFR midpoint relative to the breakpoint 
positions (taken to be 0). Both the fraction of bins harboring TFRs ≥6 bp on each 
mirror repeat arm and the number of TFRs (normalized to 20,000 bins) were 
greater for translocations (35.3±6.6 and 6,676) than for those in 20,000 random-
pick control sequences extracted from the reference human genome (24.9±4.9 
and 4,715) (P value from t-test, 4.2x10-50, Fig. 3.2a). In addition, the number of 
TFRs in each bin surrounding the translocation breakpoints was consistently 
higher than control (Fig. 3.2b). Thus, H-DNA-forming sequences are significantly 
enriched surrounding human cancer translocation breakpoints, implicating H-









Figure 3.2. H-DNA (triplex)-forming sequences (TFRs) are associated with 
translocations in human cancer genomes. (a) Running average of TFRs in the 
human cancer translocation breakpoint (red) and control (black) datasets whose 
center loop positions are located at each base along the ±100 bp flanking cancer 
translocation breakpoints or the control sites. (b) Distribution of number of 
bins/20,000 bins containing TFRs in cancer translocation breakpoint (red) and 
control (black) datasets [adapted from (166)]. 
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3.4.2. H-DNA-induced genetic instability in Saccharomyces cerevisiae. 
 
To identify the gene products involved in H-DNA-structure-induced DSB 
formation and genetic instability, we developed a yeast artificial chromosome 
(YAC) (261,263) carrying a 23-bp human H-DNA-forming sequence from a 
Burkitt’s lymphoma translocation hotspot in c-MYC or a B-DNA control sequence 
(Fig. 3.3a) adjacent to a selectable URA3 gene (266). We found for the first time, 
that this human H-DNA-forming sequence stimulated genetic instability ~9.4-fold 
above that of the control in wild-type (WT) BY4742 yeast (Fig. 3.3b, 11.60x10-5 
vs. 1.24x10-5). PCR (Fig. 3.3c) and Southern blotting (Fig. 3.3d) confirmed that 
the YAC underwent DSBs and lost the distal end of the chromosome in the 
majority of the URA3-deficient cells, consistent with our finding of H-DNA-
induced DSBs and genetic instability in mammalian cells and mice (125,128). 
Thus, the H-DNA-induced mutagenesis in yeast is comparable to that detected in 
human cells, and likely occurs via a similar processing mechanism. 
We used this YAC system to screen multiple repair-deficient strains for 
effects on H-DNA-induced mutagenesis when compared to the ~9.4-fold 
induction seen in WT cells. Due to the similarity of structural characteristics of H-
DNA to substrates processed by the NER and MMR mechanisms (i.e. bulky 
adducts, and helical distortions), cells deficient in these repair pathways were 
initially screened. Data obtained for the NER pathway are discussed below as 
included in our manuscript. Please see the section titled, “Work in progress 
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related to the H-DNA-induced mutagenesis project” at the end of this chapter for 
the MMR-related data. 
Strikingly, in yeast rad1Δ(XPF) and rad10Δ(ERCC1) strains that are 
deficient in the NER endonuclease complex Rad1-Rad10 (XPF-ERCC1), H-DNA-
induced genetic instability was significantly reduced to 37% and 24% of that 
found in the WT BY4742 strain, respectively (Fig. 3.3b; t-test, P value <0.05). 
Thus, in rad1Δ and rad10Δ cells H-DNA-induced genetic instability was only 3.3- 
fold and 2.0-fold above that of the control B-DNA sequence, significantly lower 
than the 9.4-fold induction in the WT BY4742 cells, indicating that the NER 
nuclease complex, Rad1-Rad10(ERCC1-XPF), is necessary for the H-DNA-












Figure 3.3. NER-associated H-DNA-induced genetic instability in yeast 
cells. (a) Schematic structure of YACs used for H-DNA-induced genetic 
instability in yeast. (b) H-DNA-induced fragility frequencies in reporting YACs, as 
assessed by 5-flurooratic acid (FOA) resistance, in WT (BY4742), rad1Δ or 
rad10Δ yeast strains from a yeast single-gene deletion library (GSA-5, ATCC). 
The numbers below the graph show the fold increases in H-DNA-induced genetic 
instability above the control in each cell line (Fold to Con). At least 30,000 
colonies were screened in each fragility assay. Error bars represent the s.d. from 
three repeats; two-sided t-test, P values <0.05(*), <0.01(**). (c) Representative 
agarose gel for analysis of FOAR colonies that were lysed and used as PCR 
templates using URA3For and URA3Rev primer sets. Products were separated 
on a 1% agarose gel with a 1 kb and 100 bp marker (M). Starting material for the 
fragility assay containing full length, FOAS YAC, served as a positive control (+). 
The blue arrow indicates the target region amplified. (d) Representative Southern 
blot analysis to determine presence of YAC in FOAR colonies. Isolated genomic 
DNA from colonies containing the YAC (BY) were digested with BstEII, separated 
on a 0.8% agarose gel with a 1-kb ladder (M), and probed with a digoxigenin-
labeled probe of lambda DNA digested with HindIII and detected by 
chemiluminescence. Cells lacking the YAC served as a negative control (B). 
These experiments were performed by Jennifer McKinney and Dr. Junhua Zhao 












3.4.3. H-DNA-induced genetic instability in human cells. 
 
To determine the effect(s) of NER factors on H-DNA-induced mutagenesis 
in human cells, we utilized a supF-reporter system (125) (Fig. 3.4a) in human 
cells from Xeroderma Pigmentosum (XP) patients (318). Consistent with our 
results in yeast, H-DNA-induced genetic instability was significantly decreased in 
XPF-deficient human cells to that of isogenic XPF-proficient (WT) cells (2.0-fold 
induction over the control compared to 11.1-fold in the human XPF-proficient 
cells) (Fig. 3.4b). A similar reduction in H-DNA-induced mutagenesis was also 
observed in XPA-deficient patient cells, resulting in a decrease of H-DNA-
induced mutation frequency from 11.1-fold in XPA-proficient (WT) cells over the 
control to a 2.9-fold induction over control in XPA-deficient cells (Fig. 3.4b), 
suggesting a role for functional NER in the mutagenic processing of H-DNA in 
human cells. 
Analysis of the H-DNA-induced mutation spectra in human cells revealed 
that XPF-deficiency substantially reduced deletion events from 77% (28/36 
mutants sequenced) in XPF-proficient cells to 41% (12/29 mutants sequenced) in 
XPF-deficient cells (Table 3.2; x2 test, P value <0.01), suggesting that XPF is 
involved in H-DNA processing in human cells. In addition to ERCC1-XPF, XPG is 
a structure-specific endonuclease required for cleaving damaged DNA in NER. 
Although XPG deficiency did not substantially alter the H-DNA-induced mutation 
frequency (data not shown), its absence resulted in significantly fewer deletion 
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events compared to XPG-proficient human cells; 71% (15/21) of the mutants 
contained deletions in the XPG-proficient cells versus 33% (7/21) in the XPG-
deficient cells (Table 3.2; x2 test, P value <0.05). Collectively, these results 








Figure 3.4. NER-associated H-DNA-induced genetic instability in human 
cells. (a) Schematic structure of the supF-reporter vector containing human B-
DNA or H-DNA-forming sequences. (b) H-DNA-induced mutation frequencies in 
NER-proficient (WT) and NER-deficient human cells. “Fold to Con” was 
calculated as described above in Figure 3.2b. At least 30,000 colonies were 
screened in each assay. Error bars represent the s.d. from three repeats; two-
sided t-test, P values <0.05(*), <0.01(**). These experiments were performed by 





Table 3.2. Analysis of H-DNA-induced and spontaneous (B-DNA) mutations in 
human cells. 
“*”: P value <0.05; “**”: P value <0.01 in χ2 test.  
[Zhao, et al. (submitted Nature Communications 2016)] 
 
  
Strains Replication status 






XPF+ + 77.8% (28 /36) 22.2% (8/36) 38.9% (7/18) 61.1% (11/18) 
XPF- + 41.4%** (12/29) 58.6% (17/29) 53.8% (14/26) 46.2% (12/26) 
      XPG+ + 71.4% (15/21) 28.6% (6/21) 41.2% (7/17) 58.8% (10/17) 
XPG- + 33.3%* (7/21) 66.7% (14/21) 12.5% (2/16) 87.5% (14/16) 
      XPA+ + 71.4% (10/14) 28.6% (4/14) 11.1% (2/18) 88.9% (16/18) 
XPA- + 56.5% (13/23) 43.5% (10/23) 26.7% (4/15) 73.3% (11/15) 
      HeLa, siCON + 77.8% (14/18) 22.2% (4/18) 66.7% (6/9) 33.3% (3/9) 
HeLa, siFEN + 
100.0% 
**(43/43) 0.0% (0/43) 92.9% (13/14) 7.1% (1/14) 
      XPF+, siCON - 15.0% (3/20) 85.0% (17/20) 0.0% (0/21) 100.0% (21/21) 
XPF+, siCON + 47.4% (9/19) 52.6% (10/19) 4.4% (1/23) 95.6% (22/23) 
XPF-, siCON - 12.5% (1/8) 87.5% (7/8) 19.0% (4/21) 81.0% (17/21) 
XPF-, siCON + 34.8% (8/23) 65.2% (15/23) 0.0% (0/19) 100.0% (19/19) 
      XPF+, siFEN - 30.8% (4/13) 69.2% (9/13) 25.0% (2/18) 75.0% (16/18) 
XPF+, siFEN + 28.0% (7/25) 72.0% (18/25) 6.2% (1/16) 93.8% (17/16) 
XPF-, siFEN - 14.3% (1/7) 85.7% (6/7) 83.3% (10/12) 16.7% (2/12) 
XPF-, siFEN + 15.8% (3/19) 84.2% (16/19) 5.3% (1/19) 94.7% (18/19) 
 138 
3.4.4. H-DNA is a substrate for NER-associated endonucleases. 
 
Because we detected a significant decrease in H-DNA-induced deletions 
in the absence of ERCC1-XPF (Table 3.2), we speculated that this NER 
structure-specific nuclease was involved in cleaving the H-DNA structure during 
its processing. Thus, to determine the effect of ERCC1-XPF on H-DNA-induced 
DSB formation, ligation-mediated PCR (LM-PCR) was employed to map DSBs in 
human cells. Our LM-PCR results identified DSBs near the H-DNA-containing 
region on plasmids recovered from human XPF-proficient cells with a particularly 
strong signal at 230 bp (Fig. 3.5a) near the H-DNA site. In contrast, the DSB 
signal at the H-DNA site (230 bp) was substantially diminished in the XPF-
deficient human cells (Fig. 3.5a, compare lane 4 to lane 3), further supporting a 
role for ERCC1-XPF in processing H-DNA structures to generate DSB 
intermediates, resulting in deletions and subsequent genetic instability. 
Preferred substrates for ERCC1-XPF and XPG cleavage include NER pre-
incision bubbles containing dsDNA/ssDNA junctions, stem loops, and 3’ and 5’ 
flaps (302-304); however, the activities of ERCC1-XPF and XPG on H-DNA are 
unknown. In the XPF-proficient human cell extracts, an H-DNA structure formed 
on oligonucleotide MCR2-5’ (Table 3.1 and Fig. 3.5b) (confirmed by native gel 
electrophoresis and circular dichroism, Fig. 3.6) was cleaved resulting in a 37-nt 
cleavage product, which was dramatically reduced in the XPF-deficient extracts 
(Fig. 3.5c). Interestingly, the predominant cleavage site was on the loop between 
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the two Hoogsteen hydrogen-bonded strands, rather than at the Watson-Crick 
hydrogen-bonded region adjacent to the loop. Consistent with a role for NER in 
H-DNA processing, purified human recombinant XPG also cleaved the MCR2-5’ 
H-DNA substrate, resulting in removal of the 5’ ssDNA flap at the junction 
adjacent to the Watson-Crick base-paired duplex (Fig. 3.5d). To our knowledge, 
this is the first demonstration of cleavage of H-DNA by ERCC1-XPF and XPG, 
and thus represents a novel substrate for these nucleases, further implicating 






Figure 3.5. NER-associated H-DNA-induced processing. (a) LM-PCR 
detection of DSBs on plasmids recovered from XPF-proficient or XPF-deficient 
human cells 24 hours after transfection. PCR products were separated on a 1.5% 
agarose gels. The 230-bp PCR fragment maps to a DSB hotspot within the H-
DNA-forming sequence. (b) Schematic of the H-DNA structure of oligonucleotide 
MCR2-5’. Black dots represent the Watson-Crick hydrogen-bonds, and the red * 
represent the Hoogsteen hydrogen bonds at the triplex structure. Cleavage sites 
of XPF, XPG, and FEN1 from (c), (d) and Fig. 3.7c are indicated on the structure 
in the schematic. (c) Cleavage of H-DNA in XPF-proficient and XPF-deficient 
human cell extracts. The 37-nt cleavage product is marked by an arrow. (d) H-
DNA cleavage by purified recombinant human XPG protein. A stem-loop 
substrate serves as a positive control for XPG cleavage. The cleavage products 
of 35-nt from the stem-loop, and 10-nt from the H-DNA substrates are marked by 
arrows. These experiments were performed by Dr. Junhua Zhao. [Zhao, et al. 









Figure 3.6. Circular dichroism (CD) spectrum of the triplex fold-back 
oligonucleotide MCR2-5’. The CD spectrum of MCR2-5’ at a 10 µM 
concentration in a buffer (pH 7.0) containing 20 mM HEPES, 100 mM NaCl, 0.1 
mM EDTA and 10 mM MgCl2, at 25°C. The strong negative peak at ~210 nm is 
characteristic of triplex formation (319). This experiment performed by Dr. Imee 




3.4.5. Rad27(FEN1) inhibits genomic instability caused by H-DNA. 
 
Based on our results with the NER nucleases, we speculated that other 
structure-specific endonucleases may also process H-DNA structures. For 
example, FEN1 belongs to the FEN1/XPG family of endonucleases, and shares 
a conserved active site with XPG (320). Thus, we evaluated H-DNA-induced 
mutagenesis in a rad27-deleted yeast strain, the yeast homolog of human FEN1. 
Strikingly, H-DNA-induced mutagenesis was substantially increased in the 
rad27Δ strain relative to the WT cells (Fig. 3.7a: 11.6x10-5 in WT versus 56.5x10-
5 in the rad27Δ cells; t-test, P value <0.01), ~794% over that induced by H-DNA 
in the WT strain (t-test, P value <0.01). Consistent with our results in yeast, 
depletion of FEN1 using siRNA in HeLa cells (to <10% of WT levels as assessed 
by immunoblotting, Fig. 3.8) increased H-DNA-induced genetic instability over 
the control from 6.5-fold in WT HeLa cells to 19.7-fold in the FEN1-depleted 
HeLa cells, ~485% over that induced by H-DNA in the WT cells (Fig. 3.7b; t-test, 
P value <0.05). These results implicate FEN1 in maintaining genomic stability at 
the H-DNA region, perhaps by cleaving and unwinding the mutagenic H-DNA 
structure.  
Further support for this notion was provided by our finding that human 
recombinant FEN1 protein (321) cleaved the MCR2-5’-derived H-DNA substrate 
at the base of the 5’ flap, resulting in a 10 nt cleavage product (Fig. 3.7c). 
Moreover, FEN1-depletion in HeLa cells resulted in a statistically significant 
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increase in large deletions (100%, 43/43) compared to the WT cells (Table 3.2; x2 
test, P value <0.01). Thus, we have identified H-DNA as a novel substrate for 
FEN1 cleavage, and in contrast to cleavage by the NER nucleases, FEN1 








Figure 3.7. FEN1 cleavage and inhibition of H-DNA structure-induced 
mutagenesis. (a) H-DNA-induced FOA resistance on YACs in WT (BY4247) or 
rad27Δ strains. (b) H-DNA-induced mutation frequencies on supF-mutation 
reporters in WT or FEN1-depleted HeLa cells. (c) Cleavage of H-DNA formed on 
oligonucleotide MCR2-5’ and flap structures (Table 3.1) by purified recombinant 
human FEN1 protein. The 20-nt cleavage product from its preferred substrate (a 
5’ flap), and the 10-nt product from H-DNA are marked by arrows. These 
experiments were performed by Jennifer McKinney and Dr. Junhua Zhao. [Zhao, 






Figure 3.8. SiRNA-mediated depletion of FEN1 in human cells. (a) Detection 
of FEN1 protein in HeLa cells treated with FEN1 siRNA (siFEN) or non-targeting 
control siRNA (siCON) by immunoblotting 48 hours post-treatment. (b) Detection 
of FEN1 protein in XPF-proficient or XPF-deficient human cells treated with 
FEN1 siRNA (siFEN) or non-targeting control siRNA (siCON), as assessed by 
immunoblotting 48 hours post-treatment. The amount of FEN1 expression was 
quantified using ImageJ. The percentages shown below the gel were compared 
to the expression levels in control knockdown samples. This experiment was 




3.4.6. Distinct mechanisms for replication-dependent and replication-
independent H-DNA processing. 
 
The interaction of NER and FEN1 proteins with H-DNA was confirmed by 
ChIP assays in yeast. Using primers flanking the human H-DNA sequences on 
the YAC (Table 3.1), we detected a 12-fold enrichment of Rad27(FEN1) at the H-
DNA-forming region over that of a control region (Fig. 3.9a). Enrichment of 
Rad1(XPF) and Rad2(XPG) was also detected at the H-DNA region, at a 12-fold 
and 14-fold enrichment above the control region, respectively (Fig. 3.9a). 
Notably, the absence of Rad14(XPA) reduced Rad1(XPF) binding to H-DNA by 
~4-fold (from 32-fold to 9-fold above the control, Fig. 3.9b), consistent with a 
requirement for functional NER to recruit ERCC1-XPF to H-DNA. In contrast, the 
enrichment of Rad27(FEN1) remained at similar level in the presence or absence 
of Rad14(XPA) (Fig. 3.9b). Taken together, these results support a role for NER 
in the recognition and processing of H-DNA in vivo, a mechanism distinct from 
that of FEN1. 
DNA replication plays a key role in many types of DNA structure-induced 
mutation (254). Thus, we asked whether the effect of ERCC1-XPF and FEN1 on 
H-DNA mutagenesis was dependent on DNA replication. In both replication-
proficient (Fig. 3.9c) and replication-deficient systems (Fig. 3.9d), H-DNA 
stimulated mutations over the background control levels. In both cases, XPF 
deficiency resulted in a significant decrease in H-DNA-induced mutagenesis 
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compared to XPF-proficient cells; however, its role in the replication-deficient 
system was more substantial than in the replication-proficient assay (Fig. 3.9c 
and d; t-test, P value <0.05). These results revealed a critical role for XPF in a 
replication-independent mechanism(s) of H-DNA-induced mutagenesis in human 
cells, consistent with our NER “damage” repair model (Fig. 1.7) (31,125,256). We 
posit that in non-replicating DNA, the “repair” cleavage of H-DNA by ERCC1-XPF 
and XPG results in DNA breaks that are processed by an error-prone 
microhomology-mediated end-joining (MMEJ) mechanism. In contrast, the effect 
of FEN1 on H-DNA-induced mutagenesis was dependent on DNA replication; 
FEN1-depletion in human cells resulted in an increase in H-DNA-induced 
mutagenesis only in replicating templates in both XPF-proficient and XPF-
deficient cells (Fig. 3.9c and d). These results suggest that the role of FEN1 in H-
DNA structure-induced mutagenesis was largely dependent on active DNA 
replication.  
Because H-DNA can stall replication forks in vivo (322), we hypothesize 
that in the absence of FEN1, the H-DNA structures may persist at replication 
forks leading to fork collapse, which can result in DSBs and an increased 
frequency of mutagenic events. Thus, our data support a model in which FEN1 
cleaves H-DNA structures (or their intermediates) during replication to resolve 
the mutagenic structures to ensure continuous replication. The resulting repair 
intermediates may then be processed by error-free repair pathways that are 





Figure 3.9. Association of endonucleases with H-DNA and effects of 
replication on H-DNA-induced mutagenesis. (a) Yeast ChIP results 
demonstrate enrichment of XPF(Rad1), XPG(Rad2), and FEN1(Rad27) at H-
DNA relative to control B-DNA. The ChIP signal resulting from the PCR assay of 
the H-DNA-forming sequence was normalized to the control sequence for each 
antibody used for the pulldown; “Fold (H/C)”. (b) ChIP results in rad14Δ(XPA) 
yeast demonstrate a requirement for Rad14(XPA) in the recruitment of 
XPF(Rad1), but not FEN1, to H-DNA. (c) and (d) Effects of XPF and FEN1 on H-
DNA-induced mutagenesis in replicating (c) or non-replicating systems (d). Error 
bars represent s.d. from three repeats; two-sided t-test, P values <0.05 (*), <0.01 
(**). These experiments were performed by Jennifer McKinney, Dr. Aklank Jain, 






Figure 3.10. Models of replication-dependent and replication-independent 
H-DNA-induced genetic instability in eukaryotes. (a) Formation of the H-DNA 
structure is recognized as “damage” and is cleaved by NER nucleases, 
XPF/ERCC1 and XPG. This cleavage results in DNA strand breaks and 
subsequent deletions. (b) During replication, FEN1 cleavage of H-DNA can result 
in error-free processing. However, in the absence of FEN1, the H-DNA structure 
may persist at a replication fork, causing fork collapse, which could result in 






 H-DNA structure-forming sequences often co-localize with chromosomal 
breakage and translocation hotspots in Burkitt’s lymphoma, plasmacytoma, and 
leukemias (141,166,187,299,301). In various model systems, H-DNA structures 
have been shown to stimulate mutations/deletions and subsequent genetic 
instability (125,128). Our study identified two mechanisms of H-DNA-induced 
genomic instability; one replication-dependent, and the other replication-
independent.  
  It has been reported that NER plays an important role in recognizing inter-
molecular triplex structures (120,126,323). Cleavage of TFO-directed DNA 
interstrand crosslinks by NER proteins has also been detected (120,126,324-
326). Due to the similarity in TFO-directed inter-molecular triplex DNA structures 
and intra-molecular triplex H-DNA structures, the potential role of DNA repair 
proteins on DNA structure-induced genetic instability has been speculated (256). 
Here, we identified the involvement of the Rad1(XPF) and Rad10(ERCC1) 
complex in H-DNA structure-induced genomic instability in yeast and detected 
cleavage of H-DNA by XPF in human cell extracts and purified XPG protein. In 
the NER mechanism the structure-specific nucleases, ERCC1-XPF and XPG, 
cleave at the 5’ and 3’ sides of bulky adducts, respectively, to excise the 
damaged strand (302,318,327,328). Our results demonstrating a role for ERCC1-
XPF in H-DNA-induced DSB formation and the generation of deletions suggested 
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that H-DNA may be recognized as “damaged DNA”, where the H-DNA structures 
were cleaved by ERCC1-XPF and XPG, resulting in an error-prone abortive DNA 
repair via DSB intermediates (31,125,256). Due to the structural alterations found 
in H-DNA, the cleavage sites are possibly different from the canonical ERCC1-
XPF and XPG substrates, which do not contain Hoogsteen H-bonding 
(303,318,329,330). XPG cleaved the triplex structure at the ssDNA and dsDNA 
junction of the 5’ overhang, consistent with previous reports (304,318,330). 
However, the predominant ERCC1-XPF cleavage site was identified in the loop 
3’ to the dsDNA, and not at the dsDNA region (303). In any case, these results 
implicated H-DNA as a novel substrate for ERCC1-XPF and XPG cleavage, 
which may generate strand breaks for further repair processing. 
  DSBs near the H-DNA region were detected in human XPF-proficient cells 
but not in XPF-deficient cells, consistent with the cleavage of H-DNA by ERCC1-
XPF and XPG. In fact, the majority of H-DNA-induced mutations generated in the 
human XPF- and XPG-proficient cells were deletions. In contrast, point mutations 
comprised the majority of deletions in the human XPF-deficient and XPG-
deficient cells, indicating that ERCC1-XPF and XPG promote strand breaks at H-
DNA structures. H-DNA structure-induced genomic instability was significantly 
reduced in XPF-deficient cells, and this effect did not require active DNA 
replication, suggesting that ERCC1-XPF may be functioning via NER in non-
replicating cells. Further, the recruitment of XPF and XPG proteins to H-DNA 
required XPA in ChIP assays, further supported a role for NER in the mutagenic 
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processing of H-DNA. However, we cannot exclude a role for ERCC1-XPF 
outside of NER (303,331,332) or a role for XPG in transcription (333) as 
contributors to the variations in mutation frequencies and spectra identified. 
  In contrast to the effects of ERCC1-XPF on H-DNA-induced mutagenesis, 
which were independent of DNA replication, the stabilizing effect of FEN1 on H-
DNA was largely dependent on active DNA replication. FEN1 plays an important 
role in 5’ DNA flap removal during replication and replication fork rescue 
(305,306). The cleavage of the triplex structure with a 5’ overhang by FEN1 was 
detected in our study and the depletion of FEN1 in human cells stimulated H-
DNA-induced instability in a DNA replication-dependent manner. Thus, our 
results provide a plausible explanation for the processing of H-DNA during 
replication. In the absence of FEN1, the H-DNA structure may persist at a 
replication fork, causing fork collapse, which could result in DSBs and increased 
frequencies of mutagenic events, such as the deletions that we have observed.  
Many more genes are likely involved in H-DNA-induced DNA breakage, 
repair and mutagenesis as a network in human cells, similar to that described in 
prokaryotes (334). Further work to identify candidate genes is warranted, as it will 
provide critical information for understanding the mechanisms of DNA structure-




3.6. Work in progress related to the H-DNA-induced mutagenesis project 
 
We screened mutants deficient in MMR proteins to evaluate the effect of 
these proteins on H-DNA-induced genetic instability. While the H-DNA structure 
may mimic a bulky adduct and thus become a DNA “damage” substrate of the 
NER pathway, the structure contains a single-stranded loop that may also be 
recognized as “damage” by MMR components. Additionally, our lab has found 
that the MMR, MSH2-MSH3 recognition complex, and the MMR protein MLH1 
are involved in the damage signaling and error-free repair of triplex-forming 
oligonucleotide (TFO) psoralen-directed inter-strand crosslinks (ICLs) (252,253). 
Moreover, our lab has shown interactions between MMR and NER proteins, e.g. 
MSH2-MSH3 and XPC, and XPA/RPA on TFO ICLs (130), suggesting that 
proteins from multiple repair pathways may be acting outside canonical roles in 
DNA damage recognition and repair to participate in H-DNA-induced 
mutagenesis or inhibition. Thus, we hypothesize that proteins from multiple DNA 
recognition/processing pathways are also likely to be involved in H-DNA-induced 
mutagenesis and it is of interest to screen for gene products involved in this 






3.6.1. The role of MMR proteins in H-DNA-induced genomic instability in 
yeast. 
 
We used the yeast deletion library to screen MMR components as 
described in the methods. Interestingly, we found that the msh2 mutant strain 
resulted in a decrease in H-DNA-induced mutagenesis relative to background 
level (Fig. 3.11a; 1.3-fold induction compared to 9.4-fold in WT). The deletion of 
msh3 did not result in a significant decrease in H-DNA-induced genetic instability 
(Fig 3.11a 10.3-fold compared to 9.4-fold in WT), while the deletion of other MMR 
components, msh6Δ and mlh1Δ did result in a reduction in H-DNA-induced 
mutation frequencies (Fig. 3.11a 3.6-fold and 4.7-fold, respectively compared to 
9.4-fold in WT). Our results of an effect on H-DNA mutagenesis in msh2Δ, 
msh6Δ, and mlhΔ, but not msh3Δ suggest the Msh2-Msh6 complex recognizes 
H-DNA, which is interesting since its role in MMR is to recognize single base pair 
mismatches, while the Msh2-Msh3 complex recognizes up to 10 base pair loops 
(242,244,335-337); however, it should be noted that the elevated background 
genomic instability needs to be taken into consideration (Fig. 3.11a, compare 
blue bars). If the raw data is considered, it is comparable to that of WT (Fig. 3.11, 
compare red bars), demonstrating that our H-DNA-forming sequence is still 
mutagenic in these mutant strains.  
The analysis of the mutation spectra caused by H-DNA in msh2Δ revealed 
a large percentage of point mutations (Fig. 3.11b). Of the 105 FOAR colonies we 
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analyzed in the H-DNA YAC in the Δmsh2 strain, 13 maintained the right arm of 
the YAC, compared to 0 out of 30 in the WT strain. These results suggest that in 
the msh2Δ strain containing the H-DNA YAC, the FOAR mutants are caused by 
random point mutations in the URA3 gene, most likely due to the lack of 
functional MMR pathway, and as a result of H-DNA formation. A slight increase 
in point mutations in FOAR colonies was also found in msh3Δ and msh6Δ strains 
containing the H-DNA YAC. These data are preliminary and statistical analyses 
still need to be assessed. 
 
 
3.6.2. The role of MMR proteins in H-DNA-induced genomic instability in 
human cells. 
 
 We used the plasmid-based assay described in the methods and human 
MSH2-proficient and MSH2-deficient cell lines to evaluate the role of MSH2 in H-
DNA-induced mutagenesis in human cells. Preliminary results in our lab 
demonstrated a decrease in H-DNA-induced mutagenesis in human MHS2-
deficient cells compared to MSH2-proficient when compared to the control 
plasmid (Fig 3.11c, 4-fold in MSH2-deficient cells compared to 10.3-fold in 
MSH2-proficient cells), suggesting a role for Msh2 in promoting genetic instability 
caused by H-DNA, and validating our yeast data. However, my recent results 
suggested that there was no difference in H-DNA-induced mutagenesis in human 
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MHS2-proficient and MSH2-deficient cells (3.7-fold vs. 4.0-fold, respectively) as 
well as in MLH1-proficient and MLH1-deficient cells (6-fold vs. 4.0-fold, 
respectively) (Fig. 3.11d), suggesting that neither protein is involved in H-DNA-
induced mutagenesis. These studies are on going and require further 






Figure 3.11. Preliminary data on the role of MMR proteins in H-DNA-induced 
mutagenesis in yeast and human cells. (a) H-DNA-induced FOA resistance on 
YACs in WT (BY4247) or MMR mutant strains. (b) Number of point mutations 
evaluated in FOAR colonies for WT and MMR mutant yeast strains in control (B-
DNA) and H-DNA YACs. (c) Previous data measuring H-DNA-induced mutation 
frequencies on supF-mutation reporters in WT (Hec59+Chr2) and MSH2-
deficicient (Hec59) human cells. (d) Recent data measuring H-DNA-induced 
mutation frequencies on supF-mutation reporters in MSH2 and MLH1-proficient 
and deficient human cell lines. Experiments in a and b were performed by Dr. 

















Chapter 4: Stable Integration of ADAR1 Over-expression 





 More than 10 different non-B DNA structures have been described that 
differ from the well-known Watson-Crick B-DNA double helix. For example, Z-
DNA is a left-handed helix that forms at sequences of alternative purines and 
pyrimidines with the energy provided by negative super-coiling, resulting from an 
open B-DNA duplex. Sequences that can form Z-DNA are found in various 
species of prokaryotes and eukaryotes, and are very abundant in the human 
genome, occurring 1/3,000 base pairs. While Z-DNA has been found to play a 
role in gene regulation, we have demonstrated that Z-DNA is mutagenic, 
resulting in double-strand breaks (DSBs) in human cells. Evidence suggests that 
Z-DNA is involved in several important biological processes, and Z-DNA-binding 
proteins that specifically bind to the Z-DNA structure have been identified. 
Adenosine deaminase acting on RNA 1 (ADAR1-p150) is a human protein that 
contains Z-DNA-binding domains and further suggests that Z-DNA is involved in 
transcription. We have obtained a plasmid vector that over-expresses ADAR-
p150; a tool that we will use to further study the role of Z-DNA-induced 
mutagenesis. Here we describe the development of a COS-7 mammalian cell 






 Genomic DNA typically exists in the canonical, right-handed B-
conformation that was described in 1953 by James Watson and Francis Crick 
(Fig. 4.1a, “B-DNA”) (1). However, DNA is a dynamic molecule, and can adopt 
several secondary conformations, collectively referred to as non-B DNA 
structures, that differ significantly from that of B-DNA. More than 12 non-B DNA 
structures have been identified and described, including the left-handed Z-DNA 
conformation, which is the focus of this chapter (Fig. 4.1b) (10-12,24,77,338). 
Sequences that can adopt non-B DNA structures are naturally occurring and 
abundant in the human genome. For example, sequences capable of adopting a 
Z-DNA structure have been found to occur ~1/3000 bp (41). The structure of Z-
DNA was first described in 1979 and made the cover of Nature (8), and 
continues to be an active area of research.  
Z-DNA can form at sequences of alternating purines and pyrimidines (i.e. 
(CG)n or (AT)n) repeats, resulting in a left-handed double-helical structure. 
Contrary to B-DNA, the purines within the Z-DNA region are reversed and 
positioned over the sugar in a syn conformation, while the pyrimidines remain in 
the anti conformation [reviewed in (22)]. In order to maintain normal Watson 
Crick base-pairing, the sugar pucker is altered from the C2- to the C3-endo 
position, resulting in the characteristic zigzag pattern of the sugar-phosphate 







Figure 4.1. DNA structures. (a) Watson-Crick double-stranded B-DNA. (b) Left-
handed Z-DNA structure shown the center of double-stranded B-DNA. Arrows 
indicate single-stranded B-Z junctions [a and b adapted from (256)]. (c) Van der 
Waals view of B-Z junction showing extruded base pair as determined by crystal 
structure [adapted from (340)].  
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Significant structural alterations to the DNA double helix occur in Z-DNA regions, 
including loss of the major groove and a more compact helix with 12 bp/turn 
compared to the 10.5 bp/turn of B-DNA (8,25). Additionally, the crystal structure 
of B-Z junctions revealed an extruded base pair, resulting in a small single-
stranded region at the junction (Fig. 4.1c) (18).  
Non-B DNA-forming sequences occur at high rates in the genome and are 
found in both prokaryotes as well as evolutionarily conserved across multiple 
species of eukaryotes (24). Thus, the biological function of such structures has 
been widely studied and evidence has shown that non-B DNA structures are 
likely involved in DNA metabolic processes, such as replication and transcription 
(11,32,60,123). Z-DNA-forming sequences map to transcription start sites, and it 
has been shown that this structure can play a role in regulation of gene 
expression (49,50,255,257). Non-B DNA-forming sequences can also contribute 
to genomic instability, which has been studied extensively in our laboratory; 
however, specific mechanisms have yet to be fully elucidated (see Chapters 1, 2, 
and 3 for more on the role of non-B DNA in mutagenesis and disease).  
Several non-B structures exhibit a number of similar characteristics (i.e. 
structural aspects, location, requirement for negative supercoiling, etc.); however, 
one feature unique to Z-DNA is the existence of several proteins that have been 
identified to contain Z-DNA-binding domains (ZBDs). These motifs have been 
shown to specifically recognize a left-handed, double-stranded helical structure 
via a winged-helix conformation. Z-DNA-binding proteins (ZBPs) have been 
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identified in viral (62-64), bacterial (66,67), yeast (68) and human cells 
(67,74,75,341), among others (69-74,342). ADAR1, found in humans, is among 
those ZBPs that is the most extensively studied, and is the focus of this chapter. 
Adenosine deaminase acting on RNA 1 (ADAR1), a member of the 
deaminase family, modifies viral and cellular double-stranded RNA (dsRNA), 
converting adenosine to inosine during A-to-I RNA editing (343-347) (Fig. 4.2a). 
During translation and RNA replication inosine is recognized as guanine and 
base pairs with cytosine instead of uracil in dsRNA, resulting in base substitution 
that can alter the sequence information and structure (348,349). Other proteins 
exist in the ADAR family (ADAR2 and ADAR3); however, ADAR1 is the only 
member to have ZBDs (Z-α and Z-β) (350).  
Separate promoters and alternative splicing of the ADAR1 gene give rise 
to two isoforms of ADAR1 (350-353) (Fig. 4.2b). The constitutively expressed 
ADAR1-p110 has a truncated N-terminus, and is found exclusively in the 
nucleus. Although ADAR1-p110 contains a single ZBD (Z-β), it only binds to 
dsRNA, as the Z-β domain alone is not sufficient to bind to Z-DNA. The full-
length protein, ADAR1-p150, is found in the mainly in the cytoplasm, is interferon 
(IFN) inducible, and contains both Z-α and Z-β ZBD; thus it binds dsRNA and Z-
DNA (352,354,355). The Z-α domain has been shown to specifically recognize 
the zigzag conformation and the syn conformation of the purine residues in Z-
DNA, when compared to similar sequences that do not adopt the Z-DNA 
structure (351,356). 
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The biological role for Z-DNA interaction with ADAR1 has not been clearly 
defined; however, one postulation is that Z-DNA formation is induced during 
transcription behind an active RNA polymerase, which subsequently binds 
ADAR1, and serves to localize the mRNA editing activity of ADAR1 to a specific 
region of the gene (25) (Fig. 4.2c). This interaction between Z-DNA and ADAR1 
may also allow editing to occur as the nascent mRNA is made before other 
modifications occur, as well as transiently preventing further transcription until 








Figure 4.2. Adenosine deaminase acting on RNA 1 (ADAR1). (a) ADAR1 
converts adenosine to inosine via a C6 hydrolytic deamination reaction [adapted 
from (357)]. Inosine will be recognized as guanine during translation, resulting in 
mutation. (b) ADAR1-p150 and p110 isoforms depicting organization of Z-DNA-
binding domains (Z-α and Z-β), dsRNA-binding domains (RI-RIII), and the 
deaminase catalytic domain. Arrowheads indicate amino acid residues that are 
important for catalytic function and numbers directly below each schematic 
represent amino acid position of each domain [adapted from (357)]. (c) Model for 
regulation of ADAR1 activity by Z-DNA as proposed by Alan Herbert and 
Alexander Rich in 1999 (25). Negative supercoiling that occurs behind a 
polymerase promotes formation of Z-DNA. ADAR1 binds Z-DNA, which activates 
editing of the nascent mRNA as the transcript forms [adapted from (25)]. 
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The existence of Z-DNA-binding proteins suggest a biological function for 
Z-DNA in several metabolic process. Importantly, sequences capable of forming 
Z-DNA are enriched at genomic “hotspots” that are prone to chromosomal 
breakage and translocations related to human disease 
(122,123,147,163,165,166,258). We, and others, have found that Z-DNA is 
mutagenic in bacteria, yeast, and mammalian cells, and results in the formation 
of DSBs (127,128,168); however the mechanism behind Z-DNA-induced 
mutagenesis has yet to be fully elucidated. Z-DNA-binding proteins, such as 
ADAR1 provide a useful tool to expand our knowledge of biological roles of Z-
DNA, both advantageous and deleterious.  
Here we stably integrated an expression vector that over-expresses a 
FLAG-tagged ADAR1-p150 isoform into mammalian COS-7 cells and detected a 
5.8-fold average increase in expression levels of ADAR1-p150 over endogenous 
levels. This stable cell line will be used for further studies to determine the role of 
the Z-DNA-binding protein, ADAR1-p150, in Z-DNA-induced genomic instability 





4.3. Materials and Methods 
 
4.3.1. Cell lines and plasmids. The pCMV-FLAG-ADAR1-p150 expression 
vector containing a FLAG-tagged ADAR1-p150 gene inserted in the multiple 
cloning site (MSC) between HindIII and XbaI in the parent plasmid pcDNA3 
(Invitrogen™, Life Technologies), resulting in over-expression of the p150 
isoform of FLAG-tagged ADAR1 was a gift from Dr. Qingde Wang at The 
University of Pittsburgh, PA (358). An empty vector with the same parental 
plasmid backbone (pcDNA3.1 (+/-)) as the ADAR1 over-expression vector 
(Invitrogen™, Life Technologies) was used as a control. Mammalian COS-7 
(ATCC) cells were used to make stable cell lines over-expressing ADAR1 and 
were maintained in maintained in Dulbecco’s Modified Eagle Medium (DMEM, 
Life Technologies, Carlsbad, CA) with 10% fetal bovine serum (FBS) and 400-
800 µg/mL G418Sulfate (Enzo Life Sciences, Farmingdale, NY). E. coli 
MBM7070 cells (F-lacZ (am)CA7020, lacY1, hsdR−, hsdM+, araD139 Δ(araABC-
leu)7679, galU, galK, rpsL, thi) (Lucigen, Middleton, WI) (316) were used for 
plasmid transformation. 
 
4.3.2. Verification of ADAR-p150 expression vector. The pCMV-FLAG-
ADAR1-p150 expression vector or pcDNA3.1 control vector were transformed 
into MBM7070 E. coli cells and a Qiagen HiSpeed Plasmid Maxi Kit was used to 
prepare large-scale amounts of the plasmid vectors. The pCMV-FLAG-ADAR1-
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p150 expression vector (250 ng) was digested with HindIII and XbaI to verify that 
the FLAG-tagged ADAR1 insert was present, and sent for direct DNA 
sequencing with primer (5’-CGT GTA CGG TGG GAG GTC TA-3’) to confirm the 
presence of the FLAG-tag. 
 
4.3.3. Development of stably integrated cell lines. A large-scale digest (8 µg 
plasmid DNA) was performed on the pCMV-FLAG-ADAR1-p150 and pcDNA3.1 
control vectors using AflIII to linearized the plasmids and release a 2-kb fragment 
containing the Ampicillin-resistance gene. Reactions were performed at 37°C 
overnight in 100 µL total volume, and linearized products were separated on a 
1% agarose gel. The 6-kb fragment containing the ADAR1-p150 gene and the 
3.5-kb fragment from the control plasmid were excised from the gel and purified 
using a Qiagen QIAquick Gel Extraction Kit. Ethanol precipitation was performed 
on isolated DNA in 100% ethanol at -20°C overnight. DNA was pelleted by 
centrifugation, washed with 70% ethanol, again pelleted by centrifugation, and 
resuspended in 10 µL sterile water. The linearized and purified DNA fragments 
were transfected into COS-7 cells by electroporation using a Nucleofector 
(Lonza, Walkersville, MD). Transfected cells were maintained in DMEM + 10% 
FBS without antibiotic selection for 5 days, followed by 800 µg/mL G418Sulfate 
treatment for Neomycin selection of cells containing incorporated plasmid DNA 
until single colonies were visible, then cells were maintained in DMEM + 10% 
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FBS with 400 µg/mL. Cells pellets were harvested for confirmation of ADAR1-
p150 over-expression vector by Western blotting. 
 
4.3.4. Western blotting. Cells were lysed in ice-cold RIPA buffer (50 mM Tris-
HCl (pH 7.5), 1 mM EDTA, 10 mM DTT, 0.1% Triton X-100 and CompleteTM 
proteinase inhibitor cocktail (PIC) (Roche)) for 30 min at 4°C with rotation, 
followed by sonication at 40 Amps for 5 repeats of 30 second sonication, 30 
second incubation on ice using an EpiSonic™ multi-functional bioprocessor 
(Epigentek, Farmingdale, NY). Samples were centrifuged at 4°C for 20 min at 
12,000 rpm, and the supernatant was collected for further analysis. A BCA assay 
was performed to determine protein concentrations of the lysates. Cell lysates 
(20-30 µg) were mixed with SDS gel-loading buffer and heated at 95°C for 10 
min, separated by gel electrophoresis on a 10% SDS-polyacrylamide gel, and 
transferred to nitrocellulose membranes (Bio-Rad Laboratories, Inc., Hercules, 
CA). Purified amino-terminal FLAG-BAP™ Fusion Protein was used as a control 
(20-80 ng) (Cat. Num. P7582; Sigma-Aldrich, St. Louis, MO). The blots were 
blocked for 1 hour at room temperature in TBST buffer [tris buffer saline (TBS)] 
containing 5% nonfat milk and 0.1% Tween 20). The blots were then incubated 
with diluted primary antibody for 1-2 hours at room temperature. Primary 
antibodies used in this study included rabbit anti-human PCNA antibody (Santa 
Cruz Biotechnology, Santa Cruz, CA), monoclonal ANTI-FLAG® M2, Clone, M2 
(Cat. Num. F1804; Sigma-Aldrich, St. Louis, MO), and ADAR purified MaxPab 
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mouse polyclonal anti-human antibody (Cat. Num. B01P; Abnova, Taipei, 
Taiwan). The blots were washed three times with TBST buffer for 5 min at room 
temperature, and once with TBS buffer for 5 min at room temperature. The blots 
were incubated for 1 hour at room temperature with horseradish peroxidase-
conjugated anti-rabbit IgG or mouse IgG secondary antibodies (Bio-Rad 
Laboratories, Hercules, CA). After three washes with TBST buffer for 10 min, and 
one wash with TBS buffer for 5 min at room temperature, bound secondary 
antibody was detected using Amersham ECL-Plus Western Blotting Detection 
Reagent (GE Healthcare Life Sciences). Blots were exposed to Kodak Biomax 
XAR film, and developed. ADAR1 expression was quantified and normalized to 
respective PCNA expression and ADAR1 expression in untreated cells using NIH 
ImageJ64 software. Western blotting was repeated four times. Significance was 





4.4.1. Development of a mammalian cell line with stably integrated pCMV-
ADAR1-p150 over-expression vector.  
 
Following the preparation of a large-scale quantity of the plasmid received 
from Dr. Qingde Wang, we verified the presence of the ADAR1-p150 insert by 
restriction digest with HindIII and XbaI to release the ADAR1-p150 fragment (Fig. 
4.3a, red lines). Products were separated on an agarose gel to verify fragment 
size (Fig. 4.3b). Verified pCMV-ADAR1-p150 and pcDNA3.1 control vectors were 
digested with AflIII to linearize and release the ampicillin-resistance gene (~2 kb-
fragment) (Fig. 4.3a, blue lines), and fragments were separated by gel 
electrophoresis (Fig. 4.3c). Remaining fragments of linearized DNA containing 
the FLAG-ADAR1-p150 gene (~7 kb) and control DNA (~3 kb) were isolated. 
Purified DNA fragments were transfected into mammalian COS-7 cells and 
selected for integration by neomycin-resistance with G418Sulfate for several 
weeks.  
Stable integration of the FLAG-ADAR1-p150 expression vector was 
verified by Western blotting. Our results revealed that untreated cells contained 
the same level of the ADAR1-p150 protein expression as the cells transfected 
with the control vector, while the cells transfected with the FLAG-ADAR1-p150 
expression vector resulted in over-expression of ADAR1-p150 protein (average 
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of 5.8-fold above untreated cells vs. 3.9-fold above pcDNA3.1 transfected cells) 
(Fig. 4.3d). We expected some variability between ADAR1-p150 measurements 
because it is not constitutively expressed; however we demonstrated a significant 
increase in ADAR1-p150 expression in the cells transfected with the FLAG-
ADAR-p150 vector (p<0.05 when comparing 5.8-fold vs. 3.9-fold, Student’s t-test) 
(Fig. 4.3d, lower panel). Because the ADAR antibody is polyclonal and able to 
detect the ADAR1-p110 isoform expression as well, we used this isoform 
expression level as a control to definitively confirm that only the Z-DNA-specific 
ADAR1-p150 isoform was over-expressed within our system. The ADAR1-p110 
isoform expression remained the same (1.24-fold above untreated cells vs. 1.12-
fold above pcDNA3.1 transfected cells (Fig. 4.3d, lower panel), confirming that 
we had developed a stably integrated system that specifically over-expressed the 
Z-DNA-binding protein, ADAR1-p150. Within the FLAG-ADAR1-p150 over-
expression cell line, there was a significant increase in the p150 isoform over 
p110, whereas no such increase was seen in the pcDNA3.1-transfected cells 






Figure 4.3. Verification and establishment of stable mammalian cell line 
over-expressing FLAG-ADAR1-p150. 
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Figure 4.3. Verification and establishment of stable mammalian cell line 
over-expressing FLAG-ADAR1-p150. (a) pCMV-FLAG-ADAR1-p150 
expression vector with the FLAG-ADAR1-p150 gene inserted between the HindIII 
and XbaI restriction sites (red lines). Blue lines indicate the location of the AflIII 
digest to linearize the plasmid, releasing a 2-kb fragment containing the AmpR 
gene for integration into mammalian COS-7 cells (modified from an Invitrogen 
plasmid map). (b) Confirmation of the correct FLAG-ADAR1-p150 insert following 
large-scale DNA preparation. Isolated DNA was digested with HindIII and XbaI 
restriction enzymes, resulting in two fragments; the insert (3.8 kb), and the 
backbone (5.5 kb). Undigested plasmid DNA (U) and a 1-kb marker (M) were 
included as controls. (c) pCMV-FLAG-ADAR1-p150 and pcDNA3.1 plasmids 
were linearized by restriction digestion with AflIII to release a 2-kb fragment 
containing the AmpR gene. Fragments were separated by gel electrophoresis 
(top panels), and the larger fragment was excised and isolated from the gel 
(bottom panels). (d) Stable integration of linearized pCMV-FLAG-ADAR1-p150 
expression vector into the COS-7 genome was verified by Western blotting using 
polyclonal ADAR antibody to detect ADAR1 expression. PCNA was used as a 
loading control, and untreated cells and cells transfected with the pcDNA3.1 
control vector were included as negative controls. Protein expression was 
normalized to PCNA expression, then to untreated cells. Shown is a 
representative blot of multiple repeats and average of four repeats below (* 




4.5. Discussion and Future Directions 
 
 We have developed a mammalian cell line in COS-7 cells that specifically 
over-expressed the ADAR1-p150 protein ~4.5-fold over untreated cells, and 
~4.9-fold over cells transfected with the control vector. While there are no 
commercially available antibodies that are specific to the ADAR1 p150 isoform, 
we have found a reliable antibody that can detect over-expression of the ADAR1-
p150 compared to untreated cells. Initially, having the FLAG-tag would have 
allowed the use of a FLAG antibody rather than a polyclonal ADAR antibody to 
detect over-expression; however, several attempts to use a FLAG antibody were 
unsuccessful. Thus, we determined that the ADAR polyclonal antibody was able 
to detect sufficient over-expression when compared to the expression level of the 
alternate non-Z-DNA-binding protein, ADAR1-p110.  
 
4.5.1. Immediate goals using the established cell lines described in this 
chapter.  
 
Coinciding with the main research interest of our laboratory focusing on 
the relationship between non-B DNA and genomic instability, we will use the cell 
lines established in this study to determine the mutagenic effect of Z-DNA-
forming and control plasmids in untreated, pcDNA3.1 control, and FLAG-ADAR1-
p150 over-expressing cells lines. We will transfect Z-DNA-forming and control 
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mutation-reporter plasmids into these cell lines and perform mutagenesis assays 
including mutation frequency and spectra assays as described in Chapters 2 and 
3 and previously (262). Whether or not we detect a difference in Z-DNA-induced 
mutagenesis with and without over-expression of ADAR1-p150 will be interesting 
and provide information as to the potential role of Z-DNA-binding proteins in 
genomic stability. Our prediction is that ADAR1-p150 will bind Z-DNA and 
stabilize this mutagenic structure, and will therefore lead to an increase in Z-
DNA-induced mutagenesis. 
 
4.5.2. Long-term goals using the established cell lines described in this 
chapter.  
 
If results from the mutagenesis assays suggest a role for ADAR1-p150 in 
Z-DNA-induced genomic instability, we would also perform Chromatin 
Immunoprecipitation (ChIP) assays to further confirm association of ADAR1-p150 
at the Z-DNA-forming region. We will use purified ADAR1-p150 protein with 
control and Z-DNA-forming plasmids to perform electrophoretic mobility shift 
assays (EMSA) and confirm binding as well. We will further explore ADAR1-p150 
in DNA repair deficient cells (such as those described in Chapters 2 and 3), as 
well as how this protein effects Z-DNA-induced mutagenesis in the presence of 
exogenous DNA damaging agents, such as UV irradiation. We will also 
transiently deplete ADAR1-p150 by siRNA knock-down in COS-7 cells and 
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perform mutagenesis assays as described above with control and Z-DNA-
forming mutation-reporter plasmids to further characterize the role of ADAR1-
p150 in Z-DNA-induced mutagenesis. If ADAR1 does not effect Z-DNA-induced 
mutagenesis, then we can explore other known ZBPs, such as the tumor-
associated protein, DLM-1 [also known as Z-DNA-binding protein 1 (ZBP1)] or 
























5.1. Future Directions 
 
Here, we have demonstrated that repair proteins from NER and MMR 
pathways are involved in Z-DNA and H-DNA-induced mutagenesis in yeast and 
human cells. Thus far, proteins from both pathways were found to be involved in 
Z-DNA-induced mutagenesis, while H-DNA-related mutations required several 
proteins from the NER pathway, suggesting that functional NER was required 
rather than an interaction among proteins from the two repair mechanisms. The 
mechanism(s) responsible for genomic instability caused by non-B DNA 
structures is clearly complex and many more genes are likely to be involved in 
breakage, repair and mutagenesis as a network in human cells, similar to that 
described in prokaryotes (334). Further studies to identify candidate genes and 
more concisely determine mechanistic steps are warranted, as it will provide 
critical information for understanding the mechanisms of DNA structure-induced 
genetic instability in human disease. These studies are outlined below. 
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5.2. Immediate Goals 
 
5.2.1. Determine the extent to which the Z-DNA-binding protein, ADAR1 
has an effect on Z-DNA-mutagenesis. 
 
We have developed a stably transfected mammalian cell line that over-
expresses the Z-DNA-binding protein (ZBP), ADAR1 (see Chapter 4). We will 
perform mutagenesis and mutation spectra analyses similar to those discussed 
in Chapter 2 using Z-DNA-forming and B-DNA-forming control plasmids in these 
cells to determine if the induction we see in WT cells is effected by ADAR1. We 
predict that ADAR1 will bind to and stabilize Z-DNA, resulting in an increased 
mutation frequency compared to cells containing endogenous levels of ADAR1; 
however, the binding of ADAR1 could possibly prevent binding and processing of 
repair proteins, which may decrease mutations near the Z-DNA site. Conversely, 
we will deplete ADAR1 to further determine the effect of ADAR1 on Z-DNA-
induced mutagenesis. As discussed in detail in Chapter 4, we will also perform 
ChIP and/or gel mobility-shift assays to demonstrate binding of ADAR1 to our Z-
DNA-forming plasmid. Additionally, we could test other ZBPs, such as DAI. The 
results we obtain from these assays will provide important knowledge in the role 




5.2.2. Further characterize the relationship between repair proteins found 
to be involved in Z-DNA-induced mutagenesis. 
 
We have demonstrated that the MMR and NER repair proteins MSH2-
MSH3 and (Rad10-Rad1)ERCC1-XPF, respectively, are involved in Z-DNA-
induced mutagenesis in yeast and human cells. We will further characterize this 
relationship that appears to function outside of their canonical roles in the NER 
and MMR pathways, as other components of these pathways did not 
demonstrate an effect on Z-DNA-induced mutagenesis in our assays. As 
discussed in Chapter 2, MSH2-MSH3 and (Rad10-Rad1)ERCC1-XPF have 
previously been shown to interact in yeast and human cells (280-298), and it was 
found that a region of ERCC1 that partially overlapped with XPF-binding domain 
was required for interaction with MSH2 (296). We will determine if this region of 
ERCC1 is also involved in the interaction we found between MSH2-MSH3 and 
ERCC1-XPF by using similar truncated ERCC1 proteins and co-
immunoprecipitation or ChIP assays in human cell lines, such as those used in 
the studies presented in Chapter 2. Additionally, we could test truncated MSH2, 
MSH3, or XPF as it not known which components of the complexes are involved 
in the interaction. We can perform these experiments in the presence or absence 
of Z-DNA-forming or control, non-B DNA-forming plasmids to confirm the 
interaction is specific to Z-DNA. 
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5.2.3. Double-knock out experiments in yeast and/or human cells. 
 
Since multiple proteins from within the same or different pathways are 
involved in Z-DNA-induced mutagenesis, testing one gene at a time may not fully 
reflect the effect of a protein on mutagenic processing of Z-DNA. Thus, we could 
first construct yeast knockout strains [using previously described methods (359)] 
that are deficient in two or more genes and perform the experiments described in 
Chapter 2 to more fully determine the function of those genes in processing Z-
DNA. Examples include rad1Δ msh2Δ, rad10Δ msh2Δ, and rad1Δ msh3Δ double 
knockouts. If warranted, we could also perform mutagenesis assays in human 
cells that are deficient in both XPF and MSH2 by transiently depleting MSH2 in 
XPF-deficient cells lines, to determine if there is an even greater effect on Z-
DNA-induced mutagenesis than either single deficiency alone. We could follow 
up these experiments, by performing ChIP assays to determine if other proteins 
may be enriched at the Z-DNA-forming site in the absence of XPF and MSH2. 
Additionally, we could repeat biochemical experiments described in Chapter 2 to 





5.2.4. Determine the extent to which longer repeats capable of forming 
multiple non-B DNA structures effect mutagenesis in yeast. 
 
The yeast experiments described in this document use short mirror-repeat 
or (CG)14 repeat sequences that are capable of forming H-DNA or Z-DNA, 
respectively; however, in humans, non-B DNA-forming sequences are often 
much longer, and may contain sequences capable of forming more than one type 
of non-B DNA structures. We have a longer non-B-DNA insert, as well as a 
longer (~500 bp) control insert on a YAC that we will also use to screen repair-
deficient mutants as described in Chapters 2 and 3. We found that different 
mechanisms appear to be involved in mutagenesis caused by H-DNA or Z-DNA 
in yeast; thus, it would be particularly interesting to see which gene products are 
found to be important in mutagenesis stimulated by this longer insert that is 
capable of forming multiple structures. In this way, these studies would not be 
specific to H-DNA or Z-DNA because the long insert is capable of forming 
multiple non-B DNA structures, but they would serve as a general non-B DNA-
induced mutagenesis assay in yeast cells. Ongoing studies in the lab are aimed 
at determining which structure might form in an overlapping sequence that is 
capable of forming multiple structures under various conditions (i.e., a sequence 
that can form H-DNA as well as G4 DNA). We are studying what, if any, effect 
the formation of one structure might have over the formation of the other, and 
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whether the likelihood of one structure to form over another has implications on 
genomic instability. 
 
5.2.5. Identify additional genes involved in stimulation or inhibition of non-
B DNA-induced mutagenesis. 
 
In the studies described in Chapters 2 and 3, we identified important 
components of Z-DNA and H-DNA-induced mutagenesis. However, it is clear 
that this mechanism is complex and there other components are likely to be 
involved, e.g. other structure-specific nucleases. The yeast knockout library we 
have will allow us to screen many more gene products for involvement in non-B 
DNA-induced mutagenesis in an unbiased fashion. Our previous results 
suggested that H-DNA and Z-DNA-induced mutagenesis in humans may be due 
to non-homologous end-joining (NHEJ) or micro homology-mediated end-joining 
(MMEJ) mechanisms (125,127,171); therefore we will screen yeast strains 
deficient in major components of these mechanisms, including Dnl4 and Lif1 
(yeast homologues to human DNA ligase IV and XRCC4, respectively), which 
are responsible for the ligation step in end-joining, to determine if these gene 
products also play a role in non-B DNA-induced mutagenesis. 
Moreover, DNA helicases, such as BLM, WRN, DHX9, and FANCJ have 
been implicated in maintaining genomic integrity (360-363), and human diseases 
caused by deficiencies in these enzymes are characterized by genomic instability 
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and increased susceptibility to cancers (364,365). We, and others, have 
demonstrated the ability of these helicases to unwind non-B DNA structures 
(131,172,366-370). For example, we found that human DHX9 recognizes and 
binds to H-DNA, and protects against H-DNA-induced mutagenesis, suggesting 
the helicase unwinds H-DNA to protect genomic integrity (172). Therefore, it is 
likely that helicases may also unwind other non-B DNA structures, such as Z-
DNA, and we will test this hypothesis by performing mutagenesis and in vitro 
binding assays described in Chapters 2 and 3, using a Z-DNA-forming and 
control plasmid in DHX9-defective human cells, similar to the studies performed 
with H-DNA (172). If warranted, we will test other helicases for possible activity to 
process Z-DNA. These studies would provide additional valuable information on 
how cells counteract the potential genetic instability brought on by the formation 
of non-B DNA structures, and if this counteraction is structure-specific. 
 Similarly, topoisomerases may have a destabilizing effect on Z-DNA. 
Topoisomerase I and II can alleviate the stress that negative supercoiling exerts 
on DNA by cleaving one or both strands, unwinding, and re-annealing the cut 
strands [reviewed in (371)]. The level of Z-DNA formation has been shown to 
correlate with the level of supercoiling in vivo and that the amount of Z-DNA 
formation was increased in a topoisomerase I mutant (372). Additionally, clusters 
of binding sites for topoisomerase II have been found in the Human 
Immunodeficiency Virus (HIV) integration region, which contain Z-DNA motifs, 
and cleavage activity of the enzyme was shown to occur at a Z-DNA-forming 
 186 
region in the human beta-globin gene, which is a known hotspot for 
recombination and mutation in vivo, and the cleavage activity was found to be 
proportional to the length of the repeat (373). Thus, it is possible that 
topoisomerases participate in the “repair” mechanism of non-B DNA structures, 
particularly Z-DNA, causing DSBs and genomic instability related to 
translocations and human disease. We will first use our genomic yeast-based 
assay described in Chapters 2 and 3, to screen yeast strains deficient in 
topoisomerases I and II for an effect on H-DNA and Z-DNA-induced 
mutagenesis. We will follow up these studies in human cells using transient 
knockdown of these enzymes and H-DNA and Z-DNA-forming plasmids. 
Additionally, we could use viably active purified topoisomerases, to perform in 





5.3. Ongoing Studies 
 
5.3.1. Effect of modifications to non-B DNA structures on genomic 
instability. 
 
H-DNA-forming and Z-DNA-forming sequences can comprise of guanine 
and/or cytosine-rich repeats and several of our (and others) studies implicate that 
the structure, rather than the sequence is mutagenic. Thus, it is of interest to 
determine if alterations made to the sequence and/or structure have an impact 
on the mutagenic capacity of non-B DNA structures. For example, Z-DNA (374-
376), and triplex (e.g. H-DNA) (377,378) formation can be stabilized by 
methylation of cytosine residues at the C5 position, which is very common in the 
human genome, particularly at CpG repeats in promoter regions (23). Therefore, 
this modification may provide further information on the influence of non-B DNA 
structures on gene expression. Preliminary data from our laboratory have shown 
that fully methylated Z-DNA-forming, CG repeats increase mutation frequency, 
replication fork stalling, and alterations in chromatin structure at the methylated 
Z-DNA regions (which is refractory to nucleosome assembly) in human cells 
(unpublished data), further suggesting that this modification can stabilize Z-DNA 
and enhance its mutagenic capabilities.  
Additionally, alteration of guanine residues via oxidative damage, resulting 
from reactive oxygen species, can lead to strand breaks and genomic instability 
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(379). H-DNA-forming and Z-DNA-forming sequences are often guanine-rich, 
and thus may accumulate high levels of damage in this form at these sites within 
the cell, and it is of interest to determine if this base alteration effects non-B DNA 
structures in vivo. In theory, certain guanine residues within the H-DNA 
conformation may be protected against oxidative damage, as bases are stacked 
within the triple helix, while those guanine residues in the single-stranded loop 
may be more susceptible to damage as they are less protected than in a duplex 
(20,28,29). Moreover, the bases in Z-DNA reside facing the outside of the helix 
due to the syn conformation of the guanine residues and are less protected than 
bases in B-DNA, which are focused in the center of the helix (8,25). Thus we will 
determine if H-DNA-forming and Z-DNA-forming sequences are more susceptible 
to DNA damage induced by hydroxyl radicals and how these lesions affect non-B 
DNA-induced mutagenesis in mammalian cells. Preliminary data has shown an 
increase in mutation frequency with H-DNA that has been treated with hydroxyl 
radicals, suggesting an additive effect to the pre-determined mutagenic potential 
of H-DNA (125), whereby a damaged H-DNA-forming sequence further 
stimulates cellular repair processes to excise the damaged sequence, or damage 
within the non-B region is more resistant to repair (i.e., glycosylases that are 
responsible for removing bases damaged by oxidation, have diminished access 
for repair), leading to accumulation of damage. We will continue these studies 
using Z-DNA-forming sequences as well. 
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5.3.2. Determine the effects of non-B DNA structures on metabolism, 
nutrition, and aging, using an in vivo mouse model. 
 
Obesity has become an alarming epidemic in the United States (and 
world-wide). It is estimated that 1/3 of adults and nearly 15% of children age 2-9 
years have a body mass index (BMI) of >30 kg/m2, placing them in the obese 
category (380). It is particularly alarming due to the connection of obesity to 
several chronic illnesses, such as cancers, including leukemias and lymphomas 
(381). Obesity has been shown to increase the risk cancer development and 
mortality rate (382-384), with nearly 20% of all cancer deaths in the United States 
attributed to overweight/obese body types (385,386). Consequently, 
understanding the relationship between obesity and cancer is an important step 
in cancer prevention. Interestingly, H-DNA-forming and Z-DNA-forming 
sequences have also been found at mutational “hotspots” related to leukemias 
and lymphomas (46,132,142,147,160,161,163,183,184,186-189,387). 
Additionally, mitochondrial DNA, which plays a crucial role in energy metabolism, 
has been shown to contain several non-B DNA-forming sequences, which have 
been implicated in mitochondrial deletion breakpoints [(388) and references 
therein]. Furthermore, diet has been shown to alter activity of the NHEJ repair 
pathway (389,390), and our previous results have implicated NHEJ in non-B 
DNA-induced mutagenesis in human cells (171,254). Therefore, there are 
several links between non-B DNA structures, obesity, and cancer, and we aim to 
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elucidate the underlying mechanisms contributing to these links.  
Our laboratory, in collaboration with the laboratory of Dr. John DiGiovanni 
(Professor in the Division of Pharmacology and Toxicology at UT Austin), has 
developed a non-B DNA mouse model with stably integrated H-DNA-forming and 
Z-DNA-forming sequences upstream of a mutation-reporter gene integrated on 
mouse chromosomes, and shown that these integrations are mutagenic (128). 
We will use this mouse model to determine the effect of obesity on the mutagenic 
potential of non-B DNA, by feeding the mice high-fat (obese), normal, and 
calorie-restricted diets, and determining the non-B DNA-induced mutagenesis as 
previously described (128). We will also determine tissue-specific effects by 
examining various tissues in the mice, following treatment of the various diets. In 
this manner, the effects of obesity on genomic instability can be determined in 
vivo. Our hypothesis is that a high-fat diet, consistent with obesity and increased 
reactive oxygen species, will increase non-B DNA-induced genomic instability, 
while a calorie-restricted diet, may be protective against genomic instability. 
These studies are currently being conducted, and once completed will provide 
insights into the link between obesity and cancer etiology. 
The incidence of cancer increases in an age-related fashion (391-393); as 
the aging process occurs, mutations (genetic instability) accumulate, increasing 
the prevalence for disease (394-398). The number of mutations in tumor cells 
has even been shown to dramatically increase with age (396). Increased age has 
also been shown to be associated with less efficient DNA repair (399-406). 
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Therefore, there is also evidence to suggest a link between genetic instability and 
age as a risk factor for cancer. While we have shown that H-DNA-forming and Z-
DNA-forming sequences were mutagenic in the transgenic mouse model 
described above (128), these studies were performed in young mice (2-month 
old), and age was not a factor in our results. We will repeat the mutation-reporter 
mutagenesis studies using our mouse model, which contains integrated non-B 
DNA-forming sequences, as they age and determine what, if any, age has an 
effect on the level of non-B DNA-related genomic instability, and use PCR to 
identify sites of deletions and breaks in and around the non-B DNA-forming 
region. We will also determine if the effects are tissue dependent, as we will 
examine mutagenesis in various tissue types. Other studies have demonstrated 
that genetic instabilities related to hairpins, which form at triplet repeats and are 
associated with neurological disorders, have both an age and tissue-specific 
component (407,408). Thus, we predict that mutations will increase with age as a 
result of accumulation of damage to the DNA, and it will be interesting to 
determine the effect on non-B DNA-induced mutagenesis. These studies will 






5.4. Long-term Goals 
 
5.4.1. Continue to investigate non-B DNA-induced mutagenesis in a 
chromosomal context and using an in vivo mouse model. 
 
While the studies presented here in Chapters 2 and 3 provide convincing 
evidence for the requirement of repair proteins in the mechanism responsible for 
non-B DNA-induced genomic instability, they are largely based on results 
obtained using plasmid mutation-reporter assays in human cells. However, to 
more fully mimic the mechanism of non-B DNA-stimulated mutagenesis in the 
context of chromatin, we will stably transfect Z-DNA-forming and H-DNA-forming 
sequences into human cell lines used in the studies described in Chapters 2 and 
3, including wild-type and repair-deficient cell lines (i.e., XPF- and MSH2-
deficient cells lines with Z-DNA-forming sequences). Regions containing non-B 
DNA inserts will be recovered as a mutation-reporter shuttle vector and subjected 
to blue/white screening as previously described (262) to determine mutation 
frequencies and spectra. Our hypothesis is that results from the chromosomally 
integrated non-B DNA-forming sequences will be similar to our plasmid-based 
assays, as we have already shown that these sequences are mutagenic in a 
chromosomal context in an in vivo mouse model (128), and on chromosomes in 
human cells (129).  
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Furthermore, we will continue our in vivo studies using our novel H-DNA 
and Z-DNA mutation-reporter mice (128) and will cross them with NER- or MMR-
deficient mice to confirm our findings in an in vivo, mammalian model. These 
studies will be particularly useful in determining tissue-specific effects of non-B 
DNA mutagenesis, as we will test various tissues from the mouse model for 
levels of genomic instability related to Z-DNA and H-DNA in wild-type and repair-
deficient mice. For example, as Z-DNA-forming and H-DNA-forming sequences 
map to breakpoints in leukemias and lymphomas, we can examine lymphocytes 
to determine if deletions/DSBs/translocations are more prevalent in these cells 
versus others. These studies will provide valuable information as to the 
involvement of repair proteins in non-B DNA-induced genomic instability in a 
physiologically relevant context. 
 
5.4.2. Non-B DNA and disease-related therapeutics 
 
The studies presented in Chapters 2 and 3 along with our previous studies 
(see Table 1.1) have clearly demonstrated that sequences with the capacity to 
form Z-DNA and H-DNA (and other non-B DNA structures) are mutagenic in 
multiple species, and that these sequences map to translocation breakpoint 
hotspots related to human disease, including cancers. We have begun to 
elucidate the mechanisms involved at the molecular level, and demonstrated that 
repair proteins from several pathways are involved. However, the importance of 
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acquiring such knowledge in the field of genomic instability is to ultimately design 
potential therapies to prevent diseases related to genetic instability, and/or to use 
our knowledge of how non-B DNA structures induce mutations to invoke genetic 
instability in cancer cells for targeted oncogenic therapeutics, that avoid the side 
effects of conventional chemotherapy on healthy cells. For example, the 
identification of non-B DNA ‘destabilizing’ compounds (as outlined in section 
5.2.5.), or specific domains of non-B DNA-binding repair proteins, could be used 
to design mutant repair proteins, in which domains required for repair function 
remain active, while the domain required to recognize non-B DNA structures is 
defective, preventing error-prone processing of such structures, thus decreasing 
non-B DNA-induced mutagenesis in normal cells.  
Alternatively, identification of non-B DNA ‘stabilizing’ compounds may be 
used to increase genomic instability and apoptosis in cancer cells using targeting 
gene therapy. As non-B DNA-forming sequences map to promoter regions, 
stabilizing compounds could be used to increase gene expression of tumor 
suppressor genes, such as p53 [one of the most prevalent abnormalities in 
human cancers (409-411)], by stabilizing Z-DNA (for example) in promoter 
regions to increase cell death in cancerous tumors. For example, if the human Z-
DNA-binding protein, ADAR1, is found to have an effect on Z-DNA-induced 
mutagenesis in the studies proposed here (in section 5.2.1. and Chapter 4), 
targeted overexpression of this protein in cancer cells will increase instability in 
the cancer genome, potentially resulting in cell death.  
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Evidence has linked Z-DNA regulation of gene expression to cancer. For 
example, ADAM-12 is a multifunctional protein that is over-expressed in many 
cancers, and found to be required for progressive tumor progression and 
metastasis (412-420). MeCP2 is required for ADAM-12 suppression by 
interacting with a Z-DNA-forming negative regulatory element (NRE) in the 
promoter region of ADAM-12, and deficiency of MeCP2 in breast cancer cells 
resulted in overexpression of ADAM-12 leading to cell proliferation and 
metastasis (421). Identifying a compound that mimics MeCP2, by binding at the 
Z-DNA-related NRE, could serve as a potential targeted therapy for this type of 
breast cancer. Similar studies have been performed in various models relating to 
another non-B DNA structure, G4 DNA, which is found to be enriched at 
telomeres. In cancer cells, telomeres are maintained at indefinite length, and thus 
pose a potential therapeutic target. The G4 DNA structure and potential 
therapeutic mechanisms to modulate gene expression (including telomerase, c-
MYC, vascular endothelial growth factor (VEGF), and other genes implicated in 
cancer etiology) as a cancer therapy has been demonstrated in several studies 
[(217,422-425) and extensively reviewed in (426)], establishing great promise 
and potential for non-B DNA structures as an avenue for direct and more 





5.5. Summary and Significance 
 
Since the discovery of the canonical B-DNA double-helix more than 60 
years ago by Watson and Crick (1), decades of research has been devoted to 
studying the structure of DNA, and several alternative DNA structures, 
collectively termed “non-B DNA”, have been identified and described (10-12). 
Non-B DNA structures, including Z-DNA (8,18) and H-DNA (19-21) (Fig. 1.2), do 
not conform to the Watson-Crick right-handed B-DNA, but rather result in 
significant alterations to the B-DNA double helix. For example, H-DNA is an intra-
molecular triple helix structure in which three strands of DNA interact (28,29), 
and Z-DNA is a left-handed, double helical structure (8,25). Non-B DNA 
structures form at specific repetitive sequences, which are highly abundant in the 
human genome, and the distribution of non-B DNA-forming sequences co-
localizes with promoter regions (22,23,40,80,81). H-DNA and Z-DNA have been 
implicated in the regulation of several DNA metabolic processes, including gene 
expression, and replication (41,42,49,50,82-86). Alternatively, H-DNA-forming 
and Z-DNA-forming sequences also map to regions prone to genomic instability 
related to human diseases, including genes involved in leukemias and 
lymphomas (84,147,160,177,179,186,207,269,285,289,378,387,424).  
Prior to obtaining the results presented in this document, our laboratory 
demonstrated that Z-DNA-forming and H-DNA-forming sequences are mutagenic 
and can stimulate the formation of DSBs in various model systems (from bacteria 
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to human), and that these sequences map to translocation and deletion hotspots 
in human cancer genomes (Figs. 2.3 and 3.2), implicating non-B DNA structures 
in cancer etiology (Table 1.1 and references therein). However, the underlying 
mechanism(s) for Z-DNA and H-DNA-induced mutagenesis were unknown, and 
the goal of the studies presented in this document were to elucidate such 
mechanisms. We speculated that distortions induced in the canonical B-DNA 
helix by the formation of H-DNA and Z-DNA may be recognized as “DNA 
damage” by DNA repair recognition proteins, and evidence from our laboratory 
suggest that non-B DNA may serve as substrates for nucleotide excision repair 
(NER) and/or mismatch repair (MMR) pathways 
(120,126,130,231,252,253,324,427). Taken together, the evidence implicating 
NER and MMR proteins in non-B DNA-induced mutagenesis, we hypothesized 
that the helical distortions induced by non-B DNA are recognized as 
“damage” and processed by DNA repair machinery via an error-generating 
mechanism resulting in genomic instability. We proposed three specific aims 
to address this hypothesis: 
Specific Aim 1 - Determine the extent to which NER and MMR proteins impact 
H-DNA structure-induced mutagenesis in eukaryotes. 
Specific Aim 2 - Determine the extent to which NER and MMR proteins impact 
Z-DNA structure-induced mutagenesis in eukaryotes. 




 In Specific Aims 1 and 3 (addressed in Chapter 3), we investigated the 
mechanism(s) responsible for genomic instability caused by H-DNA. Using a 
yeast artificial chromosome (YAC), we demonstrated for the first time that a 
naturally occurring, H-DNA-forming sequence is mutagenic in wild-type 
Saccharomyces cerevisiae cells when compared to a control sequence, and that 
H-DNA induced DSBs on the YAC (Fig. 3.3b and c), consistent with our findings 
of H-DNA-induced DSBs and genetic instability in mammalian cells and mice 
(125,128). Using a yeast deletion library, we screened repair-deficient cells and 
found that H-DNA-induced mutagenesis was suppressed in yeast cells deficient 
in Rad10(ERCC1) and Rad1(XPF) (Fig. 3.3b).  
Using plasmid-based mutation-reporter assays in human cells, we 
confirmed our results in yeast, demonstrating that H-DNA-induced mutagenesis 
was suppressed in human cells deficient in the NER nucleases, ERCC1-XPF and 
XPG; and in contrast, H-DNA-induced genetic instability was stimulated in cells 
deficient in FEN1, a replication-related endonuclease (Figs. 3.4 and 3.7; and 
Table 3.2), providing evidence for replication-dependent and replication-
independent models of H-DNA-induced genetic instability in eukaryotes. Using 
ligation-mediated PCR, we demonstrated that DSBs were formed near the H-
DNA-forming site in wild-type human cells, which were absent in human XPF-
deficient cells (Fig. 3.5a). Using an H-DNA-forming oligonucleotide, we identified 
the structure as a novel substrate for cleavage by ERCC1-XPF, XPG, and FEN1 
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(Fig. 3.5 and 3.7) and determined that these proteins function in distinct 
replication-independent and replication-dependent pathways of genetic instability 
(Fig. 3.9). Thus, we propose a model for H-DNA-induced mutagenesis whereby 
NER proteins recognize and process H-DNA, leading to DSBs in the absence of 
replication, while FEN1 cleavage of H-DNA can result in error-free processing 
during replication. However, in the absence of FEN1, the H-DNA structure may 
persist at a replication fork, causing fork collapse, which could result in DSBs and 
subsequent deletions (Fig. 3.10). 
 In Specific Aims 2 and 3 (addressed in Chapter 2), we investigated the 
mechanism(s) responsible for Z-DNA-induced mutagenesis in yeast and human 
cells. Using similar assays to the H-DNA studies, we used a YAC containing a Z-
DNA-forming or B-DNA-forming control sequence (Fig. 2.6) to screen a yeast 
strains deficient in DNA repair proteins. We demonstrated for the first time that a 
Z-DNA-forming sequence is mutagenic in wild-type S. cerevisiae cells when 
compared to a control sequence (Fig. 2.7). Interestingly, we found that in yeast 
strains deficient in NER and MMR protein complexes [Rad10-Rad1 (XPF-
ERCC1), and Msh2-Msh3, respectively], Z-DNA-induced mutagenesis was 
significantly decreased (Figs. 2.9 and 2.10; and Table 2.3), implicating these 
proteins in non-B DNA-induced genomic instability. Additionally, we 
demonstrated that in wild-type strains, DSBs in the Z-DNA-forming YAC were 
higher than in the B-DNA-forming control YAC, which were decreased in Rad10, 
Rad1, Msh2, or Msh3-deficient strains (Fig. 2.13).  
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Again, we confirmed our yeast results using a plasmid-based mutation-
reporter assay in wild-type and repair-deficient human cells. The results in 
human cells validated the yeast data; the increase in mutations due to the Z-
DNA-forming plasmid in wild-type cells was abrogated in cells deficient in XPF or 
MSH2 (Fig. 2.18). Using chromatin immunoprecipitation (ChIP) assays, we 
demonstrated that ERCC1-XPF and MSH2-MSH3 complexes were significantly 
enriched at Z-DNA-forming sequences relative to B-DNA-forming sequences, 
and that ERCC1-XPF recruitment was dependent on MSH2-MSH3 (Fig. 2.19). 
Furthermore, using an in vitro primer extension assay, we found that ERCC1-
XPF cleaved DNA near the Z-DNA-forming site in human whole cell extracts (Fig. 
2.22). We propose a novel relationship in which these NER and MMR complexes 
(acting outside of their canonical repair functions) recognize and attempt to repair 
Z-DNA in eukaryotic genomes, potentially resulting in error-prone processing 
causing DSBs (Fig. 2.23). Thus, our results implicate Z-DNA in cancer etiology. 
The results obtained with Z-DNA are in contrast to the H-DNA studies, 
which suggested that proteins from a single pathway, NER, are involved in H-
DNA-induced mutagenesis, rather than certain components from both NER and 
MMR, as seems to be the case for Z-DNA-induced mutagenesis. This is not 
particularly surprising, as the structures of H-DNA and Z-DNA are inherently 
different, thus it is likely that different mechanisms may be required for 
mutagenesis caused by the two structures. Furthermore, the H-DNA structure 
(Fig. 3.1b) more closely resembles bulky adducts that are recognized by NER 
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factors, while the B-Z junctions in Z-DNA (Fig. 2.1b) resemble the small loops 
recognized by MMR factors, yet the significant helical distortions caused by the 
left-handed conformation of Z-DNA may stimulate processing by NER factors, 
and thus it is conceivable that factors from both mechanisms are involved in Z-
DNA recognition and processing. 
Several significant findings were established in the studies presented 
here. First, we have shown for the first time that H-DNA and Z-DNA are 
mutagenic in a new model organism, S. cerevisiae, further implicating the 
evolutionary importance of non-B DNA structures, as they function across 
multiple species. We have presented evidence to support an intra-molecular H-
DNA structure as a novel substrate for the ERCC1-XPF, XPF, and FEN1 
structure-specific nucleases, and that ERCC1-XPF can cleave near a Z-DNA-
forming sequence. We have identified specific components of DNA repair 
pathways to function in non-B DNA-induced mechanisms in distinct, structure-
specific pathways, which present novel substrates for NER and MMR proteins. 
We propose the first descriptions of non-B DNA-induced mutagenesis that are 
consistent across multiple species of eukaryotes, including a unique relationship 
and crosstalk between DNA repair complexes from the NER and MMR pathways 
required for Z-DNA-induced mutagenesis, and replication-independent and 
replication-dependent pathways involved in H-DNA-induced mutagenesis. These 
mechanisms provide insight to an error-generating mechanism by which non-B 
DNA structures are recognized as “damage” by various repair factors, and are 
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processed in a manner that potentially leads to DSBs, which may be responsible 
for naturally-occurring, endogenous mutation “hotspots” in human cancer.  
This work clearly advances our understanding of the physiologically 
relevant connection of non-B DNA-forming sequences with translocation 
“hotspots” in human cancers such as Burkitt’s lymphoma and leukemias. Our 
findings implicate non-B DNA-forming sequences as an endogenous contributor 
to human disease and cancer etiology, and a better understanding of the 
mechanisms involved will allow for advancement in targeted therapeutics to 
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